N-CSR 1 tm2219785d1_ncsr.htm N-CSR

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM N-CSR

 

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

 

Investment Company Act file number: 811-06292

 

 

 

UBS Investment Trust 

 

(Exact name of registrant as specified in charter)

 

787 Seventh Avenue, New York, New York 10019

 

(Address of principal executive offices) (Zip code)

 

Keith A. Weller, Esq.

UBS Asset Management

One North Wacker Drive

Chicago, IL 60606

(Name and address of agent for service)
 
Copy to:

Stephen H. Bier, Esq.

Dechert LLP

1095 Avenue of the Americas

New York, NY 10036-6797

  

Registrant’s telephone number, including area code: 888-793-8637

 

Date of fiscal year end: August 31

 

Date of reporting period: August 31, 2022

 

 

 

 

 

 

Item 1. Reports to Stockholders. 

 

(a)Copy of the report transmitted to shareholders:

 

 

 

UBS U.S. Allocation Fund

Annual Report | August 31, 2022


UBS U.S. Allocation Fund

October 14, 2022

Dear shareholder,

We present you with the annual report for UBS U.S. Allocation Fund (the "Fund") for the 12 months ended August 31, 2022.

Performance

Over the 12 months ended August 31, 2022, the Fund's Class A shares returned -11.69% before deducting the maximum sales charge and returned -16.55% after deducting the maximum sales charge. During the same period, the Fund's primary benchmark, the S&P 500 Index,1 which tracks large cap US equities, returned -11.23%. Since the Fund invests in both stocks and bonds, we believe it is appropriate to also compare its performance to the UBS U.S. Allocation Fund Benchmark (the Fund's secondary benchmark),2 which returned -12.37% during the period. (Returns for all share classes over various time periods and descriptions of the indices are shown in "Performance at a glance" on page 6; please note that the returns shown do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or on the redemption of Fund shares.)

Market commentary

Q. How would you describe the economic environment during the reporting period?

A. The US economy moved in fits and starts, as it was impacted by COVID-19 and its variants, 40-year high inflation, supply chain shortages, rising interest rates and the repercussions from the war in Ukraine. These headwinds were at times offset by continued fiscal spending, robust job growth and overall solid consumer spending. Looking back, third quarter 2021 US annualized gross domestic product ("GDP") was 2.3%. The economy then expanded 6.9% over the fourth quarter of the year. GDP then contracted 1.6% over the first quarter of 2022. Finally, the Commerce Department reported that second quarter annualized GDP was -0.6%.

The US Federal Reserve Board (the "Fed") held the federal funds rate, the interest rate at which depository institutions trade federal funds (balances held at Federal Reserve Banks) with each other overnight, in a record-low range between 0.00% and 0.25% during the first half of the reporting period. However, with inflation reaching a four decade high, the Fed pivoted and in March 2022 raised the federal funds rate to a range between 0.25% and 0.50%. This was the central bank's first rate hike since 2018. The Fed again raised rates at its meetings in May, June and July 2022. These hikes pushed the federal funds rate to a range between 2.25% and 2.50%. Finally, in September—after the reporting period ended—the federal funds rate was increased to a range between 3.00% and 3.25%.

UBS U.S. Allocation Fund

Investment Objective:

Total return, consisting of long-term capital appreciation and current income

Portfolio Managers:

Nicole Goldberger

Evan Brown

UBS Asset Management (Americas) Inc.

Commencement:

Class A—May 10, 1993

Class P (formerly Class Y)—May 10, 1993

Dividend payments:

Annually, if any

1  The S&P 500 Index is an unmanaged, weighted index composed of 500 widely held common stocks varying in composition and is not available for direct investment. Investors should note that indices do not reflect the deduction of fees and expenses.

2  The UBS U.S. Allocation Fund Benchmark is an unmanaged benchmark compiled by the Advisor, constructed as follows: from July 22, 1992 (the Fund's inception) until February 29, 2004: 100% S&P 500 Index; from March 1, 2004 until May 31, 2005: 65% Russell 3000 Index, 30% Blomberg Barclays US Aggregate Index and 5% BofA Merrill Lynch US High Yield Cash Pay Index; and from June 1, 2005 until present: 65% Russell 3000 Index, 30% Bloomberg Barclays US Aggregate Index and 5% BofA Merrill Lynch US High Yield Cash Pay Constrained Index. Investors should note that indices do not reflect the deduction of fees and expenses.


1


UBS U.S. Allocation Fund

The US equity market was volatile and generated weak returns during the reporting period. The market was initially supported by the COVID-19 vaccine rollout, monetary and fiscal policy support and solid corporate profits that often exceeded expectations. However, this was more than offset by periods of risk aversion, especially late in the reporting period, given aggressive Fed rate hikes and their potential impact on the economy and corporate profits. For the 12-months ended August 31, 2022, the S&P 500 Index3 returned -11.23%.

The fixed income market also generated weak results. With inflation moving sharply higher, the Fed started removing monetary policy accommodation. In the US, both short- and long-term Treasury yields moved higher (bond yields and prices move in the opposite direction). For the 12-month reporting period, the yield on the US 10-year Treasury bond rose from 1.30% to 3.15%. The overall US bond market, as measured by the Bloomberg US Aggregate Index,4 returned -11.52% during the 12-months ended August 31, 2022. Riskier fixed income securities also declined. High yield bonds, as measured by the ICE BofAML US High Yield Cash Pay Constrained Index,5 fell -10.43%. Elsewhere, emerging markets debt, as measured by the J.P. Morgan Emerging Markets Bond Index Global (EMBI Global),6 returned -18.82%.

Portfolio commentary

What worked

•  Overall, security selection and asset allocation decisions contributed to performance during the reporting period.

•  In the US value equity portion of the Fund, performance was primarily driven by positive stock selection in the consumer discretionary and materials sectors. Notable holdings that were additive to returns included:

  – CF Industries, a nitrogen fertilizer company, was beneficial. Its shares outperformed as rising natural gas prices continued to curb ammonia production in Europe (which is also used to produce fertilizer).

  – Dollar Tree added to returns, as its shares rallied on the back of the accelerated rollout of $1.25 price points across most items in its stores, which should help offset cost pressures and support higher margins. Another positive catalyst for Dollar Tree's share price was the announcement that the current Executive Chairman was retiring before the annual meeting in June, paving the way for Rick Dreiling to be named Chairman—an advancement in activist Mantle Ridge's plans to refresh Dollar Tree's board.

3  The S&P 500 Index is an unmanaged, weighted index composed of 500 widely held common stocks varying in composition and is not available for direct investment. Investors should note that indices do not reflect the deduction of fees and expenses.

4  The Bloomberg US Aggregate Index is an unmanaged broad based index designed to measure the US dollar-denominated, investment-grade, taxable bond market. The index includes bonds from the Treasury, government-related, corporate, mortgage-backed, asset-backed and commercial mortgage-backed sectors. Investors should note that indices do not reflect the deduction of fees and expenses.

5  The ICE BofAML US High Yield Cash Pay Constrained Index is an unmanaged index of publicly placed, non-convertible, coupon-bearing US dollar denominated, below investment grade corporate debt with a term to maturity of at least one year. The index is market capitalization weighted, so that larger bond issuers have a greater effect on the index's return. However, the representation of any single bond issuer is restricted to a maximum of 2% of the total index. Investors should note that indices do not reflect the deduction of fees and expenses.

6  The J.P. Morgan Emerging Markets Bond Index Global (EMBI Global) is an unmanaged index which is designed to track total returns for US dollar denominated debt instruments issued by emerging market sovereign and quasi-sovereign entities: Brady bonds, loans and Eurobonds. Investors should note that indices do not reflect the deduction of fees and expenses.


2


UBS U.S. Allocation Fund

  – In the US growth equity portion of the Fund, an overweight to the energy and health care sectors contributed the most to performance. Stock selection in health care and industrials was also beneficial. Notable holdings that were additive to returns included:

  – AbbVie rallied along with the overall biopharma industry. AbbVie significantly outperformed due to improving prescription trends, especially for its JAK-1 inhibitor drug. Recent news (i.e., incrementally positive data for 1L MCL indication for its Imbruvica pipeline and approval for Skyrizi in Crohn's disease at the end of June) has continued to drive its outperformance versus the index and peers.

  – ConocoPhillips was a contributor as exploration and production (E&P) companies have significantly outperformed in 2022. ConocoPhillips has been well positioned to capture higher crude prices given its low hedging activities compared to its large cap E&P peers. We continue to like the company given its increase in capital returns to shareholders and its differentiated growth projects in Alaska and liquified natural gas (LNG).

  – McDonald's outperformed due to continued strong sales growth in the US, coupled with its franchise model, which insulated the company from the margin impact of higher input costs. Although McDonald's sits within the consumer discretionary sector, it is seen as a beneficiary given its value proposition. During the Global Financial Crisis, it was one of the very few restaurant chains that maintained positive same-store-sales growth.

•  Overall, asset allocation was positive for performance during the reporting period.7

  – We began the period overweight equities and underweight fixed income versus the index. In the first half of the period, an overweight to equities contributed to returns as risk assets experienced a rebound, reversing much of the damage caused by fears over rising cases of the Omicron variant of COVID-19 and the speed of the Fed's asset tapering. Within fixed income, an underweight to duration contributed to relative performance as yields rose.

  – Reducing our overweight to equities and increasing our fixed income exposure versus the Index over the second half of the reporting period was beneficial for performance. This was done in response to prevailing macroeconomic uncertainty, high inflation, COVID induced lockdowns in China, and tightening monetary policy occurring during the second half of the reporting period. Within equities, our preference for energy stocks contributed strongly to performance, as global oil demand outpaced supply, the latter of which was impacted by Russia's invasion into Ukraine. For comparison purposes, neutral Index weights for the Fund are 65.0% equities and 35.0% fixed income.

•  Relative to the benchmark, the use of fixed income and equity derivatives (futures, options, and swaps) contributed to results. These derivative instruments, which were utilized to manage the Fund's fixed income and equity exposure, were positive for performance.

What didn't work

•  In the US value equity portion of the fund, our overall positioning in information technology and industrials detracted from relative performance. The main detractors were:

  – Bio-Rad Laboratories shares declined on concerns regarding the outlook of the life sciences industry, with uncertainty around the durability of COVID-related demand tailwinds—although we believe these tailwinds will persist longer than the market thinks. Additionally, the sharp sell-off in growth stocks negatively impacted the

7  Allocations include derivative exposure.


3


UBS U.S. Allocation Fund

value of Bio-Rad's equity stake in Sartorius. Broadly speaking, we believe Bio-Rad's underlying diagnostic/life science business has a positive runway following a renewed focus on longer-term growth opportunities, such as its industry leading ddPCR (droplet digital PCR) platform. We also think margins will increase significantly from pre-pandemic levels. We continue to own this stock.

  – Not owning ExxonMobil in this portion detracted from relative performance as its shares performed well due to surging crude oil prices.

•  In the US growth equity portion of the Fund, both sector allocation and stock selection detracted from performance. With regard to sector allocation, an underweight to consumer staples and an overweight to communication services detracted from relative performance. Stock selection within information technology and consumer staples also represented a headwind for the strategy. On an individual basis, notable detractors included:

  – HubSpot's shares sold off as the changing global macroeconomic environment put pressure on enterprise software companies. We remain confident in HubStop's longer term positioning as leader in small- and medium-sized enterprise (SME) front office automation software and the company's ability to expand further into the mid-market enterprise segment and meaningfully expand its total accessible market. We continue to own this stock.

  – Match detracted from performance. The company has lowered full year guidance for fiscal year 2022 due primarily to mis-execution on new product introduction at Tinder that is expected to negatively impact user and revenue growth relative to prior expectations. Match has replaced Tinder leadership to drive improved performance, but it will likely take a few quarters to improve the product introduction cadence. We sold out of our position at the end of the quarter within this portion of the Fund.

  – Zscaler's shares underperformed as longer duration / higher growth software companies generated weak results. We exited the position given challenging optics going forward. We sold out of our position at the end of the quarter.


4


UBS U.S. Allocation Fund

We thank you for your continued support and welcome any comments or questions you may have. For additional information on the UBS family of funds,* please contact your financial advisor or visit us at www.ubs.com/am-us.

Sincerely,

 

 
Igor Lasun
President
UBS U.S. Allocation Fund
Managing Director
UBS Asset Management
(Americas) Inc.
  Nicole Goldberger
Portfolio Manager
UBS U.S. Allocation Fund
Managing Director
UBS Asset Management
(Americas) Inc.
 

 

 

Evan Brown
Portfolio Manager
UBS U.S. Allocation Fund
Managing Director
UBS Asset Management
(Americas) Inc.

This letter is intended to assist shareholders in understanding how the Fund performed during the 12 months ended August 31, 2022. The views and opinions in the letter were current as of October 14, 2022. They are not guarantees of future performance or investment results and should not be taken as investment advice. Investment decisions reflect a variety of factors, and we reserve the right to change our views about individual securities, sectors and markets at any time. As a result, the views expressed should not be relied upon as a forecast of the Fund's future investment intent. We encourage you to consult your financial advisor regarding your personal investment program.

* Mutual funds are sold by prospectus only. You should read it carefully and consider a fund's investment objectives, risks, charges, expenses and other important information contained in the prospectus before investing. The prospectus contains this and other information about the fund. Prospectuses for most of our funds can be obtained from your Financial Advisor, by calling UBS Funds at 800-647 1568 or by visiting our website at www.ubs.com/am-us.


5


UBS U.S. Allocation Fund

Performance at a glance (unaudited)

Average annual total returns for periods ended 08/31/2022

 

1 year

 

5 years

 

10 years

 

Before deducting maximum sales charge

 

Class A1

   

(11.69

)%

   

6.98

%

   

8.45

%

 

Class P2

   

(11.44

)

   

7.27

     

8.75

   

After deducting maximum sales charge

 

Class A1

   

(16.55

)

   

5.78

     

7.84

   

S&P 500 Index3

   

(11.23

)

   

11.83

     

13.08

   

UBS U.S. Allocation Fund Benchmark4

   

(12.37

)

   

7.84

     

9.04

   

Most recent calendar quarter-end returns (unaudited)

Average annual total returns for periods ended 09/30/2022

 

1 year

 

5 years

 

10 years

 

Before deducting maximum sales charge

 

Class A1

   

(16.15

)%

   

5.00

%

   

7.39

%

 

Class P2

   

(15.93

)

   

5.28

     

7.68

   

After deducting maximum sales charge

 

Class A1

   

(20.75

)

   

3.82

     

6.78

   

The annualized gross and net expense ratios, respectively, for each class of shares as in the December 29, 2021 prospectuses, were as follows: Class A—0.96% and 0.96%; and Class P—0.69% and 0.69%.

Net expenses reflect fee waivers and/or expense reimbursements, if any, pursuant to an agreement that is in effect to cap the expenses. The Fund and UBS Asset Management (Americas) Inc. have entered into a written agreement, separate from UBS AM's investment advisory agreement with the Fund, whereby UBS AM has agreed to permanently reduce its management fees based on the Fund's average daily net assets to the following rates: $0 to $250 million: 0.50%; in excess of $250 million up to $500 million: 0.45%; in excess of $500 million up to $2 billion: 0.40%; over $2 billion: 0.35%. Effective December 29, 2021, UBS AM has contractually undertaken to waive fees/reimburse a portion of the Fund's expenses, when necessary, so that the ordinary total annual operating expenses of each class through December 31, 2022 (excluding dividend expense, borrowing costs and interest expense relating to short sales, and expenses attributable to investments in other investment companies, interest, taxes, brokerage commissions, trustee elections as well as other matters related to shareholder meetings (unless otherwise separately agreed by UBS AM), and extraordinary expenses, if any) would not exceed 1.15% for Class A and 0.90% for Class P.

1  Maximum sales charge for Class A shares is 5.5%. Class A shares bear ongoing 12b-1 service fees.

2  Class P shares do not bear initial or contingent deferred sales charges or ongoing 12b-1 service and distribution fees, but Class P shares held through advisory programs may be subject to a program fee, which, if included, would have reduced performance.

3  The S&P 500 Index is an unmanaged, weighted index comprising 500 widely held common stocks varying in composition and is not available for direct investment. Investors should note that indices do not reflect the deduction of fees and expenses.

4  The UBS U.S. Allocation Fund Benchmark is an unmanaged benchmark compiled by the Advisor, constructed as follows: from June 1, 2005 until present: 65% Russell 3000 Index, 30% Bloomberg US Aggregate Bond Index, and 5% ICE BofAML US High Yield Cash Pay Constrained Index. Investors should note that indices do not reflect the deduction of fees and expenses.

Past performance does not predict future performance, and the performance information provided does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. The return and principal value of an investment will fluctuate, so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance results assume reinvestment of all dividends and capital gain distributions at net asset value on the ex-dividend dates. Current performance may be higher or lower than the performance data quoted. For month-end performance figures, please visit http://www.ubs.com/us-mutualfundperformance.


6


UBS U.S. Allocation Fund

Illustration of an assumed investment of $10,000 in Class P shares of the Fund (unaudited)

The following graph depicts the performance of UBS U.S. Allocation Fund Class P shares versus the S&P 500 Index and the UBS U.S. Allocation Fund Benchmark over the 10 years ended August 31, 2022. The performance of the other class will vary based upon the different class specific expenses and sales charges. The performance provided does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. Past performance is no guarantee of future results. Share price and returns will vary with market conditions; investors may realize a gain or loss upon redemption. It is important to note that the Fund is a professionally managed portfolio while the Indices are not available for investment and are unmanaged. The comparison is shown for illustration purposes only.

UBS U.S. Allocation Fund Class P

Illustration of an assumed investment of $10,000 in Class A shares of the Fund (unaudited)

The following graph depicts the performance of UBS U.S. Allocation Fund Class A shares versus the S&P 500 Index and the UBS U.S. Allocation Fund Benchmark over the 10 years ended August 31, 2022. The performance of the other class will vary based upon the different class specific expenses and sales charges. The performance provided does not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. Past performance is no guarantee of future results. Share price and returns will vary with market conditions; investors may realize a gain or loss upon redemption. It is important to note that the Fund is a professionally managed portfolio while the Indices are not available for investment and are unmanaged. The comparison is shown for illustration purposes only.

UBS U.S. Allocation Fund Class A


7


UBS U.S. Allocation Fund

Understanding your Fund's expenses (unaudited)

As a shareholder of the Fund, you incur two types of costs: (1) transactional costs (as applicable), including sales charges (loads); and (2) ongoing costs, including management fees; service and/or distribution (12b-1) fees (if applicable); and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The example below is based on an investment of $1,000 invested at the beginning of the period and held for the entire period, March 1, 2022 to August 31, 2022.

Actual expenses (unaudited)

The first line for each class of shares in the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over a period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line for each class of shares under the heading entitled "Expenses paid during period" to estimate the expenses you paid on your account during this period.

Hypothetical example for comparison purposes (unaudited)

The second line for each class of shares in the table below provides information about hypothetical account values and hypothetical expenses based on the Fund's actual expense ratios for each class of shares and an assumed rate of return of 5% per year before expenses, which is not the Fund's actual return for each class of shares. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing Fund costs only and do not reflect any transactional costs (as applicable), such as sales charges (loads). Therefore, the second line in the table for each class of shares is useful in comparing ongoing Fund costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

        Beginning
account value
March 1, 2022
  Ending
account value
August 31, 2022
  Expenses paid
during period1
03/01/22 to 08/31/22
  Expense
ratio during
the period
 

Class A

 

Actual

 

$

1,000.00

   

$

900.80

   

$

4.74

     

0.99

%

 
   

Hypothetical (5% annual return before expenses)

   

1,000.00

     

1,020.21

     

5.04

     

0.99

   

Class P

 

Actual

   

1,000.00

     

902.20

     

3.45

     

0.72

   
   

Hypothetical (5% annual return before expenses)

   

1,000.00

     

1,021.58

     

3.67

     

0.72

   

1  Expenses are equal to the Fund's annualized net expense ratios, multiplied by the average account value over the period, multiplied by 184 divided by 365 (to reflect the one-half year period).


8


UBS U.S. Allocation Fund

Portfolio statistics and industry diversification—(unaudited)1

As a percentage of net assets as of August 31, 2022

Top ten equity holdings

     

Apple, Inc.

   

3.4

%

 

iShares Core S&P Mid-Cap ETF

   

3.2

   

Microsoft Corp.

   

3.0

   

Amazon.com, Inc.

   

2.0

   

AbbVie, Inc.

   

1.5

   

Alphabet, Inc., Class A

   

1.4

   

Williams Cos., Inc.

   

0.9

   

Tesla, Inc.

   

0.9

   

Eli Lilly & Co.

   

0.8

   

NextEra Energy, Inc.

   

0.8

   

Total

   

17.9

%

 

Top ten fixed income holdings

     

UMBS TBA, 2.000%

   

2.0

%

 

UMBS TBA, 2.500%

   

1.8

   

UMBS TBA, 3.000%

   

1.0

   

Santander Retail Auto Lease Trust, 2.880% due 06/20/24

   

0.9

   

FNMA, 2.000% due 03/01/51

   

0.7

   

DT Auto Owner Trust, 3.870% due 11/15/24

   

0.6

   

Westlake Automobile Receivables Trust, 2.520% due 04/15/25

   

0.6

   

U.S. Treasury Notes, 2.750% due 08/15/32

   

0.5

   

FNMA, 2.500% due 08/01/51

   

0.4

   

Exeter Automobile Receivables Trust, 0.350% due 02/18/25

   

0.4

   

Total

   

8.9

%

 

Top five issuer breakdown by country or territory of origin

     

United States

   

100.9

%

 

Cayman Islands

   

0.9

   

United Kingdom

   

0.6

   

Canada

   

0.4

   

Germany

   

0.3

   

Total

   

103.1

%

 


9


UBS U.S. Allocation Fund

Portfolio statistics and industry diversification—(unaudited)1 (concluded)

As a percentage of net assets as of August 31, 2022

Asset allocation

     

Common stocks

   

56.1

%

 

Corporate bonds

   

16.3

   

Short-term investments

   

8.5

   

U.S. government agency obligations

   

7.2

   

Asset-backed securities

   

7.1

   

Mortgage-backed securities

   

4.9

   

Exchange traded funds

   

3.2

   

U.S. Treasury obligations

   

1.0

   

Non-U.S. government agency obligations

   

0.4

   

Preferred stocks

   

0.0

 

Cash equivalents and other assets less liabilities

   

(4.7

)

 

Total

   

100.0

%

 

  Amount is less than 0.05% or (0.05%).

1  The portfolio is actively managed and its composition will vary over time.


10


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Number of
shares
 

Value

 

Common stocks—56.1%

 

Aerospace & defense—0.7%

 

Boeing Co.*

   

93

   

$

14,903

   

General Dynamics Corp.

   

52

     

11,904

   

Howmet Aerospace, Inc.

   

136

     

4,819

   

L3harris Technologies, Inc.

   

38

     

8,671

   

Lockheed Martin Corp.

   

44

     

18,485

   

Northrop Grumman Corp.

   

28

     

13,384

   

Raytheon Technologies Corp.

   

249

     

22,348

   

Spirit AeroSystems Holdings, Inc., Class A

   

24,483

     

736,938

   

TransDigm Group, Inc.

   

1,326

     

796,117

   
         

1,627,569

   

Air freight & logistics—0.0%

 

C.H. Robinson Worldwide, Inc.

   

45

     

5,137

   

Expeditors International of Washington, Inc.

   

48

     

4,939

   

FedEx Corp.

   

40

     

8,432

   

United Parcel Service, Inc., Class B

   

123

     

23,925

   
         

42,433

   

Airlines—0.0%

 

Delta Air Lines, Inc.*

   

50

     

1,553

   

Southwest Airlines Co.*

   

190

     

6,973

   
         

8,526

   

Auto components—0.0%

 

Aptiv PLC*

   

268

     

25,039

   

BorgWarner, Inc.

   

259

     

9,765

   
         

34,804

   

Automobiles—1.4%

 

Ford Motor Co.

   

71,206

     

1,085,180

   

General Motors Co.

   

1,340

     

51,201

   

Tesla, Inc.*

   

7,029

     

1,937,263

   
         

3,073,644

   

Banks—1.8%

 

Bank of America Corp.

   

10,250

     

344,502

   

Bank OZK

   

20,411

     

827,258

   

Citigroup, Inc.

   

2,813

     

137,303

   

Citizens Financial Group, Inc.

   

738

     

27,070

   

Comerica, Inc.

   

176

     

14,133

   

Fifth Third Bancorp

   

987

     

33,706

   

First Republic Bank

   

251

     

38,109

   

Huntington Bancshares, Inc.

   

2,026

     

27,148

   

JPMorgan Chase & Co.

   

4,245

     

482,784

   

KeyCorp

   

1,327

     

23,475

   

M&T Bank Corp.

   

258

     

46,899

   

PNC Financial Services Group, Inc.

   

597

     

94,326

   

Regions Financial Corp.

   

1,360

     

29,471

   

Signature Bank

   

85

     

14,821

   

SVB Financial Group*

   

80

     

32,522

   

Truist Financial Corp.

   

1,956

     

91,619

   

U.S. Bancorp

   

1,950

     

88,939

   

Wells Fargo & Co.

   

38,440

     

1,680,212

   

Zions Bancorp N.A.

   

270

     

14,858

   
         

4,049,155

   
    Number of
shares
 

Value

 

Common stocks—(continued)

 

Beverages—0.8%

 

Brown-Forman Corp., Class B

   

374

   

$

27,190

   

Coca-Cola Co.

   

7,536

     

465,046

   

Constellation Brands, Inc., Class A

   

3,378

     

831,157

   

Keurig Dr Pepper, Inc.

   

1,377

     

52,491

   

Molson Coors Beverage Co., Class B

   

364

     

18,808

   

Monster Beverage Corp.*

   

731

     

64,935

   

PepsiCo, Inc.

   

2,677

     

461,167

   
         

1,920,794

   

Biotechnology—2.4%

 

AbbVie, Inc.

   

25,553

     

3,435,857

   

Amgen, Inc.

   

895

     

215,069

   

Biogen, Inc.*

   

243

     

47,477

   

BioNTech SE, ADR

   

2,300

     

332,672

   

Gilead Sciences, Inc.

   

2,098

     

133,160

   

Incyte Corp.*

   

352

     

24,791

   

Moderna, Inc.*

   

581

     

76,849

   

Regeneron Pharmaceuticals, Inc.*

   

183

     

106,334

   

Vertex Pharmaceuticals, Inc.*

   

4,008

     

1,129,294

   
         

5,501,503

   

Building products—0.0%

 

Carrier Global Corp.

   

99

     

3,873

   

Johnson Controls International PLC

   

85

     

4,602

   

Masco Corp.

   

89

     

4,527

   

Trane Technologies PLC

   

31

     

4,776

   
         

17,778

   

Capital markets—1.5%

 

Ameriprise Financial, Inc.

   

5,483

     

1,469,499

   

Bank of New York Mellon Corp.

   

1,080

     

44,852

   

BlackRock, Inc.

   

203

     

135,277

   

Cboe Global Markets, Inc.

   

148

     

17,460

   

Charles Schwab Corp.

   

10,388

     

737,029

   

CME Group, Inc.

   

519

     

101,522

   

FactSet Research Systems, Inc.

   

47

     

20,367

   

Franklin Resources, Inc.

   

366

     

9,542

   

Goldman Sachs Group, Inc.

   

494

     

164,339

   

Intercontinental Exchange, Inc.

   

800

     

80,680

   

Invesco Ltd.

   

539

     

8,877

   

MarketAxess Holdings, Inc.

   

50

     

12,429

   

Moody's Corp.

   

221

     

62,879

   

Morgan Stanley

   

2,019

     

172,059

   

MSCI, Inc.

   

108

     

48,518

   

Nasdaq, Inc.

   

480

     

28,574

   

Northern Trust Corp.

   

293

     

27,861

   

Raymond James Financial, Inc.

   

272

     

28,389

   

S&P Global, Inc.

   

495

     

174,329

   

State Street Corp.

   

523

     

35,747

   

T. Rowe Price Group, Inc.

   

311

     

37,320

   
         

3,417,549

   

Chemicals—1.0%

 

Air Products and Chemicals, Inc.

   

319

     

80,532

   

Albemarle Corp.

   

168

     

45,017

   

Celanese Corp.

   

165

     

18,292

   


11


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Number of
shares
 

Value

 

Common stocks—(continued)

 

Chemicals—(concluded)

 

CF Industries Holdings, Inc.

   

14,031

   

$

1,451,647

   

Corteva, Inc.

   

1,037

     

63,703

   

Dow, Inc.

   

1,043

     

53,193

   

DuPont de Nemours, Inc.

   

749

     

41,674

   

Eastman Chemical Co.

   

205

     

18,655

   

Ecolab, Inc.

   

364

     

59,634

   

FMC Corp.

   

186

     

20,103

   

International Flavors & Fragrances, Inc.

   

374

     

41,320

   

Linde PLC

   

720

     

203,659

   

LyondellBasell Industries N.V., Class A

   

375

     

31,125

   

Mosaic Co.

   

514

     

27,689

   

PPG Industries, Inc.

   

343

     

43,554

   

Sherwin-Williams Co.

   

350

     

81,235

   
         

2,281,032

   

Commercial services & supplies—0.0%

 

Cintas Corp.

   

22

     

8,950

   

Copart, Inc.*

   

21

     

2,513

   

Republic Services, Inc.

   

55

     

7,850

   

Waste Management, Inc.

   

71

     

12,001

   
         

31,314

   

Communications equipment—0.2%

 

Arista Networks, Inc.*

   

358

     

42,917

   

Cisco Systems, Inc.

   

6,723

     

300,653

   

F5, Inc.*

   

83

     

13,036

   

Juniper Networks, Inc.

   

477

     

13,556

   

Motorola Solutions, Inc.

   

269

     

65,477

   
         

435,639

   

Construction & engineering—0.0%

 

Quanta Services, Inc.

   

35

     

4,945

   

Construction materials—0.0%

 

Martin Marietta Materials, Inc.

   

96

     

33,380

   

Vulcan Materials Co.

   

194

     

32,299

   
         

65,679

   

Consumer finance—0.4%

 

American Express Co.

   

880

     

133,760

   

Capital One Financial Corp.

   

565

     

59,788

   

Discover Financial Services

   

400

     

40,196

   

Synchrony Financial

   

19,528

     

639,542

   
         

873,286

   

Containers & packaging—0.1%

 

Amcor PLC

   

2,197

     

26,386

   

Avery Dennison Corp.

   

124

     

22,769

   

Ball Corp.

   

465

     

25,952

   

International Paper Co.

   

517

     

21,517

   

Packaging Corp. of America

   

142

     

19,443

   

Sealed Air Corp.

   

258

     

13,883

   

Westrock Co.

   

368

     

14,937

   
         

144,887

   
    Number of
shares
 

Value

 

Common stocks—(continued)

 

Distributors—0.0%

 

Genuine Parts Co.

   

144

   

$

22,465

   

LKQ Corp.

   

262

     

13,944

   

Pool Corp.

   

43

     

14,585

   
         

50,994

   

Diversified financial services—0.7%

 

Berkshire Hathaway, Inc., Class B*

   

2,609

     

732,607

   

Voya Financial, Inc.

   

14,455

     

889,416

   
         

1,622,023

   

Diversified telecommunication services—0.1%

 

AT&T, Inc.

   

7,705

     

135,146

   

Lumen Technologies, Inc.1

   

1,225

     

12,201

   

Verizon Communications, Inc.

   

4,493

     

187,852

   
         

335,199

   

Electric utilities—1.1%

 

Alliant Energy Corp.

   

404

     

24,660

   

American Electric Power Co., Inc.

   

720

     

72,144

   

Constellation Energy Corp.

   

501

     

40,877

   

Duke Energy Corp.

   

1,143

     

122,198

   

Edison International

   

533

     

36,121

   

Entergy Corp.

   

276

     

31,823

   

Evergy, Inc.

   

299

     

20,490

   

Eversource Energy

   

463

     

41,527

   

Exelon Corp.

   

1,369

     

60,113

   

FirstEnergy Corp.

   

802

     

31,719

   

NextEra Energy, Inc.

   

20,971

     

1,783,793

   

NRG Energy, Inc.

   

313

     

12,921

   

Pinnacle West Capital Corp.

   

144

     

10,850

   

PPL Corp.

   

1,128

     

32,802

   

Southern Co.

   

1,566

     

120,692

   

Xcel Energy, Inc.

   

825

     

61,256

   
         

2,503,986

   

Electrical equipment—0.6%

 

AMETEK, Inc.

   

30

     

3,605

   

Eaton Corp. PLC

   

71

     

9,701

   

Emerson Electric Co.

   

101

     

8,256

   

Generac Holdings, Inc.*

   

19

     

4,188

   

Regal Rexnord Corp.

   

9,212

     

1,267,479

   

Rockwell Automation, Inc.

   

31

     

7,345

   
         

1,300,574

   

Electronic equipment, instruments & components—0.2%

 

Amphenol Corp., Class A

   

947

     

69,633

   

CDW Corp.

   

215

     

36,700

   

Corning, Inc.

   

1,118

     

38,370

   

Keysight Technologies, Inc.*

   

292

     

47,856

   

TE Connectivity Ltd.

   

531

     

67,018

   

Teledyne Technologies, Inc.*

   

75

     

27,627

   

Trimble, Inc.*

   

414

     

26,185

   

Zebra Technologies Corp., Class A*

   

86

     

25,941

   
         

339,330

   


12


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Number of
shares
 

Value

 

Common stocks—(continued)

 

Energy equipment & services—0.1%

 

Baker Hughes Co.

   

2,594

   

$

65,525

   

Halliburton Co.

   

2,425

     

73,065

   

Schlumberger N.V.

   

3,901

     

148,823

   
         

287,413

   

Entertainment—1.0%

 

Activision Blizzard, Inc.

   

821

     

64,440

   

Electronic Arts, Inc.

   

315

     

39,964

   

Live Nation Entertainment, Inc.*

   

136

     

12,289

   

Netflix, Inc.*

   

2,672

     

597,352

   

Take-Two Interactive Software, Inc.*

   

10,729

     

1,314,946

   

Walt Disney Co.*

   

1,937

     

217,099

   

Warner Bros Discovery, Inc.*

   

2,427

     

32,134

   
         

2,278,224

   

Equity real estate investment trusts—1.4%

 

Alexandria Real Estate Equities, Inc.

   

223

     

34,208

   

American Tower Corp.

   

680

     

172,754

   

AvalonBay Communities, Inc.

   

218

     

43,798

   

Boston Properties, Inc.

   

209

     

16,601

   

Camden Property Trust

   

171

     

21,975

   

Crown Castle, Inc.

   

3,435

     

586,801

   

Digital Realty Trust, Inc.

   

422

     

52,172

   

Duke Realty Corp.

   

565

     

33,250

   

Equinix, Inc.

   

137

     

90,060

   

Equity Residential

   

503

     

36,810

   

Essex Property Trust, Inc.

   

104

     

27,566

   

Extra Space Storage, Inc.

   

202

     

40,143

   

Federal Realty Investment Trust

   

106

     

10,735

   

Healthpeak Properties, Inc.

   

801

     

21,026

   

Host Hotels & Resorts, Inc.

   

1,063

     

18,889

   

Iron Mountain, Inc.

   

423

     

22,254

   

Kimco Realty Corp.

   

895

     

18,867

   

Mid-America Apartment Communities, Inc.

   

184

     

30,483

   

Prologis, Inc.

   

11,081

     

1,379,695

   

Public Storage

   

228

     

75,429

   

Realty Income Corp.

   

885

     

60,428

   

Regency Centers Corp.

   

234

     

14,237

   

SBA Communications Corp.

   

165

     

53,666

   

Simon Property Group, Inc.

   

479

     

48,848

   

UDR, Inc.

   

434

     

19,474

   

Ventas, Inc.

   

582

     

27,854

   

VICI Properties, Inc.

   

1,409

     

46,483

   

Vornado Realty Trust

   

221

     

5,795

   

Welltower, Inc.

   

664

     

50,896

   

Weyerhaeuser Co.

   

1,104

     

37,713

   
         

3,098,910

   

Food & staples retailing—0.5%

 

Costco Wholesale Corp.

   

850

     

443,785

   

Kroger Co.

   

1,228

     

58,870

   

Sysco Corp.

   

975

     

80,165

   

Walgreens Boots Alliance, Inc.

   

1,339

     

46,945

   

Walmart, Inc.

   

4,534

     

600,982

   
         

1,230,747

   
    Number of
shares
 

Value

 

Common stocks—(continued)

 

Food products—1.8%

 

Archer-Daniels-Midland Co.

   

1,096

   

$

96,327

   

Bunge Ltd.

   

17,931

     

1,778,217

   

Campbell Soup Co.

   

382

     

19,245

   

Conagra Brands, Inc.

   

899

     

30,908

   

General Mills, Inc.

   

1,170

     

89,856

   

Hershey Co.

   

259

     

58,190

   

Hormel Foods Corp.

   

517

     

25,995

   

J.M. Smucker Co.

   

221

     

30,938

   

Kellogg Co.

   

524

     

38,116

   

Kraft Heinz Co.

   

1,436

     

53,706

   

Lamb Weston Holdings, Inc.

   

284

     

22,586

   

McCormick & Co., Inc.

   

486

     

40,858

   

Mondelez International, Inc., Class A

   

27,100

     

1,676,406

   

Tyson Foods, Inc., Class A

   

547

     

41,233

   
         

4,002,581

   

Gas utilities—0.0%

 

Atmos Energy Corp.

   

204

     

23,130

   

Health care equipment & supplies—1.1%

 

Abbott Laboratories

   

2,946

     

302,407

   

ABIOMED, Inc.*

   

76

     

19,705

   

Align Technology, Inc.*

   

117

     

28,513

   

Baxter International, Inc.

   

834

     

47,922

   

Becton Dickinson and Co.

   

486

     

122,676

   

Boston Scientific Corp.*

   

2,402

     

96,825

   

Cooper Cos., Inc.

   

1,909

     

548,723

   

DENTSPLY SIRONA, Inc.

   

341

     

11,175

   

Dexcom, Inc.*

   

7,028

     

577,772

   

Edwards Lifesciences Corp.*

   

1,044

     

94,064

   

Hologic, Inc.*

   

388

     

26,213

   

IDEXX Laboratories, Inc.*

   

141

     

49,015

   

Intuitive Surgical, Inc.*

   

604

     

124,267

   

Medtronic PLC

   

2,260

     

198,699

   

ResMed, Inc.

   

249

     

54,760

   

STERIS PLC

   

166

     

33,429

   

Stryker Corp.

   

571

     

117,169

   

Teleflex, Inc.

   

96

     

21,721

   

Zimmer Biomet Holdings, Inc.

   

344

     

36,574

   
         

2,511,629

   

Health care providers & services—1.8%

 

AmerisourceBergen Corp.

   

258

     

37,813

   

Cardinal Health, Inc.

   

446

     

31,541

   

Centene Corp.*

   

4,398

     

394,677

   

Cigna Corp.

   

533

     

151,079

   

CVS Health Corp.

   

2,201

     

216,028

   

DaVita, Inc.*

   

77

     

6,567

   

Elevance Health, Inc.

   

411

     

199,380

   

HCA Healthcare, Inc.

   

382

     

75,586

   

Henry Schein, Inc.*

   

231

     

16,958

   

Humana, Inc.

   

213

     

102,619

   

Laboratory Corp. of America Holdings

   

4,701

     

1,058,994

   

McKesson Corp.

   

247

     

90,649

   

Molina Healthcare, Inc.*

   

107

     

36,099

   

Quest Diagnostics, Inc.

   

183

     

22,932

   


13


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Number of
shares
 

Value

 

Common stocks—(continued)

 

Health care providers & services—(concluded)

 

UnitedHealth Group, Inc.

   

3,322

   

$

1,725,214

   

Universal Health Services, Inc., Class B

   

111

     

10,860

   
         

4,176,996

   

Hotels, restaurants & leisure—1.6%

 

Airbnb, Inc., Class A*

   

204

     

23,076

   

Booking Holdings, Inc.*

   

40

     

75,032

   

Caesars Entertainment, Inc.*

   

212

     

9,141

   

Carnival Corp.*,1

   

668

     

6,319

   

Chipotle Mexican Grill, Inc.*

   

471

     

752,093

   

Darden Restaurants, Inc.

   

123

     

15,216

   

Domino's Pizza, Inc.

   

29

     

10,784

   

Expedia Group, Inc.*

   

4,135

     

424,458

   

Hilton Worldwide Holdings, Inc.

   

246

     

31,331

   

Las Vegas Sands Corp.*

   

35,133

     

1,322,055

   

Marriott International, Inc., Class A

   

278

     

42,740

   

McDonald's Corp.

   

3,315

     

836,308

   

MGM Resorts International

   

375

     

12,240

   

Norwegian Cruise Line Holdings Ltd.*

   

642

     

8,397

   

Penn Entertainment, Inc.*

   

126

     

3,935

   

Royal Caribbean Cruises Ltd.*

   

189

     

7,721

   

Starbucks Corp.

   

1,066

     

89,619

   

Wynn Resorts Ltd.*

   

67

     

4,060

   

Yum! Brands, Inc.

   

289

     

32,148

   
         

3,706,673

   

Household durables—0.0%

 

D.R. Horton, Inc.

   

343

     

24,404

   

Garmin Ltd.

   

144

     

12,743

   

Lennar Corp., Class A

   

274

     

21,221

   

Mohawk Industries, Inc.*

   

38

     

4,194

   

Newell Brands, Inc.

   

245

     

4,373

   

NVR, Inc.*

   

2

     

8,280

   

PulteGroup, Inc.

   

265

     

10,775

   

Whirlpool Corp.

   

57

     

8,926

   
         

94,916

   

Household products—0.4%

 

Church & Dwight Co., Inc.

   

479

     

40,097

   

Clorox Co.

   

237

     

34,209

   

Colgate-Palmolive Co.

   

1,610

     

125,918

   

Kimberly-Clark Corp.

   

635

     

80,975

   

Procter & Gamble Co.

   

4,649

     

641,283

   
         

922,482

   

Independent power and renewable electricity producers—0.0%

 

AES Corp.

   

862

     

21,938

   

Industrial conglomerates—0.3%

 

3M Co.

   

98

     

12,186

   

General Electric Co.

   

184

     

13,513

   

Honeywell International, Inc.

   

2,845

     

538,701

   
         

564,400

   
    Number of
shares
 

Value

 

Common stocks—(continued)

 

Insurance—1.2%

 

Aflac, Inc.

   

852

   

$

50,626

   

Allstate Corp.

   

6,801

     

819,520

   

American International Group, Inc.

   

1,138

     

58,891

   

Aon PLC, Class A

   

303

     

84,616

   

Arthur J. Gallagher & Co.

   

297

     

53,926

   

Assurant, Inc.

   

76

     

12,045

   

Brown & Brown, Inc.

   

340

     

21,434

   

Chubb Ltd.

   

618

     

116,833

   

Cincinnati Financial Corp.

   

211

     

20,459

   

Everest Re Group Ltd.

   

39

     

10,493

   

Globe Life, Inc.

   

131

     

12,732

   

Hartford Financial Services Group, Inc.

   

480

     

30,869

   

Lincoln National Corp.

   

235

     

10,824

   

Loews Corp.

   

308

     

17,035

   

Marsh & McLennan Cos., Inc.

   

6,133

     

989,682

   

MetLife, Inc.

   

1,005

     

64,652

   

Principal Financial Group, Inc.

   

335

     

25,045

   

Progressive Corp.

   

847

     

103,885

   

Prudential Financial, Inc.

   

540

     

51,705

   

Travelers Cos., Inc.

   

355

     

57,382

   

W. R. Berkley Corp.

   

303

     

19,634

   

Willis Towers Watson PLC

   

156

     

32,265

   
         

2,664,553

   

Interactive media & services—2.4%

 

Alphabet, Inc., Class A*

   

30,375

     

3,287,182

   

Alphabet, Inc., Class C*

   

5,858

     

639,401

   

Match Group, Inc.*

   

342

     

19,333

   

Meta Platforms, Inc., Class A*

   

9,534

     

1,553,375

   

Twitter, Inc.*

   

842

     

32,628

   
         

5,531,919

   

Internet & direct marketing retail—2.0%

 

Amazon.com, Inc.*

   

36,070

     

4,572,594

   

eBay, Inc.

   

566

     

24,977

   

Etsy, Inc.*

   

113

     

11,934

   
         

4,609,505

   

IT services—2.8%

 

Accenture PLC, Class A

   

1,010

     

291,345

   

Akamai Technologies, Inc.*

   

15,590

     

1,407,465

   

Automatic Data Processing, Inc.

   

666

     

162,777

   

Block, Inc.*

   

4,747

     

327,116

   

Broadridge Financial Solutions, Inc.

   

192

     

32,865

   

Cognizant Technology Solutions Corp., Class A

   

839

     

53,000

   

DXC Technology Co.*

   

341

     

8,450

   

EPAM Systems, Inc.*

   

91

     

38,812

   

Fidelity National Information Services, Inc.

   

17,399

     

1,589,747

   

Fiserv, Inc.*

   

933

     

94,410

   

FleetCor Technologies, Inc.*

   

110

     

23,378

   

Gartner, Inc.*

   

114

     

32,526

   

Global Payments, Inc.

   

450

     

55,904

   

International Business Machines Corp.

   

1,436

     

184,454

   


14


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Number of
shares
 

Value

 

Common stocks—(continued)

 

IT services—(concluded)

 

Jack Henry & Associates, Inc.

   

99

   

$

19,028

   

Mastercard, Inc., Class A

   

4,228

     

1,371,436

   

Paychex, Inc.

   

514

     

63,397

   

PayPal Holdings, Inc.*

   

1,843

     

172,210

   

VeriSign, Inc.*

   

134

     

24,417

   

Visa, Inc., Class A

   

2,650

     

526,581

   
         

6,479,318

   

Leisure products—0.2%

 

Brunswick Corp.

   

5,989

     

447,438

   

Hasbro, Inc.

   

116

     

9,143

   
         

456,581

   

Life sciences tools & services—1.5%

 

Agilent Technologies, Inc.

   

4,559

     

584,692

   

Bio-Rad Laboratories, Inc., Class A*

   

2,155

     

1,045,261

   

Bio-Techne Corp.

   

67

     

22,231

   

Charles River Laboratories International, Inc.*

   

87

     

17,857

   

Danaher Corp.

   

1,086

     

293,122

   

Illumina, Inc.*

   

263

     

53,031

   

IQVIA Holdings, Inc.*

   

4,408

     

937,405

   

Mettler-Toledo International, Inc.*

   

41

     

49,711

   

PerkinElmer, Inc.

   

199

     

26,877

   

Thermo Fisher Scientific, Inc.

   

658

     

358,821

   

Waters Corp.*

   

96

     

28,666

   

West Pharmaceutical Services, Inc.

   

126

     

37,383

   
         

3,455,057

   

Machinery—1.0%

 

AGCO Corp.

   

5,079

     

552,138

   

Caterpillar, Inc.

   

96

     

17,732

   

Cummins, Inc.

   

39

     

8,399

   

Deere & Co.

   

50

     

18,263

   

Dover Corp.

   

46

     

5,748

   

Fortive Corp.

   

48

     

3,040

   

IDEX Corp.

   

24

     

4,829

   

Illinois Tool Works, Inc.

   

52

     

10,131

   

Ingersoll Rand, Inc.

   

32,755

     

1,551,604

   

Otis Worldwide Corp.

   

54

     

3,900

   

PACCAR, Inc.

   

59

     

5,163

   

Parker-Hannifin Corp.

   

36

     

9,540

   

Westinghouse Air Brake Technologies Corp.

   

52

     

4,558

   

Xylem, Inc.

   

58

     

5,284

   
         

2,200,329

   

Media—0.6%

 

Charter Communications, Inc., Class A*

   

121

     

49,928

   

Comcast Corp., Class A

   

31,377

     

1,135,534

   

DISH Network Corp., Class A*

   

334

     

5,795

   

Fox Corp., Class A

   

292

     

9,981

   

Fox Corp., Class B

   

189

     

5,976

   

Interpublic Group of Cos., Inc.

   

373

     

10,310

   

News Corp., Class A

   

571

     

9,661

   

Omnicom Group, Inc.

   

215

     

14,383

   

Paramount Global, Class B1

   

645

     

15,087

   
         

1,256,655

   
    Number of
shares
 

Value

 

Common stocks—(continued)

 

Metals & mining—0.1%

 

Freeport-McMoRan, Inc.

   

2,065

   

$

61,124

   

Newmont Corp.

   

1,112

     

45,992

   

Nucor Corp.

   

378

     

50,252

   
         

157,368

   

Multi-utilities—0.2%

 

Ameren Corp.

   

398

     

36,863

   

Centerpoint Energy, Inc.

   

984

     

31,025

   

CMS Energy Corp.

   

401

     

27,084

   

Consolidated Edison, Inc.

   

491

     

47,990

   

Dominion Energy, Inc.

   

1,142

     

93,416

   

DTE Energy Co.

   

257

     

33,497

   

NiSource, Inc.

   

526

     

15,522

   

Public Service Enterprise Group, Inc.

   

700

     

45,052

   

Sempra Energy

   

458

     

75,556

   

WEC Energy Group, Inc.

   

434

     

44,763

   
         

450,768

   

Multiline retail—0.8%

 

Dollar General Corp.

   

226

     

53,657

   

Dollar Tree, Inc.*

   

12,448

     

1,688,945

   

Target Corp.

   

430

     

68,946

   
         

1,811,548

   

Oil, gas & consumable fuels—3.5%

 

APA Corp.

   

27,983

     

1,094,415

   

Chevron Corp.

   

5,307

     

838,824

   

ConocoPhillips

   

7,128

     

780,160

   

Coterra Energy, Inc.

   

2,204

     

68,126

   

Devon Energy Corp.

   

1,661

     

117,300

   

Diamondback Energy, Inc.

   

460

     

61,309

   

EOG Resources, Inc.

   

3,526

     

427,704

   

ExxonMobil Corp.

   

15,550

     

1,486,424

   

Hess Corp.

   

759

     

91,672

   

Kinder Morgan, Inc.

   

5,435

     

99,569

   

Marathon Oil Corp.

   

1,935

     

49,517

   

Marathon Petroleum Corp.

   

1,400

     

141,050

   

Occidental Petroleum Corp.

   

2,411

     

171,181

   

ONEOK, Inc.

   

1,234

     

75,558

   

Phillips 66

   

1,262

     

112,898

   

Pioneer Natural Resources Co.

   

596

     

150,919

   

Valero Energy Corp.

   

1,071

     

125,435

   

Williams Cos., Inc.

   

63,288

     

2,153,691

   
         

8,045,752

   

Personal products—0.1%

 

Estee Lauder Cos., Inc., Class A

   

433

     

110,147

   

Pharmaceuticals—1.7%

 

Bristol-Myers Squibb Co.

   

3,604

     

242,946

   

Catalent, Inc.*

   

332

     

29,216

   

Eli Lilly & Co.

   

6,195

     

1,866,120

   

Johnson & Johnson

   

4,438

     

716,027

   

Merck & Co., Inc.

   

4,261

     

363,719

   

Organon & Co.

   

372

     

10,613

   

Pfizer, Inc.

   

9,451

     

427,469

   


15


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Number of
shares
 

Value

 

Common stocks—(continued)

 

Pharmaceuticals—(concluded)

 

Viatris, Inc.

   

2,048

   

$

19,558

   

Zoetis, Inc.

   

795

     

124,441

   
         

3,800,109

   

Professional services—0.2%

 

Equifax, Inc.

   

33

     

6,229

   

Jacobs Solutions, Inc.

   

36

     

4,485

   

Leidos Holdings, Inc.

   

46

     

4,372

   

Nielsen Holdings PLC

   

31

     

863

   

Verisk Analytics, Inc.

   

2,364

     

442,446

   
         

458,395

   

Real estate management & development—0.0%

 

CBRE Group, Inc., Class A*

   

480

     

37,901

   

Road & rail—0.4%

 

CSX Corp.

   

369

     

11,679

   

J.B. Hunt Transport Services, Inc.

   

27

     

4,698

   

Norfolk Southern Corp.

   

43

     

10,455

   

Old Dominion Freight Line, Inc.

   

9

     

2,443

   

Union Pacific Corp.

   

3,875

     

869,976

   
         

899,251

   

Semiconductors & semiconductor equipment—2.9%

 

Advanced Micro Devices, Inc.*

   

2,587

     

219,559

   

Analog Devices, Inc.

   

838

     

126,982

   

Applied Materials, Inc.

   

1,466

     

137,907

   

Broadcom, Inc.

   

2,460

     

1,227,811

   

Enphase Energy, Inc.*

   

214

     

61,298

   

Intel Corp.

   

6,530

     

208,438

   

KLA Corp.

   

236

     

81,215

   

Lam Research Corp.

   

1,963

     

859,617

   

Marvell Technology, Inc.

   

13,824

     

647,240

   

Microchip Technology, Inc.

   

896

     

58,464

   

Micron Technology, Inc.

   

15,929

     

900,466

   

Monolithic Power Systems, Inc.

   

69

     

31,269

   

NVIDIA Corp.

   

7,537

     

1,137,635

   

NXP Semiconductors N.V.

   

416

     

68,465

   

ON Semiconductor Corp.*

   

695

     

47,795

   

Qorvo, Inc.*

   

192

     

17,238

   

QUALCOMM, Inc.

   

1,823

     

241,128

   

Skyworks Solutions, Inc.

   

226

     

22,272

   

SolarEdge Technologies, Inc.*

   

88

     

24,285

   

Teradyne, Inc.

   

274

     

23,191

   

Texas Instruments, Inc.

   

1,502

     

248,146

   

Universal Display Corp.

   

1,412

     

157,763

   
         

6,548,184

   

Software—6.3%

 

Adobe, Inc.*

   

766

     

286,055

   

ANSYS, Inc.*

   

139

     

34,514

   

Autodesk, Inc.*

   

345

     

69,600

   

Cadence Design Systems, Inc.*

   

440

     

76,459

   

Ceridian HCM Holding, Inc.*

   

192

     

11,451

   

Citrix Systems, Inc.

   

224

     

23,020

   

Fortinet, Inc.*

   

10,707

     

521,324

   
    Number of
shares
 

Value

 

Common stocks—(continued)

 

Software—(concluded)

 

HubSpot, Inc.*

   

1,962

   

$

661,272

   

Intuit, Inc.

   

450

     

194,301

   

Microsoft Corp.

   

25,814

     

6,749,587

   

NortonLifeLock, Inc.

   

1,011

     

22,839

   

Oracle Corp.

   

16,631

     

1,233,189

   

Palo Alto Networks, Inc.*

   

816

     

454,357

   

Paycom Software, Inc.*

   

81

     

28,447

   

PTC, Inc.*

   

155

     

17,808

   

Roper Technologies, Inc.

   

162

     

65,218

   

Salesforce, Inc.*

   

6,786

     

1,059,430

   

ServiceNow, Inc.*

   

2,007

     

872,282

   

Splunk, Inc.*

   

8,869

     

798,476

   

Synopsys, Inc.*

   

242

     

83,737

   

Tyler Technologies, Inc.*

   

65

     

24,148

   

VMware, Inc., Class A

   

8,426

     

977,669

   
         

14,265,183

   

Specialty retail—0.7%

 

Advance Auto Parts, Inc.

   

51

     

8,601

   

AutoZone, Inc.*

   

19

     

40,265

   

Bath & Body Works, Inc.

   

221

     

8,250

   

Best Buy Co., Inc.

   

205

     

14,491

   

CarMax, Inc.*

   

163

     

14,416

   

Home Depot, Inc.

   

963

     

277,748

   

Lowe's Cos., Inc.

   

5,048

     

980,019

   

O'Reilly Automotive, Inc.*

   

65

     

45,313

   

Ross Stores, Inc.

   

291

     

25,105

   

TJX Cos., Inc.

   

1,076

     

67,089

   

Tractor Supply Co.

   

108

     

19,996

   

Ulta Beauty, Inc.*

   

50

     

20,993

   
         

1,522,286

   

Technology hardware, storage & peripherals—3.7%

 

Apple, Inc.

   

49,362

     

7,760,694

   

Hewlett Packard Enterprise Co.

   

2,097

     

28,519

   

HP, Inc.

   

1,674

     

48,060

   

NetApp, Inc.

   

374

     

26,976

   

Seagate Technology Holdings PLC

   

333

     

22,298

   

Western Digital Corp.*

   

13,549

     

572,581

   
         

8,459,128

   

Textiles, apparel & luxury goods—0.4%

 

Lululemon Athletica, Inc.*

   

2,686

     

805,692

   

Nike, Inc., Class B

   

1,188

     

126,463

   

PVH Corp.

   

73

     

4,106

   

Ralph Lauren Corp.

   

50

     

4,566

   

Tapestry, Inc.

   

297

     

10,315

   

VF Corp.

   

266

     

11,026

   
         

962,168

   

Tobacco—0.2%

 

Altria Group, Inc.

   

3,497

     

157,785

   

Philip Morris International, Inc.

   

2,998

     

286,279

   
         

444,064

   


16


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Number of
shares
 

Value

 

Common stocks—(concluded)

 

Trading companies & distributors—0.2%

 

Fastenal Co.

   

87

   

$

4,379

   

United Rentals, Inc.*

   

1,642

     

479,530

   

W.W. Grainger, Inc.

   

10

     

5,549

   
         

489,458

   

Water utilities—0.0%

 

American Water Works Co., Inc.

   

253

     

37,558

   

Wireless telecommunication services—0.0%

 

T-Mobile U.S., Inc.*

   

657

     

94,582

   
Total common stocks
(cost—$123,241,672)
   

127,850,449

   

Preferred stocks—0.0%

 

Financial services—0.0%

 
SquareTwo Financial Corp.2,3
(cost—$0)
   

35,000

     

0

   

Exchange traded funds—3.2%

 
iShares Core S&P Mid-Cap ETF
(cost—$6,749,100)
   

29,709

     

7,218,693

   
    Face
amount
     

Asset-backed securities—7.1%

 
American Credit Acceptance Receivables Trust,
Series 2018-4, Class D,
4.400%, due 01/13/254
 

$

827,367

     

827,409

   
Ares XLVIII CLO Ltd.,
Series 2018-48A, Class C,
3 mo. USD LIBOR + 1.800%,
4.510%, due 07/20/304,5
   

725,000

     

681,774

   
Capital One Multi-Asset Execution Trust,
Series 2005-B3, Class B3,
3 mo. USD LIBOR + 0.550%,
3.062%, due 05/15/285
   

350,000

     

340,241

   
CCG Receivables Trust,
Series 2020-1, Class C,
1.840%, due 12/14/274
   

275,000

     

263,863

   
Drive Auto Receivables Trust,
Series 2018-4, Class D,
4.090%, due 01/15/26
   

85,763

     

85,805

   
Series 2020-2, Class C,
2.280%, due 08/17/26
   

621,283

     

618,686

   
DT Auto Owner Trust,
Series 2019-1A, Class D,
3.870%, due 11/15/244
   

1,446,499

     

1,446,575

   
Series 2021-1A, Class C,
0.840%, due 10/15/264
   

325,000

     

312,417

   
Series 2021-1A, Class D,
1.160%, due 11/16/264
   

325,000

     

302,980

   
Enterprise Fleet Financing LLC,
Series 2020-1, Class A2,
1.780%, due 12/22/254
   

396,941

     

393,877

   
Exeter Automobile Receivables Trust,
Series 2020-2A, Class C,
3.280%, due 05/15/254
   

421,738

     

420,838

   
    Face
amount
 

Value

 

Asset-backed securities—(concluded)

 
Series 2021-3A, Class A3,
0.350%, due 02/18/25
 

$

944,012

   

$

940,380

   
Series 2021-4A, Class A3,
0.680%, due 07/15/25
   

898,355

     

891,024

   
Highbridge Loan Management Ltd.,
Series 12A-18, Class B,
3 mo. USD LIBOR + 1.850%,
4.590%, due 07/18/314,5
   

700,000

     

658,864

   
HPEFS Equipment Trust,
Series 2021-1A, Class D,
1.030%, due 03/20/314
   

675,000

     

640,346

   
Invitation Homes Trust,
Series 2018-SFR1, Class C,
1 mo. USD LIBOR + 1.250%,
3.630%, due 03/17/374,5
   

149,978

     

148,251

   
New Residential Advance Receivables Trust
Advance Receivables Backed Notes,
Series 2020-APT1, Class AT1,
1.035%, due 12/16/524
   

175,000

     

172,379

   
NRZ Advance Receivables Trust,
Series 2020-T3, Class AT3,
1.317%, due 10/15/524
   

60,000

     

59,743

   
OneMain Financial Issuance Trust,
Series 2020-2A, Class A,
1.750%, due 09/14/354
   

600,000

     

538,173

   
Series 2020-2A, Class B,
2.210%, due 09/14/354
   

300,000

     

261,928

   
Series 2021-1A, Class A1,
1.550%, due 06/16/364
   

600,000

     

522,888

   
Santander Retail Auto Lease Trust,
Series 2019-C, Class C,
2.390%, due 11/20/234
   

327,724

     

327,480

   
Series 2019-C, Class D,
2.880%, due 06/20/244
   

2,165,000

     

2,161,169

   
Series 2021-C, Class C,
1.110%, due 03/20/264
   

325,000

     

303,100

   
Tesla Auto Lease Trust,
Series 2020-A, Class D,
2.330%, due 02/20/244
   

150,000

     

146,734

   
Series 2021-A, Class D,
1.340%, due 03/20/254
   

575,000

     

534,700

   
Series 2021-B, Class D,
1.320%, due 09/22/254
   

325,000

     

299,550

   
Voya CLO Ltd.,
Series 2018-2A, Class C1,
3 mo. USD LIBOR + 1.850%,
4.362%, due 07/15/314,5
   

700,000

     

649,582

   
Westlake Automobile Receivables Trust,
Series 2020-1A, Class C,
2.520%, due 04/15/25
   

1,287,532

     

1,282,503

   
Total asset-backed securities
(cost—$16,730,868)
   

16,233,259

   

Corporate bonds—16.3%

 

Advertising—0.0%

 
Clear Channel Outdoor Holdings, Inc.
5.125%, due 08/15/274
   

35,000

     

31,347

   


17


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Aerospace & defense—0.2%

 
Bombardier, Inc.
7.500%, due 03/15/254
 

$

41,000

   

$

40,104

   
Howmet Aerospace, Inc.
5.900%, due 02/01/27
   

20,000

     

20,104

   

6.750%, due 01/15/28

   

32,000

     

32,960

   
Raytheon Technologies Corp.
4.125%, due 11/16/28
   

150,000

     

146,889

   
TransDigm UK Holdings PLC
6.875%, due 05/15/26
   

60,000

     

57,934

   
TransDigm, Inc.
5.500%, due 11/15/27
   

30,000

     

26,997

   

6.250%, due 03/15/264

   

50,000

     

49,125

   

6.375%, due 06/15/26

   

30,000

     

28,800

   

7.500%, due 03/15/27

   

35,000

     

34,125

   
         

437,038

   

Agriculture—0.1%

 
Darling Ingredients, Inc.
5.250%, due 04/15/274
   

30,000

     

29,424

   

6.000%, due 06/15/304

   

40,000

     

40,051

   
Reynolds American, Inc.
5.700%, due 08/15/35
   

70,000

     

64,543

   
         

134,018

   

Airlines—0.2%

 
American Airlines, Inc./AAdvantage Loyalty IP Ltd.
5.500%, due 04/20/264
   

31,000

     

29,490

   
Delta Air Lines, Inc.
7.000%, due 05/01/254
   

250,000

     

258,816

   
Delta Airlines Pass-Through Trust,
Series 2020-1, Class AA,
2.000%, due 06/10/28
   

96,845

     

83,974

   
United Airlines, Inc.
4.375%, due 04/15/264
   

38,000

     

34,646

   

4.625%, due 04/15/294

   

30,000

     

26,325

   
         

433,251

   

Auto manufacturers—0.4%

 
Allison Transmission, Inc.
5.875%, due 06/01/294
   

35,000

     

32,903

   
Ford Motor Co.
6.100%, due 08/19/32
   

30,000

     

29,212

   

6.625%, due 10/01/28

   

35,000

     

35,864

   

7.450%, due 07/16/31

   

55,000

     

58,250

   

9.000%, due 04/22/25

   

56,000

     

62,649

   

9.625%, due 04/22/30

   

30,000

     

35,086

   
Ford Motor Credit Co. LLC
4.542%, due 08/01/26
   

200,000

     

186,214

   
General Motors Co.
6.600%, due 04/01/36
   

200,000

     

201,810

   
General Motors Financial Co., Inc.
4.000%, due 10/06/26
   

200,000

     

192,038

   
PM General Purchaser LLC
9.500%, due 10/01/284
   

70,000

     

60,635

   
         

894,661

   
    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Auto parts & equipment—0.0%

 
Dana, Inc.
4.250%, due 09/01/30
 

$

20,000

   

$

16,143

   

5.625%, due 06/15/28

   

20,000

     

17,946

   
         

34,089

   

Banks—3.4%

 
Bank of America Corp.
4.200%, due 08/26/24
   

120,000

     

119,805

   

6.110%, due 01/29/37

   

850,000

     

901,041

   
Series Z,
(fixed, converts to FRN on 10/23/24),
6.500%, due 10/23/246
   

30,000

     

30,187

   
Bank of New York Mellon Corp.
1.600%, due 04/24/25
   

150,000

     

141,219

   
Bank of Nova Scotia
(fixed, converts to FRN on 05/04/32),
4.588%, due 05/04/37
   

150,000

     

135,591

   
Barclays PLC
4.337%, due 01/10/28
   

305,000

     

288,396

   
(fixed, converts to FRN on 08/09/32),
5.746%, due 08/09/33
   

200,000

     

195,967

   
Citigroup, Inc.
(fixed, converts to FRN on 03/20/29),
3.980%, due 03/20/30
   

275,000

     

257,220

   

5.500%, due 09/13/25

   

300,000

     

307,767

   
(fixed, converts to FRN on 01/30/23),
5.950%, due 01/30/236
   

35,000

     

34,650

   

6.675%, due 09/13/43

   

200,000

     

226,177

   
Credit Suisse Group AG
4.550%, due 04/17/26
   

250,000

     

239,639

   
Deutsche Bank AG
(fixed, converts to FRN on 01/07/27),
2.552%, due 01/07/28
   

150,000

     

127,875

   

3.700%, due 05/30/24

   

125,000

     

122,843

   
Goldman Sachs Group, Inc.
3.750%, due 02/25/26
   

150,000

     

147,046

   
3 mo. USD LIBOR + 1.600%,
4.643%, due 11/29/235
   

600,000

     

605,001

   

5.150%, due 05/22/45

   

210,000

     

199,915

   
HSBC Holdings PLC
6.500%, due 09/15/37
   

200,000

     

207,581

   
JPMorgan Chase & Co.
3.875%, due 09/10/24
   

550,000

     

547,598

   
(fixed, converts to FRN on 01/29/26),
3.960%, due 01/29/27
   

200,000

     

194,569

   
(fixed, converts to FRN on 07/24/47),
4.032%, due 07/24/48
   

350,000

     

299,532

   
Series R,
(fixed, converts to FRN on 08/01/23),
6.000%, due 08/01/236
   

60,000

     

58,683

   
Lloyds Banking Group PLC
4.582%, due 12/10/25
   

400,000

     

389,905

   
Mitsubishi UFJ Financial Group, Inc.
3.677%, due 02/22/27
   

350,000

     

336,190

   


18


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Banks—(concluded)

 
Morgan Stanley
4.300%, due 01/27/45
 

$

225,000

   

$

201,055

   

4.350%, due 09/08/26

   

815,000

     

805,422

   
Royal Bank of Canada
2.300%, due 11/03/31
   

200,000

     

166,124

   
Societe Generale SA
4.000%, due 01/12/274
   

200,000

     

190,739

   
Sumitomo Mitsui Financial Group, Inc.
3.544%, due 01/17/28
   

150,000

     

142,105

   
Wells Fargo & Co.
(fixed, converts to FRN on 06/17/26),
3.196%, due 06/17/27
   

95,000

     

89,488

   
         

7,709,330

   

Beverages—0.1%

 
Anheuser-Busch Cos. LLC/Anheuser-Busch
InBev Worldwide, Inc.
4.700%, due 02/01/36
   

75,000

     

72,561

   

4.900%, due 02/01/46

   

30,000

     

28,481

   
Primo Water Holdings, Inc.
4.375%, due 04/30/294
   

93,000

     

79,496

   
         

180,538

   

Biotechnology—0.1%

 
Biogen, Inc.
3.250%, due 02/15/51
   

56,000

     

38,962

   
Gilead Sciences, Inc.
2.950%, due 03/01/27
   

200,000

     

189,445

   

4.750%, due 03/01/46

   

50,000

     

47,849

   
         

276,256

   

Building materials—0.1%

 
Builders FirstSource, Inc.
4.250%, due 02/01/324
   

10,000

     

7,982

   

5.000%, due 03/01/304

   

30,000

     

26,587

   

6.375%, due 06/15/324

   

10,000

     

9,275

   
Masco Corp.
4.500%, due 05/15/47
   

150,000

     

126,973

   
New Enterprise Stone & Lime Co., Inc.
5.250%, due 07/15/284
   

61,000

     

54,210

   

9.750%, due 07/15/284

   

12,000

     

10,377

   
SRM Escrow Issuer LLC
6.000%, due 11/01/284
   

51,000

     

46,262

   
Summit Materials LLC/Summit Materials
Finance Corp.
5.250%, due 01/15/294
   

35,000

     

31,482

   
         

313,148

   

Chemicals—0.3%

 
Chemours Co.
4.625%, due 11/15/294
   

45,000

     

37,125

   

5.375%, due 05/15/27

   

30,000

     

27,671

   
DuPont de Nemours, Inc.
4.725%, due 11/15/28
   

100,000

     

100,815

   
    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Chemicals—(concluded)

 
LYB International Finance II BV
3.500%, due 03/02/27
 

$

150,000

   

$

142,295

   
NOVA Chemicals Corp.
4.250%, due 05/15/294
   

25,000

     

20,563

   

5.250%, due 06/01/274

   

85,000

     

75,046

   
Nutrien Ltd.
4.200%, due 04/01/29
   

100,000

     

96,926

   
Tronox, Inc.
4.625%, due 03/15/294
   

40,000

     

33,272

   
WR Grace Holdings LLC
4.875%, due 06/15/274
   

30,000

     

27,746

   

5.625%, due 10/01/244

   

60,000

     

59,250

   
         

620,709

   

Commercial services—0.5%

 
ASGN, Inc.
4.625%, due 05/15/284
   

69,000

     

60,981

   
Avis Budget Car Rental LLC/Avis
Budget Finance, Inc.
5.375%, due 03/01/294
   

10,000

     

8,715

   

5.750%, due 07/15/274

   

92,000

     

87,170

   
Block, Inc.
3.500%, due 06/01/31
   

34,000

     

27,973

   
Carriage Services, Inc.
4.250%, due 05/15/294
   

55,000

     

46,749

   
Garda World Security Corp.
9.500%, due 11/01/274
   

83,000

     

75,648

   
Gartner, Inc.
4.500%, due 07/01/284
   

10,000

     

9,229

   
Legends Hospitality Holding Co. LLC/Legends
Hospitality Co.-Issuer, Inc.
5.000%, due 02/01/264
   

30,000

     

27,375

   
MoneyGram International, Inc.
5.375%, due 08/01/264
   

103,000

     

101,092

   
NESCO Holdings II, Inc.
5.500%, due 04/15/294
   

45,000

     

39,600

   
Prime Security Services Borrower LLC/Prime
Finance, Inc.
3.375%, due 08/31/274
   

5,000

     

4,303

   

5.750%, due 04/15/264

   

45,000

     

43,298

   
Quanta Services, Inc.
2.350%, due 01/15/32
   

400,000

     

316,049

   
Williams Scotsman International, Inc.
4.625%, due 08/15/284
   

60,000

     

53,928

   
WW International, Inc.
4.500%, due 04/15/294
   

34,000

     

21,233

   
Yale University,
Series 2020,
1.482%, due 04/15/30
   

100,000

     

83,885

   
ZipRecruiter, Inc.
5.000%, due 01/15/304
   

20,000

     

16,600

   
         

1,023,828

   


19


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Computers—0.4%

 
Ahead DB Holdings LLC
6.625%, due 05/01/284
 

$

30,000

   

$

26,925

   
Apple, Inc.
3.450%, due 02/09/45
   

200,000

     

173,596

   

3.850%, due 05/04/43

   

210,000

     

193,006

   
Booz Allen Hamilton, Inc.
3.875%, due 09/01/284
   

160,000

     

142,320

   

4.000%, due 07/01/294

   

40,000

     

35,267

   
International Business Machines Corp.
5.875%, due 11/29/32
   

175,000

     

190,307

   
KBR, Inc.
4.750%, due 09/30/284
   

75,000

     

67,865

   
Science Applications International Corp.
4.875%, due 04/01/284
   

70,000

     

64,749

   
Seagate HDD Cayman
4.091%, due 06/01/29
   

50,000

     

42,750

   
         

936,785

   

Distribution & wholesale—0.0%

 
American Builders & Contractors Supply Co., Inc.
3.875%, due 11/15/294
   

46,000

     

37,691

   

4.000%, due 01/15/284

   

10,000

     

9,045

   
         

46,736

   

Diversified financial services—0.7%

 
AerCap Ireland Capital DAC/AerCap Global
Aviation Trust
3.000%, due 10/29/28
   

200,000

     

170,024

   

6.500%, due 07/15/25

   

29,000

     

29,695

   
Avolon Holdings Funding Ltd.
2.750%, due 02/21/284
   

200,000

     

162,928

   
Capital One Bank USA N.A.
3.375%, due 02/15/23
   

70,000

     

69,843

   
Capital One Financial Corp.
3.750%, due 07/28/26
   

200,000

     

192,668

   
CME Group, Inc.
3.750%, due 06/15/28
   

150,000

     

147,249

   
Enact Holdings, Inc.
6.500%, due 08/15/254
   

95,000

     

90,725

   
Intercontinental Exchange, Inc.
3.000%, due 06/15/50
   

200,000

     

145,850

   
Nationstar Mortgage Holdings, Inc.
5.125%, due 12/15/304
   

29,000

     

22,836

   

5.500%, due 08/15/284

   

40,000

     

33,439

   

6.000%, due 01/15/274

   

35,000

     

31,130

   
Navient Corp.
6.750%, due 06/15/26
   

260,000

     

246,568

   
OneMain Finance Corp.
5.625%, due 03/15/23
   

40,000

     

39,644

   

7.125%, due 03/15/26

   

115,000

     

107,121

   
Rocket Mortgage LLC / Rocket Mortgage
Co-Issuer, Inc.
2.875%, due 10/15/264
   

150,000

     

126,000

   

3.625%, due 03/01/294

   

16,000

     

12,880

   
Visa, Inc.
2.000%, due 08/15/50
   

50,000

     

32,405

   
         

1,661,005

   
    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Electric—1.1%

 
Alabama Power Co.
6.000%, due 03/01/39
 

$

30,000

   

$

32,842

   
Berkshire Hathaway Energy Co.
3.750%, due 11/15/23
   

80,000

     

79,984

   

4.450%, due 01/15/49

   

50,000

     

46,531

   
Calpine Corp.
4.625%, due 02/01/294
   

30,000

     

25,481

   

5.125%, due 03/15/284

   

35,000

     

31,084

   
Clearway Energy Operating LLC
4.750%, due 03/15/284
   

65,000

     

60,856

   
Dominion Energy, Inc.
3.900%, due 10/01/25
   

150,000

     

148,005

   
Duke Energy Carolinas LLC
2.550%, due 04/15/31
   

150,000

     

131,292

   
Duke Energy Ohio, Inc.
4.300%, due 02/01/49
   

150,000

     

135,379

   
Edison International
4.950%, due 04/15/25
   

188,000

     

188,272

   
Exelon Corp.
3.400%, due 04/15/26
   

170,000

     

164,928

   

4.450%, due 04/15/46

   

300,000

     

268,884

   
FirstEnergy Corp.,
Series C,
5.350%, due 07/15/47
   

20,000

     

18,400

   
Florida Power & Light Co.
5.950%, due 02/01/38
   

45,000

     

50,151

   
Georgia Power Co.,
Series B,
3.700%, due 01/30/50
   

150,000

     

119,702

   
Leeward Renewable Energy Operations LLC
4.250%, due 07/01/294
   

25,000

     

20,607

   
National Rural Utilities Cooperative Finance Corp.
3.900%, due 11/01/28
   

100,000

     

96,544

   
Northern States Power Co.
2.600%, due 05/15/23
   

50,000

     

49,715

   
NRG Energy, Inc.
3.625%, due 02/15/314
   

30,000

     

23,829

   

5.250%, due 06/15/294

   

10,000

     

8,938

   
Oncor Electric Delivery Co. LLC
3.750%, due 04/01/45
   

40,000

     

34,023

   
PG&E Corp.
5.000%, due 07/01/28
   

50,000

     

44,398

   
Public Service Electric and Gas Co.
2.450%, due 01/15/30
   

150,000

     

133,857

   
Southern California Edison Co.
3.650%, due 02/01/50
   

175,000

     

133,929

   
Southwestern Electric Power Co.
3.250%, due 11/01/51
   

250,000

     

181,059

   
Virginia Electric and Power Co.
4.600%, due 12/01/48
   

100,000

     

94,989

   
Vistra Operations Co. LLC
5.000%, due 07/31/274
   

75,000

     

69,801

   

5.625%, due 02/15/274

   

60,000

     

57,750

   
         

2,451,230

   


20


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Electrical components & equipment—0.0%

 
Energizer Holdings, Inc.
4.375%, due 03/31/294
 

$

54,000

   

$

43,925

   

4.750%, due 06/15/284

   

30,000

     

24,958

   
WESCO Distribution, Inc.
7.250%, due 06/15/284
   

30,000

     

30,248

   
         

99,131

   

Electronics—0.0%

 
II-VI, Inc.
5.000%, due 12/15/294
   

40,000

     

35,615

   
Sensata Technologies, Inc.
4.375%, due 02/15/304
   

50,000

     

44,549

   
         

80,164

   

Energy-alternate sources—0.0%

 
TerraForm Power Operating LLC
4.750%, due 01/15/304
   

72,000

     

63,746

   

Engineering & construction—0.1%

 
Arcosa, Inc.
4.375%, due 04/15/294
   

35,000

     

31,705

   
Artera Services LLC
9.033%, due 12/04/254
   

68,000

     

55,877

   
Dycom Industries, Inc.
4.500%, due 04/15/294
   

45,000

     

40,168

   
Great Lakes Dredge & Dock Corp.
5.250%, due 06/01/294
   

77,000

     

65,676

   
Weekley Homes LLC/Weekley Finance Corp.
4.875%, due 09/15/284
   

15,000

     

12,434

   
         

205,860

   

Entertainment—0.2%

 
Affinity Gaming
6.875%, due 12/15/274
   

89,000

     

77,286

   
Caesars Entertainment, Inc.
6.250%, due 07/01/254
   

53,000

     

51,750

   

8.125%, due 07/01/274

   

88,000

     

86,457

   
CDI Escrow Issuer, Inc.
5.750%, due 04/01/304
   

20,000

     

18,530

   
Churchill Downs, Inc.
5.500%, due 04/01/274
   

35,000

     

33,536

   
Cinemark USA, Inc.
5.250%, due 07/15/284
   

10,000

     

8,101

   

5.875%, due 03/15/264

   

35,000

     

31,052

   
International Game Technology PLC
5.250%, due 01/15/294
   

20,000

     

18,700

   
Jacobs Entertainment, Inc.
6.750%, due 02/15/294
   

80,000

     

71,000

   
Magallanes, Inc.
5.050%, due 03/15/424
   

150,000

     

122,627

   
         

519,039

   
    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Environmental control—0.0%

 
Covanta Holding Corp.
4.875%, due 12/01/294
 

$

35,000

   

$

29,531

   

5.000%, due 09/01/30

   

25,000

     

21,071

   
GFL Environmental, Inc.
4.750%, due 06/15/294
   

25,000

     

21,687

   
         

72,289

   

Food—0.1%

 
Kroger Co.
3.875%, due 10/15/46
   

250,000

     

208,334

   
Performance Food Group, Inc.
5.500%, due 10/15/274
   

40,000

     

37,705

   
United Natural Foods, Inc.
6.750%, due 10/15/284
   

60,000

     

57,631

   
         

303,670

   

Food service—0.0%

 
Aramark Services, Inc.
5.000%, due 02/01/284
   

65,000

     

59,821

   

Forest products & paper—0.0%

 
Clearwater Paper Corp.
4.750%, due 08/15/284
   

35,000

     

31,293

   

Healthcare-products—0.2%

 
Abbott Laboratories
3.750%, due 11/30/26
   

62,000

     

62,191

   

4.900%, due 11/30/46

   

50,000

     

52,503

   
Avantor Funding, Inc.
4.625%, due 07/15/284
   

70,000

     

63,691

   
Medline Borrower LP
5.250%, due 10/01/294
   

24,000

     

20,170

   
Medtronic, Inc.
4.375%, due 03/15/35
   

97,000

     

96,273

   
Zimmer Biomet Holdings, Inc.
4.250%, due 08/15/35
   

50,000

     

44,877

   
         

339,705

   

Healthcare-services—0.5%

 
Acadia Healthcare Co., Inc.
5.000%, due 04/15/294
   

35,000

     

32,405

   

5.500%, due 07/01/284

   

55,000

     

52,103

   
Centene Corp.
3.000%, due 10/15/30
   

18,000

     

15,044

   

4.625%, due 12/15/29

   

90,000

     

84,784

   
CHS/Community Health Systems, Inc.
5.625%, due 03/15/274
   

90,000

     

76,320

   

6.875%, due 04/15/294

   

53,000

     

33,125

   

8.000%, due 03/15/264

   

195,000

     

182,325

   
DaVita, Inc.
4.625%, due 06/01/304
   

33,000

     

26,566

   
Encompass Health Corp.
4.500%, due 02/01/28
   

100,000

     

87,484

   


21


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Healthcare-services—(concluded)

 
Legacy LifePoint Health LLC
4.375%, due 02/15/274
 

$

50,000

   

$

43,461

   

6.750%, due 04/15/254

   

35,000

     

34,356

   
Select Medical Corp.
6.250%, due 08/15/264
   

75,000

     

71,749

   
Tenet Healthcare Corp.
4.625%, due 06/15/284
   

10,000

     

9,090

   

4.875%, due 01/01/264

   

34,000

     

32,300

   

5.125%, due 11/01/274

   

55,000

     

50,958

   

6.125%, due 10/01/284

   

121,000

     

111,017

   

6.125%, due 06/15/304

   

30,000

     

28,803

   
UnitedHealth Group, Inc.
4.625%, due 07/15/35
   

40,000

     

39,857

   
         

1,011,747

   

Home builders—0.1%

 
Forestar Group, Inc.
3.850%, due 05/15/264
   

25,000

     

21,243

   
Installed Building Products, Inc.
5.750%, due 02/01/284
   

40,000

     

36,857

   
KB Home
6.875%, due 06/15/27
   

20,000

     

19,794

   
Picasso Finance Sub, Inc.
6.125%, due 06/15/254
   

27,000

     

27,054

   
         

104,948

   

Housewares—0.0%

 
Newell Brands, Inc.
5.625%, due 04/01/36
   

65,000

     

58,214

   

5.750%, due 04/01/46

   

5,000

     

4,100

   
         

62,314

   

Insurance—0.5%

 
Allstate Corp.
3.280%, due 12/15/26
   

200,000

     

194,779

   

3.850%, due 08/10/49

   

50,000

     

42,613

   
American International Group, Inc.
2.500%, due 06/30/25
   

75,000

     

71,496

   
Aon Global Ltd.
4.750%, due 05/15/45
   

150,000

     

139,451

   
Berkshire Hathaway Finance Corp.
4.250%, due 01/15/49
   

100,000

     

94,222

   
Hartford Financial Services Group, Inc.
6.100%, due 10/01/41
   

150,000

     

160,237

   
Lincoln National Corp.
4.000%, due 09/01/23
   

150,000

     

150,090

   
MetLife, Inc.
4.125%, due 08/13/42
   

130,000

     

116,763

   
Prudential Financial, Inc.
6.625%, due 06/21/40
   

110,000

     

125,436

   
Teachers Insurance & Annuity
Association of America
4.270%, due 05/15/474
   

50,000

     

45,030

   
         

1,140,117

   
    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Internet—0.1%

 
Alibaba Group Holding Ltd.
2.125%, due 02/09/31
 

$

200,000

   

$

166,422

   
Amazon.com, Inc.
2.500%, due 06/03/50
   

150,000

     

104,360

   
Uber Technologies, Inc.
4.500%, due 08/15/294
   

25,000

     

21,703

   

7.500%, due 09/15/274

   

25,000

     

25,032

   
         

317,517

   

Investment companies—0.0%

 
Icahn Enterprises LP/Icahn Enterprises
Finance Corp.
6.250%, due 05/15/26
   

40,000

     

38,345

   

Iron & steel—0.0%

 
Big River Steel LLC/BRS Finance Corp.
6.625%, due 01/31/294
   

44,000

     

43,795

   
Commercial Metals Co.
4.125%, due 01/15/30
   

20,000

     

17,492

   
TMS International Corp.
6.250%, due 04/15/294
   

35,000

     

24,413

   
         

85,700

   

Leisure time—0.2%

 
Carnival Corp.
5.750%, due 03/01/274
   

70,000

     

54,425

   

7.625%, due 03/01/264

   

60,000

     

51,081

   
Harley-Davidson, Inc.
3.500%, due 07/28/25
   

250,000

     

241,881

   
NCL Corp. Ltd.
5.875%, due 03/15/264
   

30,000

     

24,259

   
Royal Caribbean Cruises Ltd.
5.500%, due 08/31/264
   

44,000

     

35,171

   

7.500%, due 10/15/27

   

25,000

     

21,275

   

9.125%, due 06/15/234

   

30,000

     

30,243

   

11.625%, due 08/15/27

   

20,000

     

19,603

   
         

477,938

   

Lodging—0.0%

 
Hilton Domestic Operating Co., Inc.
4.000%, due 05/01/314
   

40,000

     

33,806

   
Hilton Grand Vacations Borrower Escrow
LLC/Hilton Grand Vacations Borrower ESC
4.875%, due 07/01/314
   

10,000

     

8,255

   

5.000%, due 06/01/294

   

25,000

     

22,120

   
Travel + Leisure Co.
6.625%, due 07/31/264
   

35,000

     

33,918

   
         

98,099

   

Machinery-diversified—0.1%

 
Deere & Co.
3.900%, due 06/09/42
   

150,000

     

140,078

   
GrafTech Finance, Inc.
4.625%, due 12/15/284
   

77,000

     

65,698

   
Mueller Water Products, Inc.
4.000%, due 06/15/294
   

25,000

     

22,493

   
         

228,269

   


22


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Media—0.9%

 
CCO Holdings LLC/CCO Holdings Capital Corp.
4.250%, due 02/01/314
 

$

25,000

   

$

20,399

   

4.250%, due 01/15/344

   

40,000

     

30,454

   

4.750%, due 03/01/304

   

98,000

     

84,234

   

5.375%, due 06/01/294

   

60,000

     

54,816

   
Charter Communications Operating LLC/Charter
Communications Operating Capital
4.200%, due 03/15/28
   

150,000

     

141,417

   
Comcast Corp.
2.887%, due 11/01/51
   

439,000

     

309,081

   

3.969%, due 11/01/47

   

85,000

     

73,003

   

4.150%, due 10/15/28

   

300,000

     

297,383

   
CSC Holdings LLC
6.500%, due 02/01/294
   

200,000

     

184,047

   
Fox Corp.
3.050%, due 04/07/25
   

25,000

     

24,160

   

5.576%, due 01/25/49

   

50,000

     

48,343

   
Gray Escrow II, Inc.
5.375%, due 11/15/314
   

55,000

     

46,485

   
Gray Television, Inc.
5.875%, due 07/15/264
   

40,000

     

38,595

   
Liberty Interactive LLC
8.250%, due 02/01/30
   

35,000

     

26,775

   
Nexstar Media, Inc.
4.750%, due 11/01/284
   

10,000

     

9,050

   

5.625%, due 07/15/274

   

40,000

     

38,087

   
Radiate Holdco LLC/Radiate Finance, Inc.
4.500%, due 09/15/264
   

10,000

     

8,620

   

6.500%, due 09/15/284

   

60,000

     

44,684

   
Sirius XM Radio, Inc.
3.875%, due 09/01/314
   

25,000

     

20,188

   

4.000%, due 07/15/284

   

55,000

     

47,920

   

4.125%, due 07/01/304

   

25,000

     

21,182

   

5.500%, due 07/01/294

   

35,000

     

32,728

   
Time Warner Cable LLC
6.550%, due 05/01/37
   

25,000

     

24,556

   
Time Warner Entertainment Co. LP
8.375%, due 03/15/23
   

35,000

     

35,844

   
Univision Communications, Inc.
4.500%, due 05/01/294
   

40,000

     

34,990

   

6.625%, due 06/01/274

   

50,000

     

48,251

   

7.375%, due 06/30/304

   

25,000

     

24,813

   
Walt Disney Co.
2.000%, due 09/01/29
   

100,000

     

86,384

   

4.950%, due 10/15/45

   

120,000

     

119,082

   
         

1,975,571

   

Mining—0.2%

 
Arconic Corp.
6.125%, due 02/15/284
   

75,000

     

70,401

   
Hudbay Minerals, Inc.
6.125%, due 04/01/294
   

25,000

     

22,006

   
    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Mining—(concluded)

 
Novelis Corp.
3.250%, due 11/15/264
 

$

10,000

   

$

8,900

   

3.875%, due 08/15/314

   

4,000

     

3,228

   

4.750%, due 01/30/304

   

75,000

     

65,250

   
Teck Resources Ltd.
3.900%, due 07/15/30
   

200,000

     

180,614

   
         

350,399

   

Miscellaneous manufacturers—0.3%

 
Amsted Industries, Inc.
4.625%, due 05/15/304
   

35,000

     

31,063

   

5.625%, due 07/01/274

   

20,000

     

19,394

   
Eaton Corp.
2.750%, due 11/02/22
   

70,000

     

69,946

   
GE Capital Funding LLC
3.450%, due 05/15/25
   

200,000

     

193,780

   
GE Capital International Funding Co.
Unlimited Co.
4.418%, due 11/15/35
   

200,000

     

189,107

   
Illinois Tool Works, Inc.
2.650%, due 11/15/26
   

110,000

     

105,677

   
         

608,967

   

Oil & gas—0.8%

 
Aker BP ASA
3.750%, due 01/15/304
   

150,000

     

134,818

   
Antero Resources Corp.
7.625%, due 02/01/294
   

17,000

     

17,292

   
Apache Corp.
5.100%, due 09/01/40
   

51,000

     

43,350

   
Ascent Resources Utica Holdings
LLC/ARU Finance Corp.
5.875%, due 06/30/294
   

41,000

     

36,900

   

7.000%, due 11/01/264

   

29,000

     

28,202

   

8.250%, due 12/31/284

   

10,000

     

9,938

   
BP Capital Markets America, Inc.
3.017%, due 01/16/27
   

75,000

     

71,738

   
California Resources Corp.
7.125%, due 02/01/264
   

63,000

     

61,932

   
Comstock Resources, Inc.
5.875%, due 01/15/304
   

15,000

     

13,724

   

6.750%, due 03/01/294

   

65,000

     

62,041

   
ConocoPhillips Co.
3.758%, due 03/15/424
   

150,000

     

131,527

   
Ecopetrol SA
5.375%, due 06/26/26
   

325,000

     

304,566

   
EOG Resources, Inc.
3.900%, due 04/01/35
   

50,000

     

46,018

   
EQT Corp.
3.125%, due 05/15/264
   

150,000

     

141,157

   

7.000%, due 02/01/30

   

18,000

     

19,262

   
Equinor ASA
4.800%, due 11/08/43
   

50,000

     

50,192

   


23


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Oil & gas—(concluded)

 
ExxonMobil Corp.
4.114%, due 03/01/46
 

$

50,000

   

$

46,020

   
Hilcorp Energy I LP/Hilcorp Finance Co.
5.750%, due 02/01/294
   

79,000

     

71,912

   

6.000%, due 04/15/304

   

10,000

     

9,206

   

6.250%, due 11/01/284

   

20,000

     

18,899

   
Marathon Petroleum Corp.
4.750%, due 09/15/44
   

110,000

     

96,765

   
Murphy Oil Corp.
7.050%, due 05/01/29
   

44,000

     

42,890

   
Nabors Industries, Inc.
9.000%, due 02/01/254
   

67,000

     

67,116

   
Occidental Petroleum Corp.
5.500%, due 12/01/25
   

2,000

     

2,054

   

5.875%, due 09/01/25

   

42,000

     

43,051

   

6.375%, due 09/01/28

   

26,000

     

27,155

   

6.450%, due 09/15/36

   

32,000

     

34,198

   

6.950%, due 07/01/24

   

29,000

     

30,270

   

8.500%, due 07/15/27

   

26,000

     

29,119

   
Shell International Finance BV
4.375%, due 05/11/45
   

100,000

     

93,401

   
Southwestern Energy Co.
5.375%, due 03/15/30
   

55,000

     

51,550

   
         

1,836,263

   

Oil & gas services—0.1%

 
Archrock Partners LP/Archrock Partners
Finance Corp.
6.250%, due 04/01/284
   

11,000

     

10,010

   

6.875%, due 04/01/274

   

22,000

     

20,625

   
Oceaneering International, Inc.
4.650%, due 11/15/24
   

58,000

     

54,109

   
USA Compression Partners LP/USA Compression
Finance Corp.
6.875%, due 09/01/27
   

64,000

     

59,164

   
Weatherford International Ltd.
8.625%, due 04/30/304
   

7,000

     

6,327

   

11.000%, due 12/01/244

   

25,000

     

25,383

   
         

175,618

   

Packaging & containers—0.1%

 
Cascades, Inc./Cascades USA, Inc.
5.375%, due 01/15/284
   

35,000

     

31,520

   
Graphic Packaging International LLC
3.500%, due 03/15/284
   

40,000

     

35,189

   

4.750%, due 07/15/274

   

20,000

     

19,099

   
Owens-Brockway Glass Container, Inc.
5.375%, due 01/15/254
   

39,000

     

36,275

   

6.625%, due 05/13/274

   

28,000

     

25,989

   
         

148,072

   

Pharmaceuticals—0.4%

 
AbbVie, Inc.
3.200%, due 05/14/26
   

30,000

     

28,747

   

3.800%, due 03/15/25

   

90,000

     

88,953

   

4.450%, due 05/14/46

   

200,000

     

179,877

   
    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Pharmaceuticals—(concluded)

 
Bausch Health Americas, Inc.
9.250%, due 04/01/264
 

$

25,000

   

$

15,000

   
Bristol-Myers Squibb Co.
4.125%, due 06/15/39
   

250,000

     

234,177

   
Pfizer, Inc.
7.200%, due 03/15/39
   

270,000

     

346,222

   
         

892,976

   

Pipelines—0.8%

 
Antero Midstream Partners LP/Antero
Midstream Finance Corp.
5.375%, due 06/15/294
   

25,000

     

22,923

   
Blue Racer Midstream LLC/Blue Racer
Finance Corp.
7.625%, due 12/15/254
   

67,000

     

66,665

   
Buckeye Partners LP
4.500%, due 03/01/284
   

40,000

     

35,414

   

5.600%, due 10/15/44

   

12,000

     

8,921

   

5.850%, due 11/15/43

   

15,000

     

11,445

   
Cheniere Energy, Inc.
4.625%, due 10/15/28
   

9,000

     

8,672

   
CNX Midstream Partners LP
4.750%, due 04/15/304
   

71,000

     

59,937

   
Crestwood Midstream Partners LP/Crestwood
Midstream Finance Corp.
8.000%, due 04/01/294
   

25,000

     

24,786

   
DCP Midstream Operating LP
5.375%, due 07/15/25
   

25,000

     

25,063

   
Enbridge Energy Partners LP
7.375%, due 10/15/45
   

100,000

     

118,838

   
Energy Transfer LP
5.400%, due 10/01/47
   

100,000

     

89,089

   
EnLink Midstream LLC
5.625%, due 01/15/284
   

29,000

     

27,859

   

6.500%, due 09/01/30

   

30,000

     

29,850

   
EQM Midstream Partners LP
4.750%, due 01/15/314
   

13,000

     

11,243

   

6.500%, due 07/01/274

   

20,000

     

19,305

   

7.500%, due 06/01/274

   

30,000

     

29,665

   
Genesis Energy LP/Genesis Energy Finance Corp.
5.625%, due 06/15/24
   

32,000

     

30,603

   

8.000%, due 01/15/27

   

54,000

     

51,165

   
Hess Midstream Operations LP
4.250%, due 02/15/304
   

13,000

     

11,160

   

5.125%, due 06/15/284

   

38,000

     

35,292

   

5.625%, due 02/15/264

   

62,000

     

60,454

   
Holly Energy Partners LP/Holly Energy
Finance Corp.
5.000%, due 02/01/284
   

29,000

     

27,004

   

6.375%, due 04/15/274

   

10,000

     

9,732

   
Kinder Morgan, Inc.
4.300%, due 03/01/28
   

150,000

     

146,528

   

5.550%, due 06/01/45

   

120,000

     

116,720

   
MPLX LP
4.875%, due 06/01/25
   

120,000

     

120,516

   


24


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Pipelines—(concluded)

 
Plains All American Pipeline LP/PAA Finance Corp.
3.800%, due 09/15/30
 

$

150,000

   

$

133,055

   
Sabine Pass Liquefaction LLC
5.000%, due 03/15/27
   

180,000

     

179,375

   
Venture Global Calcasieu Pass LLC
3.875%, due 08/15/294
   

28,000

     

24,430

   
Western Midstream Operating LP
3.350%, due 02/01/25
   

44,000

     

41,513

   

4.650%, due 07/01/26

   

200,000

     

190,334

   

5.450%, due 04/01/44

   

5,000

     

4,380

   
Williams Cos., Inc.
4.300%, due 03/04/24
   

80,000

     

80,023

   
         

1,851,959

   

Real estate—0.0%

 
Howard Hughes Corp.
5.375%, due 08/01/284
   

19,000

     

16,910

   

Real estate investment trusts—0.2%

 
AvalonBay Communities, Inc.
3.450%, due 06/01/25
   

70,000

     

68,702

   
Boston Properties LP
2.750%, due 10/01/26
   

40,000

     

37,241

   
Iron Mountain, Inc.
4.875%, due 09/15/274
   

45,000

     

41,303

   

5.000%, due 07/15/284

   

60,000

     

54,752

   

5.250%, due 07/15/304

   

45,000

     

39,825

   
iStar, Inc.
4.750%, due 10/01/24
   

30,000

     

30,012

   
Ladder Capital Finance Holdings
LLLP/Ladder Capital Finance Corp.
4.750%, due 06/15/294
   

30,000

     

25,421

   
Service Properties Trust
7.500%, due 09/15/25
   

20,000

     

19,193

   
VICI Properties LP/VICI Note Co., Inc.
4.500%, due 09/01/264
   

37,000

     

34,865

   

4.625%, due 12/01/294

   

55,000

     

50,806

   
         

402,120

   

Retail—0.8%

 
Academy Ltd.
6.000%, due 11/15/274
   

35,000

     

32,672

   
Asbury Automotive Group, Inc.
4.625%, due 11/15/294
   

20,000

     

17,150

   
Bath & Body Works, Inc.
6.625%, due 10/01/304
   

80,000

     

72,677

   
Beacon Roofing Supply, Inc.
4.125%, due 05/15/294
   

58,000

     

48,574

   

4.500%, due 11/15/264

   

5,000

     

4,691

   
Group 1 Automotive, Inc.
4.000%, due 08/15/284
   

54,000

     

46,137

   
Home Depot, Inc.
2.125%, due 09/15/26
   

300,000

     

281,640

   

3.350%, due 09/15/25

   

40,000

     

39,661

   

3.350%, due 04/15/50

   

200,000

     

159,381

   
    Face
amount
 

Value

 

Corporate bonds—(continued)

 

Retail—(concluded)

 
Lithia Motors, Inc.
4.625%, due 12/15/274
 

$

20,000

   

$

18,519

   
Lowe's Cos., Inc.
2.800%, due 09/15/41
   

300,000

     

213,628

   
Macy's Retail Holdings LLC
5.875%, due 04/01/294
   

53,000

     

45,872

   
McDonald's Corp.
3.800%, due 04/01/28
   

425,000

     

417,124

   

4.875%, due 12/09/45

   

20,000

     

19,584

   
Patrick Industries, Inc.
4.750%, due 05/01/294
   

30,000

     

24,563

   

7.500%, due 10/15/274

   

40,000

     

37,492

   
QVC, Inc.
4.750%, due 02/15/27
   

40,000

     

33,037

   

4.850%, due 04/01/24

   

30,000

     

28,862

   
Target Corp.
1.950%, due 01/15/27
   

150,000

     

139,602

   
White Cap Buyer LLC
6.875%, due 10/15/284
   

52,000

     

45,559

   
         

1,726,425

   

Semiconductors—0.3%

 
Broadcom, Inc.
3.137%, due 11/15/354
   

340,000

     

257,613

   
NVIDIA Corp.
2.850%, due 04/01/30
   

100,000

     

90,224

   
NXP BV/NXP Funding LLC
5.550%, due 12/01/28
   

100,000

     

102,094

   
NXP BV/NXP Funding LLC/NXP USA, Inc.
3.875%, due 06/18/26
   

95,000

     

91,972

   
QUALCOMM, Inc.
3.250%, due 05/20/27
   

80,000

     

78,063

   
         

619,966

   

Software—0.4%

 
Dun & Bradstreet Corp.
5.000%, due 12/15/294
   

40,000

     

35,500

   
Fiserv, Inc.
3.200%, due 07/01/26
   

90,000

     

85,637

   
Microsoft Corp.
2.525%, due 06/01/50
   

120,000

     

87,340

   

3.500%, due 02/12/35

   

250,000

     

238,964

   
Oracle Corp.
2.800%, due 04/01/27
   

250,000

     

228,852

   

5.375%, due 07/15/40

   

366,000

     

329,359

   
         

1,005,652

   

Telecommunications—1.0%

 
Altice France Holding SA
10.500%, due 05/15/274
   

200,000

     

172,544

   
AT&T, Inc.
3.800%, due 12/01/57
   

117,000

     

88,565

   

6.000%, due 08/15/40

   

380,000

     

401,529

   
CommScope, Inc.
6.000%, due 03/01/264
   

25,000

     

23,628

   

8.250%, due 03/01/274

   

35,000

     

29,996

   


25


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Corporate bonds—(concluded)

 

Telecommunications—(concluded)

 
Consolidated Communications, Inc.
6.500%, due 10/01/284
 

$

92,000

   

$

74,032

   
Deutsche Telekom International Finance BV
8.750%, due 06/15/30
   

150,000

     

184,186

   
DKT Finance ApS
7.000%, due 06/17/237
 

EUR

100,000

     

97,480

   
Frontier Communications Holdings LLC
5.875%, due 10/15/274
 

$

90,000

     

83,947

   

6.750%, due 05/01/294

   

35,000

     

30,187

   
GoTo Group, Inc.
5.500%, due 09/01/274
   

45,000

     

33,100

   
Level 3 Financing, Inc.
4.250%, due 07/01/284
   

86,000

     

71,487

   

5.250%, due 03/15/26

   

35,000

     

35,595

   
Lumen Technologies, Inc.
5.125%, due 12/15/264
   

35,000

     

30,243

   

5.625%, due 04/01/25

   

5,000

     

4,850

   
Rogers Communications, Inc.
5.000%, due 03/15/44
   

40,000

     

36,482

   
Sprint Capital Corp.
6.875%, due 11/15/28
   

115,000

     

121,434

   
Sprint Corp.
7.625%, due 03/01/26
   

150,000

     

158,644

   
Verizon Communications, Inc.
2.355%, due 03/15/32
   

209,000

     

171,465

   

4.016%, due 12/03/29

   

432,000

     

414,477

   
Viasat, Inc.
5.625%, due 09/15/254
   

60,000

     

52,695

   

5.625%, due 04/15/274

   

20,000

     

18,400

   
         

2,334,966

   

Transportation—0.3%

 
Burlington Northern Santa Fe LLC
5.150%, due 09/01/43
   

210,000

     

217,799

   
Norfolk Southern Corp.
3.400%, due 11/01/49
   

100,000

     

78,574

   
Union Pacific Corp.
3.375%, due 02/01/35
   

300,000

     

266,141

   
United Parcel Service, Inc.
3.750%, due 11/15/47
   

50,000

     

44,395

   
         

606,909

   

Trucking & leasing—0.0%

 
Fortress Transportation and Infrastructure
Investors LLC
5.500%, due 05/01/284
   

46,000

     

39,140

   
Total corporate bonds
(cost—$41,544,827)
   

37,115,594

   

Mortgage-backed securities—4.9%

 
Angel Oak Mortgage Trust,
Series 2019-5, Class A1,
2.593%, due 10/25/494,8
   

53,312

     

51,471

   
Series 2020-4, Class A1,
1.469%, due 06/25/654,8
   

70,769

     

67,331

   
    Face
amount
 

Value

 

Mortgage-backed securities—(continued)

 
Series 2020-5, Class A1,
1.373%, due 05/25/654,8
 

$

49,161

   

$

46,425

   
Series 2020-R1, Class A1,
0.990%, due 04/25/534,8
   

123,527

     

119,123

   
Series 2021-4, Class A1,
1.035%, due 01/20/654,8
   

148,613

     

125,794

   
Series 2021-5, Class A1,
0.951%, due 07/25/664,8
   

228,769

     

202,313

   
Angel Oak Mortgage Trust I LLC,
Series 2018-3, Class A1,
3.649%, due 09/25/484,8
   

6,387

     

6,345

   
Series 2019-4, Class A1,
2.993%, due 07/26/494,8
   

18,144

     

18,026

   
Arbor Multifamily Mortgage Securities Trust,
Series 2021-MF3, Class B,
2.511%, due 10/15/544
   

375,000

     

298,252

   
Series 2022-MF4, Class B,
3.403%, due 02/15/554,8
   

650,000

     

545,714

   
BAMLL Commercial Mortgage Securities Trust,
Series 2015-200P, Class D,
3.716%, due 04/14/334,8
   

400,000

     

366,159

   
BANK,
Series 2020-BN30, Class A4,
1.925%, due 12/15/53
   

350,000

     

289,896

   
BX Commercial Mortgage Trust,
Series 2021-SOAR, Class D,
1 mo. USD LIBOR + 1.400%,
3.792%, due 06/15/384,5
   

347,369

     

328,263

   
BX Mortgage Trust,
Series 2021-PAC, Class D,
1 mo. USD LIBOR + 1.298%,
3.690%, due 10/15/364,5
   

325,000

     

302,640

   
BX Trust,
Series 2021-LGCY, Class D,
1 mo. USD LIBOR + 1.302%,
3.693%, due 10/15/23 4,5
   

800,000

     

745,279

   
Series 2021-MFM1, Class D,
1 mo. USD LIBOR + 1.500%,
3.891%, due 01/15/34 4,5
   

175,000

     

165,375

   
Citigroup Commercial Mortgage Trust,
Series 2018-C5, Class A4,
4.228%, due 06/10/518
   

350,000

     

343,738

   
COLT Funding LLC,
Series 2021-3R, Class A1,
1.051%, due 12/25/644,8
   

299,099

     

274,547

   
COLT Mortgage Loan Trust,
Series 2020-2, Class A1,
1.853%, due 03/25/654,8
   

4,870

     

4,810

   
Series 2020-3, Class A1,
1.506%, due 04/27/654,8
   

19,913

     

19,164

   
Series 2021-2, Class A1,
0.924%, due 08/25/664,8
   

140,740

     

119,895

   
Series 2021-3, Class A1,
0.956%, due 09/27/664,8
   

182,888

     

154,641

   
COLT Mortgage Pass-Through Certificates,
Series 2021-1R, Class A1,
0.857%, due 05/25/654,8
   

42,424

     

38,983

   


26


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

Mortgage-backed securities—(continued)

 
CSMC Trust,
Series 2020-NQM1, Class A1,
1.208%, due 05/25/654,9
 

$

94,170

   

$

88,765

   
Deephaven Residential Mortgage Trust,
Series 2021-1, Class A1,
0.715%, due 05/25/654,8
   

88,985

     

82,201

   
Extended Stay America Trust,
Series 2021-ESH, Class D,
1 mo. USD LIBOR + 2.250%,
4.642%, due 07/15/384,5
   

911,391

     

882,316

   
Flagstar Mortgage Trust,
Series 2018-5, Class A2,
4.000%, due 09/25/484,8
   

262,685

     

255,981

   
GS Mortgage Securities Trust,
Series 2017-GS5, Class B,
4.047%, due 03/10/508
   

325,000

     

301,221

   
GS Mortgage-Backed Securities Corp. Trust,
Series 2021-NQM1, Class A1,
1.017%, due 07/25/614,8
   

263,336

     

240,349

   
GS Mortgage-Backed Securities Trust,
Series 2020-NQM1, Class A1,
1.382%, due 09/27/604,8
   

50,722

     

46,953

   
Hilton USA Trust,
Series 2016-SFP, Class B,
3.323%, due 11/05/354
   

425,000

     

412,057

   
JPMBB Commercial Mortgage Securities Trust,
Series 2014-C26, Class AS,
3.800%, due 01/15/48
   

250,000

     

239,881

   
Med Trust,
Series 2021-MDLN, Class D,
1 mo. USD LIBOR + 2.000%,
4.392%, due 11/15/384,5
   

800,000

     

759,041

   
MFA Trust,
Series 2021-NQM2, Class A1,
1.029%, due 11/25/644,8
   

101,877

     

90,243

   
MHC Commercial Mortgage Trust,
Series 2021-MHC, Class D,
1 mo. USD LIBOR + 1.601%,
3.992%, due 04/15/384,5
   

700,000

     

666,750

   
Morgan Stanley Bank of America
Merrill Lynch Trust,
Series 2016-C32, Class AS,
3.994%, due 12/15/498
   

260,000

     

247,793

   
Series 2017-C34, Class C,
4.315%, due 11/15/528
   

150,000

     

134,172

   
New Residential Mortgage Loan Trust,
Series 2021-NQM3, Class A1,
1.156%, due 11/27/564,8
   

403,097

     

356,899

   
ONE Mortgage Trust,
Series 2021-PARK, Class C,
1 mo. USD LIBOR + 1.100%,
3.491%, due 03/15/364,5
   

850,000

     

799,760

   
Residential Mortgage Loan Trust,
Series 2019-3, Class A1,
2.633%, due 09/25/594,8
   

46,000

     

44,790

   
Series 2020-1, Class A1,
2.376%, due 01/26/604,8
   

28,850

     

27,585

   
    Face
amount
 

Value

 

Mortgage-backed securities—(concluded)

 
Series 2020-2, Class A1,
1.654%, due 05/25/604,8
 

$

32,026

   

$

31,553

   
SLG Office Trust,
Series 2021-OVA, Class C,
2.851%, due 07/15/414
   

150,000

     

122,452

   
Verus Securitization Trust,
Series 2019-4, Class A1,
2.642%, due 11/25/594,9
   

32,515

     

31,929

   
Series 2020-4, Class A1,
1.502%, due 05/25/654,9
   

37,125

     

35,574

   
Series 2020-5, Class A1,
1.218%, due 05/25/654,9
   

86,494

     

81,572

   
Series 2021-1, Class A1,
0.815%, due 01/25/664,8
   

120,587

     

108,003

   
Series 2021-R1, Class A1,
0.820%, due 10/25/634,8
   

131,182

     

122,903

   
Series 2021-R3, Class A1,
1.020%, due 04/25/644,8
   

250,336

     

236,894

   
Vista Point Securitization Trust,
Series 2020-2, Class A1,
1.475%, due 04/25/654,8
   

31,298

     

29,474

   
Total mortgage-backed securities
(cost—$12,142,650)
   

11,111,295

   

Non-U.S. government agency obligations—0.4%

 
Chile Government International Bond
3.125%, due 01/21/26
   

200,000

     

191,038

   
Mexico Government International Bond
3.250%, due 04/16/30
   

200,000

     

178,225

   

4.750%, due 04/27/32

   

200,000

     

193,300

   
Panama Government International Bond
6.700%, due 01/26/36
   

265,000

     

284,759

   
Total non-U.S. government agency obligations
(cost—$981,033)
   

847,322

   

U.S. government agency obligations—7.2%

 
FHLMC
3.000%, due 11/01/46
   

84,630

     

79,634

   

3.000%, due 07/01/47

   

107,606

     

101,241

   

3.000%, due 08/01/47

   

107,021

     

100,692

   

4.000%, due 05/01/47

   

94,506

     

93,616

   

5.000%, due 03/01/38

   

10,199

     

10,609

   

5.500%, due 05/01/37

   

48,981

     

51,922

   

5.500%, due 08/01/40

   

12,639

     

13,395

   

6.500%, due 08/01/28

   

22,814

     

23,880

   
FNMA
2.000%, due 01/01/51
   

496,857

     

429,552

   

2.000%, due 03/01/51

   

1,773,486

     

1,529,512

   

2.500%, due 08/01/35

   

242,194

     

229,554

   

2.500%, due 08/01/51

   

1,106,759

     

991,086

   

3.000%, due 11/01/48

   

177,663

     

167,018

   

3.000%, due 02/01/50

   

184,848

     

172,489

   

3.500%, due 12/01/47

   

73,670

     

71,106

   

3.500%, due 02/01/48

   

503,621

     

486,091

   

4.000%, due 12/01/39

   

30,691

     

30,684

   

4.000%, due 02/01/41

   

15,420

     

15,413

   

4.000%, due 08/01/45

   

97,074

     

96,282

   


27


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

    Face
amount
 

Value

 

U.S. government agency obligations—(concluded)

 

4.500%, due 09/01/37

 

$

105,050

   

$

106,622

   

4.500%, due 07/01/47

   

45,634

     

45,976

   

5.000%, due 10/01/39

   

4,747

     

4,954

   

5.000%, due 05/01/40

   

3,527

     

3,683

   

5.500%, due 08/01/39

   

17,817

     

18,869

   

7.000%, due 08/01/32

   

73,626

     

79,975

   

7.500%, due 02/01/33

   

1,097

     

1,145

   
GNMA I
4.000%, due 07/15/42
   

26,092

     

26,118

   
GNMA II
3.000%, due 01/20/47
   

42,879

     

40,835

   

3.000%, due 07/20/47

   

118,017

     

112,332

   

3.000%, due 08/20/47

   

88,821

     

84,543

   

3.500%, due 04/20/47

   

109,023

     

106,227

   

6.000%, due 11/20/28

   

239

     

248

   

6.000%, due 02/20/29

   

495

     

513

   

6.000%, due 02/20/34

   

204,145

     

217,285

   
UMBS TBA
2.000%
   

5,350,000

     

4,601,128

   
2.500%    

4,700,000

     

4,195,737

   
3.000%    

2,375,000

     

2,197,008

   
Total U.S. government agency obligations
(cost—$17,712,582)
   

16,536,974

   
    Face
amount
 

Value

 

U.S. treasury obligations—1.0%

 
U.S. Treasury Bonds
3.375%, due 08/15/42
 

$

450,000

   

$

439,102

   
U.S. Treasury Notes
2.500%, due 03/31/27
   

225,000

     

216,650

   

2.750%, due 07/31/27

   

650,000

     

632,582

   

2.750%, due 08/15/32

   

1,150,000

     

1,109,391

   
Total U.S. treasury obligations
(cost—$2,424,594)
   

2,397,725

   
    Number of
shares
     

Short-term investments—8.5%

 

Investment companies—8.5%

 
State Street Institutional U.S. Government
Money Market Fund, 2.250%10
(cost—$19,360,180)
   

19,360,180

     

19,360,180

   
Total investments
(cost—$240,887,506)—104.7%
   

238,671,491

   

Liabilities in excess of other assets—(4.7)%

       

(10,768,088

)

 

Net assets—100.0%

 

$

227,903,403

   

Futures contracts

Number of
contracts
 

Currency

      Expiration
date
  Current
notional
amount
 

Value

  Unrealized
appreciation
(depreciation)
 

Index futures buy contracts:

 
 

115

   

USD

     

Russell 2000 Value Index Futures

 

September 2022

 

$

9,863,467

   

$

10,606,450

   

$

742,983

   

U.S. treasury futures buy contracts:

 
 

44

   

USD

     

U.S. Treasury Note 10 Year Futures

 

December 2022

 

$

5,170,455

   

$

5,143,875

   

$

(26,580

)

 
 

8

   

USD

      U.S. Treasury Note 10 Year
Ultra Futures
 

December 2022

   

1,008,387

     

1,001,500

     

(6,887

)

 
 

9

   

USD

     

U.S. Treasury Ultra Bond Futures

 

December 2022

   

1,359,084

     

1,345,500

     

(13,584

)

 

Total

                         

$

17,401,393

   

$

18,097,325

   

$

695,932

   

Index futures sell contracts:

 
 

8

   

USD

     

S&P 500 Index Futures

 

September 2022

 

$

(1,523,401

)

 

$

(1,582,600

)

 

$

(59,199

)

 

Interest rate futures sell contracts:

 
 

1

   

USD

     

U.S. Long Bond Futures

 

December 2022

 

$

(137,162

)

 

$

(135,843

)

 

$

1,319

   
 

6

   

USD

     

U.S. Treasury Note 2 Year Futures

 

December 2022

   

(1,250,992

)

   

(1,249,969

)

   

1,023

   
 

6

   

USD

     

U.S. Treasury Note 5 Year Futures

 

December 2022

   

(667,116

)

   

(664,922

)

   

2,194

   

Total

                         

$

(3,578,671

)

 

$

(3,633,334

)

 

$

(54,663

)

 
Net unrealized appreciation (depreciation)                                           

$

641,269

   


28


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

Centrally cleared credit default swap agreements on credit indices—buy protection11

Referenced obligations

  Notional
amount
(000)
  Maturity
date
  Payment
frequency
  Payments
made by
the Portfolio12
  Upfront
payments
received
(made)
 

Value

  Unrealized
appreciation
(depreciation)
 

CDX North America Investment Grade Series 38

 

USD

6,000

   

06/20/27

 

Quarterly

   

1.000

%

 

$

(3,704

)

 

$

(31,562

)

 

$

(35,266

)

 

OTC Total return swap agreements

Counterparty

  Notional
amount
(000)
  Maturity
date
  Payment
frequency
  Payments
made by the
Portfolio12
  Payments
received by
the Portfolio12
  Upfront
payments
received
(made)
 

Value

  Unrealized
appreciation
(depreciation)
 

BOA

 

USD

0

   

12/20/22

  Quarterly   Markit iBoxx
USD Liquid
High Yield
Index
  12 Month SOFR  

$

   

$

(2,259

)

 

$

(2,259

)

 

JPMCB

 

USD

1

   

12/20/22

  Quarterly   Markit iBoxx
USD Liquid
High Yield
Index
  12 Month SOFR    

     

(6,968

)

   

(6,968

)

 

MSCI

 

USD

2

   

12/20/22

 

Quarterly

  Markit iBoxx
USD Liquid
High Yield
Index
  12 Month SOFR    

     

6,168

     

6,168

   
                                               

$

   

$

(3,059

)

 

$

(3,059

)

 

Fair valuation summary

The following is a summary of the fair valuations according to the inputs used as of August 31, 2022 in valuing the Fund's investments. In the event the Fund holds investments (other than a money market fund) for which fair value is measured using the NAV per share practical expedient (or its equivalent), a separate column will be added to the fair value hierarchy table; this is intended to permit reconciliation to the amounts presented in the Portfolio of investments:

Assets



Description
  Unadjusted
quoted prices in
active markets for
identical investments
(Level 1)
  Other significant
observable inputs
(Level 2)
  Unobservable
inputs
(Level 3)
 

Total

 

Common stocks

 

$

127,850,449

   

$

   

$

   

$

127,850,449

   

Preferred stocks

   

     

     

0

     

0

   

Exchange traded funds

   

7,218,693

     

     

     

7,218,693

   

Asset-backed securities

   

     

16,233,259

     

     

16,233,259

   

Corporate bonds

   

     

37,115,594

     

     

37,115,594

   

Mortgage-backed securities

   

     

11,111,295

     

     

11,111,295

   

Non-U.S. government agency obligations

   

     

847,322

     

     

847,322

   

U.S. government agency obligations

   

     

16,536,974

     

     

16,536,974

   

U.S. Treasury obligations

   

     

2,397,725

     

     

2,397,725

   

Short-term investments

   

     

19,360,180

     

     

19,360,180

   

Futures contracts

   

747,519

     

     

     

747,519

   

Swap agreements

   

     

6,168

     

     

6,168

   

Total

 

$

135,816,661

   

$

103,608,517

   

$

0

   

$

239,425,178

   


29


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

Fair valuation summary—(concluded)

Liabilities



Description
  Unadjusted
quoted prices in
active markets for
identical investments
(Level 1)
  Other significant
observable inputs
(Level 2)
  Unobservable
inputs
(Level 3)
 

Total

 

Futures contracts

 

$

(106,250

)

 

$

   

$

   

$

(106,250

)

 

Swap agreements

   

     

(40,789

)

   

     

(40,789

)

 

Total

 

$

(106,250

)

 

$

(40,789

)

 

$

   

$

(147,039

)

 

At August 31, 2022, there were no transfers in or out of Level 3.

Securities valued using unobservable inputs, i.e. Level 3, were not considered significant to the Fund.

Portfolio footnotes

  Amount represents less than 0.05% or (0.05%)

*  Non-income producing security.

1  Security, or portion thereof, was on loan at the period end.

2  Security fair valued by the Valuation Committee under the direction of the Board of Trustees.

3  Significant unobservable inputs were used in the valuation of this security; i.e. Level 3.

4  Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933. These securities are considered liquid, unless noted otherwise, and may be resold in transactions exempt from registration, normally to qualified institutional buyers. Securities exempt from registration pursuant to Rule 144A, in the amount of $31,546,237, represented 13.8% of the Fund's net assets at period end.

5  Variable or floating rate security. The interest rate shown is the rate in effect as of period end and changes periodically.

6  Perpetual investment. Date shown reflects the next call date.

7  Security was purchased pursuant to Regulation S under the Securities Act of 1933, which exempts from registration securities offered and sold outside of the United States. Such a security cannot be sold in the United States without either an effective registration statement filed pursuant to the Securities Act of 1933, or pursuant to an exemption from registration.

8  Variable or floating rate security for which the interest rate adjusts periodically based on changes in current interest rates and prepayments on the underlying pool of assets. Rate shown is the rate in effect as of period end.

9  Step bond—coupon rate increases in increments to maturity. The rate disclosed is the rate at the period end; the maturity date disclosed is the ultimate maturity date.

10  Rate shown reflects 7 day yield as of August 31, 2022.

11  If the Fund is a buyer of protection and a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced obligation or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced obligation.

12  Payments made or received are based on the notional amount.


30


UBS U.S. Allocation Fund

Portfolio of investments—August 31, 2022

Portfolio acronyms:

ADR  American Depositary Receipt

BOA  Bank of America

DAC  Designated Activity Company

DB  Deutsche Bank AG

ETF  Exchange Traded Fund

FHLMC  Federal Home Loan Mortgage Corporation

FNMA  Federal National Mortgage Association

FRN  Floating Rate Note

GNMA  Government National Mortgage Association

GS  Goldman Sachs

HSBC  HSBC Bank PLC

JPMCB  JPMorgan Chase Bank

LIBOR  London Interbank Offered Rate

MSCI  Morgan Stanley Capital International

OTC  Over The Counter

SOFR  Secured Overnight Financing Rate

TBA  To-Be-Announced Security

Currency type abbreviations:

EUR  Euro

USD  United States Dollar

See accompanying notes to financial statements
31


UBS U.S. Allocation Fund

Statement of assets and liabilities
August 31, 2022

Assets:

 

Investments, at value (cost—$240,887,506)1

 

$

238,671,491

   

Cash

   

224,189

   

Cash collateral on futures

   

747,460

   

Cash collateral on swap agreements

   

92,249

   

Due from broker

   

433

   

Receivable for investments sold

   

2,238,779

   

Receivable for interest and dividends

   

785,811

   

Receivable for foreign tax reclaims

   

455

   

Receivable for variation margin on futures contracts

   

641,676

   

Receivable for variation margin on centrally cleared swap agreements

   

64,181

   

OTC swap agreements, at value

   

6,168

   

Other assets

   

22,707

   

Total assets

   

243,495,599

   

Liabilities:

 

Due to broker

   

680,694

   

Payable for investments purchased

   

13,967,426

   

Payable for fund shares redeemed

   

515,470

   

Payable to affiliate

   

144,676

   

Payable to custodian

   

106,624

   

OTC swap agreements, at value

   

9,227

   

Accrued expenses and other liabilities

   

168,079

   

Total liabilities

   

15,592,196

   

Net assets

 

$

227,903,403

   

Net assets consist of:

 

Beneficial interest shares of $0.001 par value (unlimited amount authorized)

 

$

212,193,512

   

Distributable earnings (accumulated losses)

   

15,709,891

   

Net assets

 

$

227,903,403

   

Class A

 

Net assets

 

$

195,883,967

   

Shares outstanding

   

4,314,248

   

Net asset value per share

 

$

45.40

   

Maximum offering price per share (net asset value plus maximum sales charge of 5.50%)

 

$

48.04

   

Class P

 

Net assets

 

$

32,019,436

   

Shares outstanding

   

686,195

   

Net asset value and offering price per share

 

$

46.66

   

1  Includes $33,247 of investments in securities on loan, at value, plus accrued interest and dividends, if any.

See accompanying notes to financial statements
32


UBS U.S. Allocation Fund

Statement of operations
For the year ended August 31, 2022

Investment income:

 

Dividends

 

$

1,979,828

   

Interest

   

2,580,005

   

Securities lending

   

31,160

   

Foreign tax withheld

   

(649

)

 

Total income

   

4,590,344

   

Expenses:

 

Investment management and administration fees

   

1,286,265

   

Service fees—Class A

   

560,449

   

Transfer agency and related services fees—Class A

   

101,808

   

Transfer agency and related services fees—Class P

   

10,757

   

Custody and fund accounting fees

   

76,848

   

Trustees fees

   

15,893

   

Professional services fees

   

192,069

   

Printing and shareholder report fees

   

69,889

   

Federal and state registration fees

   

42,839

   

Insurance expense

   

2,771

   

Other expenses

   

52,936

   

Total expenses

   

2,412,524

   

Net investment income (loss)

   

2,177,820

   

Net realized and unrealized gains (loss) from investment activities:

 

Net realized gain (loss) on:

 

Investments

   

18,081,781

   

Options and swaptions written

   

64,012

   

Futures contracts

   

(2,607,371

)

 

Swap agreements

   

(386,918

)

 

Foreign currency transactions

   

24,041

   

Net realized gain (loss)

   

15,175,545

   

Change in net unrealized appreciation (depreciation) on:

 

Investments

   

(49,331,226

)

 

Options and swaptions written

   

(3,587

)

 

Futures contracts

   

643,981

   

Swap agreements

   

678,208

   

Translation of other assets and liabilities denominated in foreign currency

   

9,670

   

Net change in unrealized appreciation (depreciation)

   

(48,002,954

)

 

Net realized and unrealized gain (loss)

   

(32,827,409

)

 

Net increase (decrease) in net assets resulting from operations

 

$

(30,649,589

)

 

See accompanying notes to financial statements
33


UBS U.S. Allocation Fund

Statement of changes in net assets

   

For the years ended August 31,

 
   

2022

 

2021

 

From operations:

 

Net investment income (loss)

 

$

2,177,820

   

$

1,505,295

   

Net realized gain (loss)

   

15,175,545

     

46,008,244

   

Net change in unrealized appreciation (depreciation)

   

(48,002,954

)

   

5,650,451

   

Net increase (decrease) in net assets resulting from operations

   

(30,649,589

)

   

53,163,990

   

Total distributions–Class A

   

(35,954,769

)

   

(15,276,332

)

 

Total distributions–Class P

   

(5,310,113

)

   

(2,245,882

)

 

Total distributions

   

(41,264,882

)

   

(17,522,214

)

 

From beneficial interest transactions:

 

Proceeds from shares sold

   

3,121,077

     

3,253,591

   

Cost of shares redeemed

   

(20,126,706

)

   

(21,796,461

)

 

Shares issued on reinvestment of dividends and distributions

   

37,193,664

     

15,742,724

   

Net increase (decrease) in net assets from beneficial interest transactions

   

20,188,035

     

(2,800,146

)

 

Net increase (decrease) in net assets

   

(51,726,436

)

   

32,841,630

   

Net assets:

 

Beginning of year

   

279,629,839

     

246,788,209

   

End of year

 

$

227,903,403

   

$

279,629,839

   

See accompanying notes to financial statements
34


UBS U.S. Allocation Fund
Financial highlights

Selected data for a share of beneficial interest outstanding throughout each year is presented below:

Class A

   

Years ended August 31,

 
   

2022

 

2021

 

2020

 

2019

 

2018

 

Net asset value, beginning of year

 

$

60.43

   

$

52.91

   

$

46.27

   

$

51.30

   

$

47.61

   

Income (loss) from investment operations:

 

Net investment income (loss)1

   

0.42

     

0.30

     

0.48

     

0.61

     

0.44

   

Net realized and unrealized gain (loss)

   

(6.37

)

   

11.04

     

7.13

     

(0.89

)

   

4.37

   

Net increase (decrease) from operations

   

(5.95

)

   

11.34

     

7.61

     

(0.28

)

   

4.81

   

Dividends from net investment income

   

(0.05

)

   

(0.64

)

   

(0.34

)

   

(0.51

)

   

(0.26

)

 

Distributions from net realized gain

   

(9.03

)

   

(3.18

)

   

(0.63

)

   

(4.24

)

   

(0.86

)

 

Total dividends and distributions

   

(9.08

)

   

(3.82

)

   

(0.97

)

   

(4.75

)

   

(1.12

)

 

Net asset value, end of year

 

$

45.40

   

$

60.43

   

$

52.91

   

$

46.27

   

$

51.30

   

Total investment return2

   

(11.69

)%

   

22.37

%

   

16.65

%

   

0.84

%

   

10.24

%

 

Ratios to average net assets:

 

Expenses

   

0.97

%

   

0.94

%

   

0.99

%

   

0.98

%

   

1.00

%3

 

Net investment income (loss)

   

0.81

%

   

0.54

%

   

1.00

%

   

1.33

%

   

0.89

%

 

Supplemental data:

 

Net assets, end of year (000's)

 

$

195,884

   

$

243,513

   

$

216,656

   

$

203,857

   

$

170,947

   

Portfolio turnover

   

96

%

   

69

%

   

129

%

   

86

%

   

132

%

 

1  Calculated using the average shares method.

2  Total investment return is calculated assuming a $10,000 investment on the first day of each year reported, reinvestment of all dividends and other distributions, if any, at net asset value on the ex-dividend dates, and a sale at net asset value on the last day of each year reported. The figures do not include any applicable sales charges or redemption fees; results would be lower if they were included. Returns do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares.

3  Includes interest expense representing less than 0.005%.

See accompanying notes to financial statements


35


UBS U.S. Allocation Fund
Financial highlights (concluded)

Selected data for a share of beneficial interest outstanding throughout each year is presented below:

Class P

   

Years ended August 31,

 
   

2022

 

2021

 

2020

 

2019

 

2018

 

Net asset value, beginning of year

 

$

61.87

   

$

54.07

   

$

47.25

   

$

52.27

   

$

48.49

   

Income (loss) from investment operations:

 

Net investment income (loss)1

   

0.57

     

0.46

     

0.62

     

0.75

     

0.58

   

Net realized and unrealized gain (loss)

   

(6.55

)

   

11.30

     

7.30

     

(0.92

)

   

4.45

   

Net increase (decrease) from operations

   

(5.98

)

   

11.76

     

7.92

     

(0.17

)

   

5.03

   

Dividends from net investment income

   

(0.20

)

   

(0.78

)

   

(0.47

)

   

(0.61

)

   

(0.39

)

 

Distributions from net realized gain

   

(9.03

)

   

(3.18

)

   

(0.63

)

   

(4.24

)

   

(0.86

)

 

Total dividends and distributions

   

(9.23

)

   

(3.96

)

   

(1.10

)

   

(4.85

)

   

(1.25

)

 

Net asset value, end of year

 

$

46.66

   

$

61.87

   

$

54.07

   

$

47.25

   

$

52.27

   

Total investment return2

   

(11.44

)%

   

22.69

%

   

16.98

%

   

1.08

%

   

10.52

%

 

Ratios to average net assets:

 

Expenses

   

0.70

%

   

0.67

%

   

0.72

%

   

0.71

%

   

0.74

%3

 

Net investment income (loss)

   

1.08

%

   

0.81

%

   

1.28

%

   

1.60

%

   

1.16

%

 

Supplemental data:

 

Net assets, end of year (000's)

 

$

32,019

   

$

36,117

   

$

30,132

   

$

27,495

   

$

29,196

   

Portfolio turnover

   

96

%

   

69

%

   

129

%

   

86

%

   

132

%

 

1  Calculated using the average shares method.

2  Total investment return is calculated assuming a $10,000 investment on the first day of each year reported, reinvestment of all dividends and other distributions, if any, at net asset value on the ex-dividend dates, and a sale at net asset value on the last day of each year reported. The figures do not include any applicable sales charges or redemption fees; results would be lower if they were included. Returns do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares.

3  Includes interest expense representing less than 0.005%.

See accompanying notes to financial statements


36


UBS U.S. Allocation Fund

Notes to financial statements

Organization and significant accounting policies

UBS U.S. Allocation Fund (the "Fund") is a series of UBS Investment Trust (the "Trust") and is registered with the US Securities and Exchange Commission ("SEC") under the Investment Company Act of 1940 (the "1940 Act"), as amended, as an open-end, diversified management investment company. The Trust was organized on March 28, 1991, as a business trust under the laws of the Commonwealth of Massachusetts and currently has one operating series.

UBS Asset Management (Americas) Inc. ("UBS AM" or the "Advisor") serves as the investment advisor and administrator for the Fund. UBS Asset Management (US) Inc. ("UBS AM (US)") serves as the principal underwriter for the Fund. UBS AM and UBS AM (US) are indirect wholly owned subsidiaries of UBS Group AG. UBS Group AG is an internationally diversified organization with headquarters in Zurich, Switzerland. UBS Group AG operates in many areas of the financial services industry.

The Fund currently offers Class A and Class P shares. Each class represents interests in the same assets of the Fund, and the classes are identical except for differences in their sales charge structures, ongoing service and distribution charges and certain transfer agency and related services expenses. All classes of shares have equal voting privileges except that each class has exclusive voting rights with respect to its service and/or distribution plan, if any. Class P shares have no service or distribution plan.

In the normal course of business the Fund may enter into contracts that contain a variety of representations that provide indemnification for certain liabilities. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet occurred. However, the Fund has not had any prior claims or losses pursuant to these contracts and expects the risk of loss to be remote.

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") is the exclusive reference of authoritative US generally accepted accounting principles ("US GAAP") recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal laws are also sources of authoritative US GAAP for SEC registrants. The Fund's financial statements are prepared in accordance with US GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

In January 2021, the FASB issued Accounting Standards ("FASB") Update No. 2021-01 ("ASU 2021-01"), "Reference Rate Reform (Topic 848)". ASU 2021-01 is an update of ASU 2020-04, which is in response to concerns about structural risks of interbank offered rates, and particularly the risk of cessation of LIBOR, regulators have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. ASU 2020-04 is elective and applies to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The ASU 2021-01 update clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The amendments in this update become effective no later than December 31, 2022, for all entities. UBS AM is currently evaluating the implications, if any, of the additional requirements and its impact on the Fund's financial statements.

The following is a summary of significant accounting policies:

Investment transactions, investment income and expenses—Investment transactions are recorded on the trade date. Realized gains and losses from investment transactions and foreign exchange transactions are calculated using the identified cost method. Dividend income and expense are recorded on the ex-dividend date ("ex-date") except in


37


UBS U.S. Allocation Fund

Notes to financial statements

the case of certain dividends from foreign securities which are recorded as soon after the ex-date as the Fund, using reasonable diligence, becomes aware of such dividends. Interest income is recorded on an accrual basis. Discounts are accreted and premiums are amortized as adjustments to interest income and the identified cost of investments.

Income, expenses (excluding class-specific expenses) and realized/unrealized gains/losses are allocated proportionately to each class of shares based upon the relative net asset value of outstanding shares (or the value of dividend eligible shares, as appropriate) of each class at the beginning of the day after adjusting for current capital share activity of the respective classes. Class specific expenses are charged directly to the applicable class of shares.

Dividends and distributions—Dividends and distributions to shareholders are recorded on the ex-dividend date. The amount of dividends from investment income and distributions from realized capital gains and/or return of capital are determined in accordance with US federal income tax regulations, which may differ from US GAAP. These "book/tax" differences are either considered temporary or permanent in nature. To the extent these differences are permanent in nature, such amounts are reclassified within the capital accounts based on their federal tax-basis treatment; temporary differences do not require reclassification.

Foreign currency translation—The books and records of the Fund are maintained in US dollars. Foreign currency amounts are translated into US dollars as follows: (1) the foreign currency market value of investment securities and other assets and liabilities stated in foreign currencies are translated into US dollars based on the current exchange rates each business day; and (2) purchases and sales of investment securities and income and expenses are translated at the rate of exchange prevailing on the respective dates of such transactions. The resulting exchange gains and losses are included in the Statement of operations.

The Fund does not generally isolate the effect of fluctuations in foreign exchange rates from the effect of the changes in market prices of securities. However, the Fund does isolate the effect of fluctuations in foreign exchange rates when determining the realized gain or loss upon the sale or maturity of foreign currency-denominated securities pursuant to US federal income tax regulations. Net realized foreign currency transaction gain (loss) is treated as ordinary income (loss) for income tax reporting purposes.

Concentration of risk—Investing in securities of foreign issuers and currency transactions may involve certain considerations and risks not typically associated with investments in the United States. These risks include revaluation of currencies, adverse fluctuations in foreign currency values and possible adverse political, social and economic developments, including those particular to a specific industry, country or region, which could cause the securities and their markets to be less liquid and prices more volatile than those of comparable US companies and US government securities. These risks are greater with respect to securities of issuers located in emerging market countries in which the Fund invests.

The ability of the issuers of debt securities held by the Fund to meet their obligations may be affected by economic and political developments particular to a specific industry, country, state or region.

Investments in bonds with ratings of BB (Standard & Poor's Financial Services LLC or Fitch Ratings, Inc.) or Ba (Moody's Investors Service, Inc.) or below (commonly referred to as "high yield" bonds), or deemed of equivalent quality, have an increased risk of defaulting or otherwise being unable to honor a financial obligation. These securities are considered to be predominantly speculative with respect to an issuer's capacity to pay interest and repay principal in accordance with the terms of the obligations. Lower-quality bonds are more likely to be subject to an issuer's default or downgrade than investment grade (higher-quality) bonds.

Many financial instruments, financings or other transactions to which the Fund may be a party use or may use a floating rate based on the London Interbank Offered Rate ("LIBOR"). LIBOR is widely used in financial markets. In July 2017, the United Kingdom's financial regulatory body announced that after 2021 it will cease its active


38


UBS U.S. Allocation Fund

Notes to financial statements

encouragement of banks to provide the quotations needed to sustain LIBOR. That announcement suggests that LIBOR may cease to be published or utilized after that time. Various financial industry groups have begun planning for that transition, but the effect of the transition process and its ultimate success cannot yet be determined. The transition process may lead to increased volatility and illiquidity in markets for instruments the terms of which are based on LIBOR. It could also lead to a reduction in the value of some LIBOR-based investments and reduce the effectiveness of new hedges placed against existing LIBOR-based investments. Since the usefulness of LIBOR as a benchmark could deteriorate during the transition period. The willingness and ability of issuers to include enhanced provisions in new and existing contracts or instruments also remains uncertain. Any of these factors may adversely affect the Fund's performance or NAV. Certain LIBOR tenors were discontinued by the end of 2021, while the discontinuation of others have been extended to June 2023.

Certain impacts to public health conditions particular to the coronavirus "COVID-19" outbreak that occurred may have a significant negative impact on the operations and profitability of the Fund's investments. The extent of the impact to the financial performance of the Fund will depend on future developments, including (i) the duration and spread of the outbreak, (ii) the restrictions and advisories, (iii) the effects on the financial markets, and (iv) the effects on the economy overall, all of which are highly uncertain and cannot be predicted.

The conflict between Ukraine and the Russian Federation has resulted in significant volatility and uncertainty in financial markets. NATO, EU and G7 member countries have imposed severe and coordinated sanctions against Russia. Restrictive measures have also been imposed by Russia, and some securities traded in that country have materially declined in value and/or may no longer be tradable. These actions have resulted in significant disruptions to investing activities and businesses with operations in Russia. The longer-term impact to geopolitical norms, supply chains and investment valuations is uncertain.

Valuation of investments

The Fund generally calculates its net asset value on days that the New York Stock Exchange ("NYSE") is open. The Fund calculates net asset value separately for each class as of the close of regular trading on the NYSE (generally, 4:00 p.m., Eastern time). The NYSE normally is not open, and the Fund does not price its shares, on most national holidays and Good Friday. To the extent that the Fund's assets are traded in other markets on days when the NYSE is not open, the value of the Fund's assets may be affected on those days. If trading on the NYSE is halted for the day before 4:00 p.m., Eastern time, the Fund's net asset value per share generally will still be calculated as of the close of regular trading on the NYSE. The time at which the Fund calculates its net asset value and until which purchase, sale or exchange orders are accepted may be changed as permitted by the SEC.

The Fund calculates its net asset value based on the current market value, where available, for its portfolio investments. The Fund normally obtains market values for its investments from independent pricing sources and broker-dealers. Independent pricing sources may use reported last sale prices, official market closing prices, current market quotations or valuations from computerized "evaluation" systems that derive values based on comparable investments. An evaluation system incorporates parameters such as security quality, maturity and coupon, and/ or research and evaluations by its staff, including review of broker-dealer market price quotations, if available, in determining the valuation of the portfolio investments. Investments also may be valued based on appraisals derived from information concerning the investment or similar investments received from recognized dealers in those holdings.

Investments traded in the over-the-counter ("OTC") market and listed on The NASDAQ Stock Market, Inc. ("NASDAQ") normally are valued at the NASDAQ Official Closing Price. Other OTC securities are valued at the last bid price on the valuation date available prior to valuation. Investments which are listed on US and foreign stock exchanges normally are valued at the market closing price, the last sale price on the day the securities are valued or, lacking any sales on such day, at the last available bid price. Investments listed on foreign stock exchanges may be fair valued based on significant events that have occurred subsequent to the close of the foreign markets. In cases where investments are traded on more than one exchange, the investments are valued on the exchange designated


39


UBS U.S. Allocation Fund

Notes to financial statements

as the primary market by UBS AM. If a market value is not readily available from an independent pricing source for a particular investment, that investment is valued at fair value as determined in good faith by or under the direction of the Fund's Board of Trustees (the "Board"). Foreign currency exchange rates are generally determined as of the close of the NYSE.

Certain investments in which the Fund invests may be traded in markets that close before 4:00 p.m., Eastern time. Normally, developments that occur between the close of the foreign markets and 4:00 p.m., Eastern time, will not be reflected in the Fund's net asset value. However, if the Fund determines that such developments are so significant that they will materially affect the value of the Fund's investments, the Fund may adjust the previous closing prices to reflect what is believed to be the fair value of these investments as of 4:00 p.m., Eastern time.

The Fund may use a systematic fair valuation model provided by an independent third party to value investments principally traded in foreign markets in order to adjust for possible stale pricing that may occur between the close of the foreign exchanges and the time for valuation. The systematic fair valuation model may use calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant ADRs and futures contracts. If an investment is valued at a "fair value," that value is likely to be different from the last quoted market price for the investment. The use of the fair valuation model may result in securities being transferred between Level 1 and Level 2 of the fair valuation hierarchy at the end of the reporting period.

The amortized cost method of valuation, which approximates market value, generally is used to value short-term debt instruments with 60 days or less remaining to maturity, unless the Board determines that this does not represent fair value.

Investments in open-end investment companies are valued at the daily closing net asset value of the respective investment company. Pursuant to the Fund's use of the practical expedient within ASC Topic 820, Fair Value Measurement, investments in investment companies without publicly published prices are also valued at the daily net asset value.

All investments quoted in foreign currencies are valued daily in US dollars on the basis of the foreign currency exchange rates prevailing at the time such valuation is determined by the Fund's custodian.

Futures contracts are generally valued at the settlement price established each day on the exchange on which they are traded. Forward foreign currency contracts, if any, are valued daily using forward exchange rates quoted by independent pricing services.

Swaps are marked-to-market daily based upon values from third party vendors or quotations from market makers to the extent available. In the event that market quotations are not readily available or deemed unreliable, the swap is valued at fair value as determined in good faith by or under the direction of the Board.

The Board has delegated to the Equities, Fixed Income and Multi-Asset Valuation Committee ("VC") the responsibility for making fair value determinations with respect to the Fund's portfolio holdings. The VC is comprised of representatives of management. The VC provides reports to the Board at each quarterly meeting regarding any investments that have been fair valued, valued pursuant to standing instructions approved by the VC, or where non-vendor pricing sources had been used to make fair value determinations when sufficient information exists during the prior quarter. Fair valuation determinations are subject to review at least monthly by the VC during scheduled meetings. Pricing decisions, processes, and controls over fair value determinations are subject to internal and external reviews, including annual internal compliance reviews and periodic internal audit reviews.

The types of investments for which such fair value pricing may be necessary include, but are not limited to: foreign investments under some circumstances; securities of an issuer that has entered into a restructuring; investments


40


UBS U.S. Allocation Fund

Notes to financial statements

whose trading has been halted or suspended; fixed income securities that are in default and for which there is no current market value quotation; and investments that are restricted as to transfer or resale. The need to fair value the Fund's portfolio investments may also result from low trading volume in foreign markets or thinly traded domestic investments, and when a security that is subject to a trading limit or collar on the exchange or market on which it is primarily traded reaches the "limit up" or "limit down" price and no trading has taken place at that price. Various factors may be reviewed in order to make a good faith determination of an investment's fair value. These factors include, but are not limited to, fundamental analytical data relating to the investment; the nature and duration of restrictions on disposition of the investment; and the evaluation of forces which influence the market in which the investment is purchased and sold. Valuing investments at fair value involves greater reliance on judgment than valuing investments that have readily available market quotations. Fair value determinations can also involve reliance on quantitative models employed by a fair value pricing service.

US GAAP requires disclosure regarding the various inputs that are used in determining the value of the Fund's investments. These inputs are summarized into the three broad levels listed below:

Level 1—Unadjusted quoted prices in active markets for identical investments.

Level 2—Other significant observable inputs, including but not limited to, quoted prices for similar investments, interest rates, prepayment speeds and credit risks.

Level 3—Unobservable inputs inclusive of the Fund's own assumptions in determining the fair value of investments.

A fair value hierarchy table has been included near the end of the Fund's Portfolio of investments.

Investments

Asset-backed securities—The Fund may invest in asset-backed securities ("ABS"), representing interests in pools of certain types of underlying installment loans, home equity loans, leases of various types of real and personal property and receivables from revolving lines of credit (credit cards). Such assets are securitized through the use of trusts or special purpose corporations. The yield characteristics of ABS differ from those of traditional debt securities. One such major difference is that principal may be prepaid at any time because the underlying obligations generally may be prepaid at any time. ABS may decrease in value as a result of increases in interest rates and may benefit less than other fixed-income securities from declining interest rates because of the risk of prepayment.

Mortgage-backed securities—The Fund may invest in mortgage-backed securities ("MBS"), representing direct or indirect interests in pools of underlying mortgage loans that are secured by real property. These securities provide investors with payments consisting of both principal and interest as the mortgages in the underlying mortgage pools are paid.

The timely payment of principal and interest (but not the market value) on MBS issued or guaranteed by Ginnie Mae (formally known as the Government National Mortgage Association or GNMA) is backed by Ginnie Mae and the full faith and credit of the US government. Obligations issued by Fannie Mae (formally known as the Federal National Mortgage Association or FNMA) and Freddie Mac (formally known as the Federal Home Loan Mortgage Company or FHLMC) are historically supported only by the credit of the issuer, but currently are guaranteed by the US government in connection with such agencies being placed temporarily into conservatorship by the US government.

Some MBS are sponsored or issued by private entities. Payments of principal and interest (but not the market value) of such private MBS may be supported by pools of mortgage loans or other MBS that are guaranteed, directly or indirectly, by the US government or one of its agencies or instrumentalities, or they may be issued without any government guarantee of the underlying mortgage assets but with some form of non-government credit enhancement.


41


UBS U.S. Allocation Fund

Notes to financial statements

Collateralized mortgage obligations ("CMO") are a type of MBS. A CMO is a debt security that may be collateralized by whole mortgage loans or mortgage pass-through securities. The mortgage loans or mortgage pass-through securities are divided into classes or tranches with each class having its own characteristics. Investors typically receive payments out of the interest and principal on the underlying mortgages. The portions of these payments that investors receive, as well as the priority of their rights to receive payments, are determined by the specific terms of the CMO class.

The yield characteristics of MBS differ from those of traditional debt securities. Among the major differences are that interest and principal payments are made more frequently, usually monthly, and that principal may be prepaid at any time because the underlying mortgage loans or other obligations generally may be prepaid at any time. Prepayments on a pool of mortgage loans are influenced by a variety of economic, geographic, social, and other factors. Generally, prepayments on fixed-rate mortgage loans will increase during a period of falling interest rates and decrease during a period of rising interest rates. Certain classes of CMOs and other MBS are structured in a manner that makes them extremely sensitive to changes in prepayment rates. Such classes include interest-only ("IO") and principal-only ("PO") classes. IOs are entitled to receive all or a portion of the interest, but none (or only a nominal amount) of the principal payments, from the underlying mortgage assets. If the mortgage assets underlying an IO experience greater than anticipated principal prepayments, then the total amount of interest payments allocable to the IO class, and therefore the yield to investors, generally will be reduced. Conversely, PO classes are entitled to receive all or a portion of the principal payments, but none of the interest, from the underlying mortgage assets. PO classes are purchased at substantial discounts from par and the yield to investors will be reduced if principal payments are slower than expected.

Real estate investment trusts—The Fund may invest in real estate investment trusts ("REITs"). Distributions from a REIT are initially recorded as dividend income and may subsequently be recharacterized by the REIT at the end of its tax year as a return of capital and/or capital gains. The Fund estimates the character of dividends received from REITs for financial reporting purposes based on the distribution history of each REIT. Once actual distribution characterizations are made available by the REITs, typically after calendar year end, the Fund updates its accounting and/or tax books and records.

Repurchase agreements—The Fund may purchase securities or other obligations from a bank or securities dealer (or its affiliate), subject to the seller's agreement to repurchase them at an agreed upon date (or upon demand) and price. The Fund maintains custody of the underlying obligations prior to their repurchase, either through its regular custodian or through a special "tri-party" custodian or sub-custodian that maintains a separate account for both the Fund and its counterparty. The underlying collateral is valued daily in an effort to ensure that the value, including accrued interest, is at least equal to the repurchase price.

Repurchase agreements carry certain risks not associated with direct investments in securities, including a possible decline in the market value of the underlying obligations. If their value becomes less than the repurchase price, plus any agreed-upon additional amount, the counterparty must provide additional collateral so that the collateral is at least equal to the repurchase price plus any agreed-upon additional amount. The difference between the total amount to be received upon repurchase of the obligations and the price that was paid by the Fund upon acquisition is accrued as interest and included in its net investment income. In the event of default of the obligation to repurchase, the Fund generally has the right to liquidate the collateral and apply the proceeds in satisfaction of the obligation. Repurchase agreements involving obligations other than U.S. government securities (such as commercial paper, corporate bonds, equities and mortgage loans) may be subject to special risks and may not have the benefit of certain protections in the event of counterparty insolvency. If the seller (or seller's guarantor, if any) becomes insolvent, the Fund may suffer delays, costs and possible losses in connection with the disposition or retention of the collateral. Under certain circumstances, in the event of default or bankruptcy by the other party to the agreement, realization and/or retention of the collateral may be subject to legal proceedings. The Fund intends to enter into repurchase agreements only in transactions with counterparties believed by UBS AM to present minimal credit risk.


42


UBS U.S. Allocation Fund

Notes to financial statements

The Fund may participate in joint repurchase agreement transactions with other funds managed or advised by UBS AM in accordance with an exemptive order granted by the SEC pursuant to Section 17(d) of the 1940 Act and Rule 17d-1 thereunder. Under certain circumstances, the Fund may engage in a repurchase agreement transaction with a yield of zero in order to invest cash amounts remaining in its portfolio at the end of the day in order to avoid having the Fund potentially exposed to a fee for uninvested cash held in a business account at a bank.

Restricted securities—The Fund may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expenses, and prompt sale at an acceptable price may be difficult. Information regarding restricted securities, if any, is included in the Fund's portfolio footnotes.

Securities traded on to-be-announced basis—The Fund may from time to time purchase, or short sell, securities on a to-be-announced ("TBA") basis. In a TBA transaction, the Fund commits to purchasing securities for which all specific information is not yet known at the time of the trade, particularly the face amount and maturity date of the underlying securities. Securities purchased on a TBA basis are not settled until they are delivered to the Fund , normally 15 to 45 days later. Beginning on the date the Fund enters into a TBA transaction, cash, U.S. government securities or other liquid securities are segregated in an amount equal in value to the purchase price of the TBA security. These transactions are subject to market fluctuations and their current value is determined in the same manner as for other securities.

Treasury Inflation Protected Securities—The Fund may purchase Treasury inflation protected securities ("TIPS") which are debt securities issued by the US Treasury. TIPS adjust for inflation based on changes in the published Consumer Price Index ("CPI"). During periods of inflation when the CPI index increases, the principal amount of the debt to which the rate of interest is applied increases, which in turn increases the yield. During periods of deflation when the CPI index decreases, the principal amount of the debt to which the rate of interest is applied decreases, which in turn lowers the yield. At maturity, TIPS return the higher of the principal amount at maturity or the initial face amount of the debt.

Derivative instruments

Purchased options—The Fund may purchase put and call options in order to gain exposure to or protect against changes in the markets or in an attempt to enhance income or gains. Purchasing call options tends to increase exposure to the underlying instrument. Purchasing put options tends to decrease exposure to the underlying instrument.

The Fund pays a premium which is included in the Statement of assets and liabilities as an investment and subsequently marked-to-market to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. Purchased options are shown as portfolio holdings within the Portfolio of investments and are included in the Statement of assets and liabilities in investments, at value.

The risk associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying future, security or currency transaction to determine the realized gain or loss.

Option writing—The Fund may write (sell) put and call options, including, but not limited to, options on foreign or US securities, indices, foreign currencies, options on futures contracts and options on swap agreements (commonly referred to as swaptions), in order to gain exposure to or protect against changes in the markets or in an attempt to enhance income or gains.


43


UBS U.S. Allocation Fund

Notes to financial statements

When the Fund writes a call or a put option, an amount equal to the premium received by the Fund is included on the Fund's Statement of assets and liabilities as a liability. The amount of the liability is subsequently marked-to-market to reflect the current market value of the option written. If an option which the Fund has written either expires on its stipulated expiration date or the Fund enters into a closing purchase transaction, the Fund realizes a gain (or loss if the cost of a closing purchase transaction exceeds the premium received when the option was written) without regard to any unrealized gain or loss on the underlying security or derivative instrument, and the liability related to such option is extinguished. If a call option, which the Fund has written, is exercised, the Fund recognizes a realized gain or loss (long-term or short-term, depending on the holding period of the underlying security) from the sale of the underlying security or derivative instrument and the proceeds from the sale are increased by the premium originally received. If a put option, which the Fund has written, is exercised, the amount of the premium originally received reduces the cost of the security or derivative instrument which the Fund purchases upon exercise of the option.

In writing an option, the Fund bears the market risk of an unfavorable change in the price of the derivative instrument, security, or currency underlying the written option. Exercise of an option written by the Fund could result in the Fund selling or buying a derivative instrument, security or currency at a price different from current market value.

In the normal course of trading activities, the Fund trades and holds certain fair valued derivative contracts that constitute guarantees. Such contracts include written put options, where the Fund will be obligated to purchase securities at specified prices (i.e. the options are exercised by the counterparties). It also includes written swaptions, where the Fund will be obligated to enter into a swap agreement.

The maximum payout for written put options is limited to the number of put option contracts written and the related strike prices, respectively. Maximum payout amounts could be offset by the subsequent sale, if any, of assets obtained via the execution of a payout event.

Futures contracts—The Fund may purchase or sell futures contracts as part of its investment strategy, to increase or reduce its exposure to an asset class without purchasing or selling the underlying securities, either as a hedge or to enhance income or realized gains. Generally, a futures contract is a standard binding agreement to buy or sell a specified quantity of an underlying reference asset, such as a specific security or currency, at a specified price at a specified later date.

Upon entering into a futures contract, the Fund is required to deliver to a broker an amount of cash and/or US government securities equal to a certain percentage of the contract amount. This amount is known as the "initial margin." Subsequent payments, known as "variation margin", generally are made or received by the Fund, depending on the daily fluctuations in the value of the underlying futures contracts. Such variation margin is recorded for financial statement purposes on a daily basis as an unrealized appreciation or depreciation on futures until the futures contract is closed or expires, at which time the net gain or loss is reclassified to realized gain or loss on futures.

Using futures contracts involves various market risks, including interest rate and equity risk. Risks of entering into futures contracts include the possibility that there may be an illiquid market or that a change in the value of the contract may not correlate with changes in the value of the underlying securities. To the extent that market prices move in an unexpected direction, there is a risk that the Fund will not achieve the anticipated benefits of the futures contract or may realize a loss.

Futures contracts, if any, are shown as portfolio holdings within the Portfolio of investments. Variation margin, if applicable, is shown in Variation margin receivable or payable on futures contracts within the Statement of assets and liabilities.

Swap agreements—The Fund may engage in swap agreements, including, but not limited to, credit default and total return swap agreements. The Fund expects to enter into these transactions to preserve a return or spread on a


44


UBS U.S. Allocation Fund

Notes to financial statements

particular investment or to hedge a portion of the portfolio's duration, to protect against any increase in the price of securities the Fund anticipates purchasing at a later date, to gain exposure to certain markets in the most economical way possible or in an attempt to enhance income or gains.

The Fund accrues for interim payments on swap agreements on a daily basis, with the net amount recorded within unrealized appreciation or depreciation of swap agreements. Once interim payments are settled in cash, the net amount is recorded as realized gain/loss on swap agreements, in addition to realized gain/loss recorded upon the termination of swap agreements on the Statement of operations. Fluctuations in the value of swap agreements are recorded for financial statement purposes as unrealized appreciation or depreciation on swap agreements.

The Fund may enter into interest rate swap agreements with another party to receive or pay interest (e.g., an exchange of fixed rate payments for floating rate payments) to protect themselves from interest rate fluctuations. This type of swap is an agreement that obligates two parties to exchange a series of cash flows at specified intervals based upon or calculated by reference to a specified interest rate(s) for a specified amount. The payment flows are usually netted against each other, with the difference being paid by one party to the other. Interest rate swap agreements are subject to general market risk, liquidity risk, counterparty risk and interest rate risk.

Credit default swap agreements involve commitments to make or receive payments in the event of a default of a security or other credit event of the referenced obligation. As a buyer, the Fund would make periodic payments to the counterparty, and the Fund would receive payments only upon the occurrence of a default or credit event. If no default or credit event occurs, the Fund will lose its periodic stream of payments over the term of the contract. However, if a default or a credit event does occur, the Fund typically would receive full notional value for the referenced obligation that may have little or no value. As a seller, the Fund would receive periodic payments from the counterparty, and the Fund would make payments only upon the occurrence of a default or a credit event. If no default or credit event occurs, the Fund will gain the periodic stream of payments it received over the term of the contract and the counterparty will lose its periodic stream of payments over the term of the contract. However, if a default or credit event occurs, the Fund typically would pay full notional value for the referenced obligation that may have little or no value. Credit default swap agreements may involve greater risks than if the Fund had invested in the referenced obligation directly and are subject to general market risk, liquidity risk and credit risk.

Credit default swap agreements on credit indices involve one party making a stream of payments to another party in exchange for the right to receive a specified return in the event of a write-down, principal shortfall, interest shortfall or default of all or part of the referenced entities comprising the credit index. A credit index is a list of a basket of credit instruments or exposures designed to be representative of some part of the credit market as a whole. These indices are made up of referenced credits that are judged by a poll of dealers to be the most liquid entities in the credit default swap market based on the sector of the index. Components of the indices may include, but are not limited to, investment grade securities, high yield securities, asset backed securities, emerging markets, and/or various credit ratings within each sector. Credit indices are traded using credit default swaps with standardized terms including a fixed spread and standard maturity dates. An index credit default swap references all the names in the index, and if there is a default, the credit event is settled based on that name's weight in the index. The composition of the indices changes periodically, usually every six months, and for most indices, each name has an equal weight in the index. The Fund may use credit default swap agreements on credit indices to hedge a portfolio of credit default swaps or bonds with a credit default swap on indices which is less expensive than it would be to buy many credit default swaps to achieve a similar effect. Credit default swap agreements on credit indices are benchmarks for protecting investors owning bonds against default, and traders use them to speculate on changes in credit quality.

Credit default swap agreements on corporate issues or sovereign issues of an emerging market country involve one party making a stream of payments to another party in exchange for the right to receive a specified return in the event of a default or other credit event. If a credit event occurs and cash settlement is not elected, a variety of other obligations may be delivered in lieu of the specific referenced obligation. The ability to deliver other obligations may


45


UBS U.S. Allocation Fund

Notes to financial statements

result in a cheapest-to-deliver option (the buyer of protection's right to choose the deliverable obligation with the lowest value following a credit event). The Fund may use credit default swap agreements on corporate issues or sovereign issues of an emerging market country to provide a measure of protection against defaults of the issuers (i.e., to reduce risk where the Fund owns or has exposure to the referenced obligation) or to take an active long or short position with respect to the likelihood of a particular issuer's default.

The maximum potential amount of future payments (undiscounted) that the Fund as a seller of protection could be required to make under a credit default swap agreement would be an amount equal to the notional amount of the agreement, which may exceed the amount of the value reflected on the Statement of assets and liabilities. Notional amounts of all credit default swap agreements outstanding as of the period end for which the Fund is the seller of protection are disclosed under the section "Credit default swap agreements on corporate issues and credit indices—sell protection" in the Portfolio of investments. These potential amounts would be partially offset by any recovery values of the respective referenced obligations, upfront payments received upon entering into the agreement, or net amounts received from the settlement of buy protection credit default swap agreements entered into, if any, by the Fund for the same referenced entity or entities.

Total return swap agreements involve commitments to pay or receive interest in exchange for a market-linked return based on notional amounts. To the extent the total return of the security or index underlying the transactions exceeds or falls short of the offsetting interest rate obligation, the Fund will receive a payment from or make a payment to the counterparty, respectively. Total return swap agreements are marked-to-market daily, and the change, if any, is recorded as unrealized appreciation or depreciation. Total return swap agreements are subject to general market risk, liquidity risk, counterparty risk, interest rate risk, credit risk and the risk that there may be unfavorable changes in the underlying investments or instruments.

The use of swap agreements involves investment techniques, risks, and transaction costs different from those associated with ordinary portfolio security transactions, including assumptions about market conditions, interest rates, and other applicable factors. As a result, the performance of the Fund will be different than if it had used ordinary portfolio security transactions. OTC swap agreements do not involve the delivery of securities and are subject to counterparty risk. If the other party to a swap agreement defaults and fails to consummate the transaction, the Fund's risk of loss will consist of the net amount of interest or other payments that the Fund is contractually entitled to receive. Therefore, the Fund would consider the creditworthiness of the counterparty to a swap agreement in evaluating potential credit risk.

Certain clearinghouses offer clearing for limited types of derivatives transactions, such as interest rate and credit default swap agreements. Centrally cleared swap agreements must be transacted through a futures commission merchant ("FCM") and cleared through a clearinghouse that serves as a central counterparty. The performance of a centrally cleared swap transaction is effectively guaranteed by a central clearinghouse, thereby reducing the Fund's exposure to the credit risk of its original counterparty. The Fund will be required to post specified levels of margin with the clearinghouse or at the instruction of the clearinghouse; the margin required by a clearinghouse may be greater than the margin the Fund would be required to post in an uncleared transaction. Centrally cleared swap agreements, if any, are reported on the Statement of assets and liabilities based on variation margin received or paid, if any.

Swap agreements, if any, are shown as portfolio holdings within the Portfolio of investments.

Derivatives by underlying risk—Investment companies value their derivatives at fair value and recognize changes in fair value through the Statement of operations. Although certain of a Fund's investments in derivatives may be intended to hedge risk from a portfolio implementation/economic perspective, derivatives are considered to be "non-hedge transactions" for purposes of disclosure under US GAAP as reflected in the Fund's financial reports.


46


UBS U.S. Allocation Fund

Notes to financial statements

The volume of derivatives as disclosed in the Fund's Portfolio of investments is representative of the volume of derivatives outstanding during the period ended August 31, 2022.

Swap agreements and options written entered into by the Fund may contain credit-risk related contingent features that could be triggered subject to certain circumstances. Such circumstances include agreed upon net asset value thresholds. If triggered, the derivative counterparty could request additional cash margin and/or terminate the derivative contract. The aggregate fair value of the derivative contracts that are in a net liability position that contain these triggers can be found in the Portfolio of investments. The aggregate fair value of assets that are already posted as collateral as of August 31, 2022, if any, is reflected in the Statement of assets and liabilities.

At August 31, 2022, the Fund had the following derivatives categorized by underlying risk:

Asset derivatives1

    Interest
rate risk
  Foreign
exchange
risk
  Credit
risk
  Equity
risk
  Total
value
 

Futures contracts

 

$

4,536

   

$

   

$

   

$

742,983

   

$

747,519

   

Swap agreements

   

     

     

     

6,168

     

6,168

   

Total value

 

$

4,536

   

$

   

$

   

$

749,151

   

$

753,687

   

1  In the Statement of assets and liabilities, options and swaptions purchased are shown within investments, at value, swap agreements (except centrally cleared swap agreements) are shown within swap agreements, at value, while forward foreign currency contracts are shown using unrealized appreciation on forward foreign currency contracts. Futures contracts are reported in the table above using cumulative appreciation of futures contracts and centrally cleared swap agreements are reported at value, as reported in the futures contracts and centrally cleared swap agreements tables at the end of the Portfolio of investments, respectively, but only the variation margin to be received, if any, is reported within the Statement of assets and liabilities.

Liability derivatives1

    Interest
rate risk
  Foreign
exchange
risk
  Credit
risk
  Equity
risk
  Total
value
 

Futures contracts

 

$

(47,051

)

 

$

   

$

   

$

(59,199

)

 

$

(106,250

)

 

Swap agreements

   

     

     

(31,562

)

   

(9,227

)

   

(40,789

)

 

Total

 

$

(47,051

)

 

$

   

$

(31,562

)

 

$

(68,426

)

 

$

(147,039

)

 

1  In the Statement of assets and liabilities, options and swaptions written are shown within options and swaptions written, at value, swap agreements (except centrally cleared swap agreements) are shown within swap agreements, at value, while forward foreign currency contracts are shown within unrealized depreciation on forward foreign currency contracts. Futures contracts are reported in the table above using cumulative depreciation of futures contracts and centrally cleared swap agreements are reported at value, as reported in the futures contracts and centrally cleared swap agreements are reported at value, as reported in the futures contracts and centrally cleared swap agreements tables at the end of the Portfolio of investments, respectively, but only the variation margin to be paid, if any, is reported within the Statement of assets and liabilities.


47


UBS U.S. Allocation Fund

Notes to financial statements

During the period ended August 31, 2022, net realized gain (loss) from derivatives were as follows:

Realized gain (loss)1

    Interest
rate risk
  Foreign
exchange
risk
  Credit
risk
  Equity
risk
  Total
value
 

Options and swaptions purchased

 

$

23,260

   

$

   

$

   

$

   

$

23,260

   

Options and swaptions written

   

64,012

     

     

     

     

64,012

   

Futures contracts

   

188,435

     

     

     

(2,795,806

)

   

(2,607,371

)

 

Swap agreements

   

(4,772

)

   

     

(308,050

)

   

(74,096

)

   

(386,918

)

 

Total net realized gains (loss)

 

$

270,935

   

$

   

$

(308,050

)

 

$

(2,869,902

)

 

$

(2,907,017

)

 

1  The net realized gain (loss) is shown in the Statement of operations in net realized gain (loss) on futures contracts, options and swaptions written, swap agreements and forward foreign currency contracts, unless otherwise noted. The net realized gain (loss) on options and swaptions purchased is shown in the Statement of operations in net realized gain (loss) on investments.

During the period ended August 31, 2022, net unrealized appreciation (depreciation) from derivatives were as follows:

Net change in unrealized appreciation (depreciation)1

    Interest
rate risk
  Foreign
exchange
risk
  Credit
risk
  Equity
risk
  Total
value
 

Options and swaptions purchased

 

$

3,429

   

$

   

$

   

$

   

$

3,429

   

Options and swaptions written

   

(3,587

)

   

     

     

     

(3,587

)

 

Futures contracts

   

(16,623

)

   

     

     

660,604

     

643,981

   

Swap agreements

   

     

     

688,574

     

(10,366

)

   

678,208

   

Net change in appreciation (depreciation)

 

$

(16,781

)

 

$

   

$

688,574

   

$

650,238

   

$

1,322,031

   

1  The change in net unrealized appreciation (depreciation) is shown in the Statement of operations in change in net unrealized appreciation (depreciation) on futures contracts, options and swaptions written, swap agreements and forward foreign currency contracts, unless otherwise noted. The change in net unrealized appreciation (depreciation) of options and swaptions purchased is shown in the Statement of operations in change in net unrealized appreciation (depreciation) on investments.

Offsetting of certain derivatives—The Fund typically enters into International Swaps and Derivatives Association, Inc. Master Agreements ("ISDA Master Agreements") or similar master agreements with its OTC derivative contract counterparties in order to, among other things, reduce its credit risk to counterparties. ISDA Master Agreements include provisions for general obligations, representations, collateral and events of default or termination. Under an ISDA Master Agreement, the Fund typically may offset with the counterparty certain derivative financial instrument's payables and/or receivables with collateral held and/or posted and create one single net payment (close-out netting) in the event of default or termination. The Statement of assets and liabilities is presented gross of any netting.

At August 31, 2022, derivative assets and liabilities (by type) on a gross basis and derivatives subject to an enforceable master netting arrangement ("MNA") or similar were as follows:

UBS U.S. Allocation Fund

Derivative Financial Instruments:

 

Assets

 

Liabilities

 

Total gross amount of derivative assets and liabilities in the Statement of assets and liabilities1

 

$

753,687

   

$

(147,039

)

 

Derivatives not subject to a MNA or similar agreements

   

(747,519

)

   

137,812

   

Total gross amount of assets and liabilities subject to MNA or similar agreements

 

$

6,168

   

$

(9,227

)

 


48


UBS U.S. Allocation Fund

Notes to financial statements

The following tables present the Fund derivative assets and liabilities subject to MNA by counterparty net of amounts available for offset under a MNA and net of the related collateral received/pledged by the Fund as of the period end.

Counterparty

  Gross amount of
assets
  Financial
instruments
and derivatives
available for
offset
  Collateral
received2
  Net amount
of assets
 

MSCI

 

$

6,168

   

$

   

$

   

$

6,168

   

Counterparty

  Gross amount of
liabilities
  Financial
instruments
and derivatives
available for
offset
  Collateral
pledged2
  Net amount
of liabilities
 

BOA

 

$

(2,259

)

 

$

   

$

   

$

(2,259

)

 

JPMCB

   

(6,968

)

   

     

     

(6,968

)

 

Total

 

$

(9,227

)

 

$

   

$

   

$

(9,227

)

 

1  Includes cumulative appreciation/depreciation of futures contracts and centrally cleared swaps, at value as reported in the futures contracts and centrally cleared swaps tables in the Portfolio of investments, but only the unpaid variation margin is reported within the Statement of assets and liabilities within variation margin on futures contracts and centrally cleared swap agreements, respectively.

2  In some instances, the actual collateral received and/or pledged may be more than the amount shown and may be comprised of cash collateral, non-cash collateral or combination of both.

Investment advisor and administrator fees and other transactions with affiliates

The Board has approved an Investment Advisory and Administration Contract (the "Advisory Contract"), under which UBS AM serves as investment advisor and administrator of the Fund. In accordance with the Advisory Contract, the Fund is to pay UBS AM an investment advisory and administration fee, which is to be accrued daily and paid monthly, at an annual rate of 0.50% of the Fund's average daily net assets up to $250 million and 0.45% thereafter.

UBS AM has agreed to permanently reduce its advisory and administration fee based on the Fund's average daily net assets so that it is assessed as follows: $0 to $250 million—0.50%; in excess of $250 million up to $500 million—0.45%; in excess of $500 million up to $2 billion—0.40%; and over $2 billion—0.35%. Accordingly, for the year ended August 31, 2022, UBS AM did not waive any investment advisory and administration fees. At August 31, 2022, the Fund owed UBS AM $101,152 for investment advisory and administration fees.

UBS AM has contractually undertaken to waive fees/reimburse a portion of the Fund's expenses, when necessary, to maintain the total annual operating expenses (excluding (1) dividend expense, borrowing costs and interest expense relating to short sales, and (2) investments in other investment companies, interest, taxes, brokerage commissions, trustee elections as well as other matters related to shareholder meetings (unless otherwise separately agreed by UBS AM), and extraordinary expenses, if any) of Class A and Class P shares at a level not to exceed 1.15% and 0.90%, respectively through December 31, 2022. The Fund will repay UBS AM for any previously waived fees/reimbursed expenses during the three-year period following August 31, 2019, to the extent that operating expenses (with certain exclusions such as dividend expense, borrowing costs, and interest expense relating to short sales, and interest, taxes, brokerage commissions, trustee elections as well as other matters related to shareholder meetings (unless otherwise separately agreed by UBS AM), and extraordinary expenses, if any) are otherwise below the expense caps in effect at the time the fees or expenses were waived/reimbursed. For the period ended August 31, 2022, the Fund had no fee waivers/expense reimbursements subject to repayment. Accordingly, for the period ended August 31, 2022 UBS AM did not waive any investment advisory and administration fees.


49


UBS U.S. Allocation Fund

Notes to financial statements

During the period ended August 31, 2022, the Fund engaged in purchase and sale transactions where an affiliate was underwriter. In such cases, the affiliate underwriter was not compensated and each trade was approved by the board.

During the period ended August 31, 2022, the Fund engaged in purchase and sale transactions with funds that have a common investment adviser, UBS AM. These interfund purchase and sale transactions were effected in compliance with Rule 17a-7 under the 1940 Act. There were no purchases for the period ended August 31, 2022, while the proceeds from such sales were $137,511 and net realized loss recognized was $17,597.

Service and distribution plans

UBS AM (US) is the principal underwriter of the Fund's shares. The Fund has adopted service and/or distribution plans (the "Plans") pursuant to Rule 12b-1 under the 1940 Act for Class A shares. The Plans govern payments made for the expenses incurred in the service and/or distribution of Class A shares. The Fund pays UBS AM (US) monthly service fees at an annual rate of 0.25% of the average daily net assets of Class A shares. At August 31, 2022, the Fund owed UBS AM (US) $43,524 for service and distribution fees.

UBS AM (US) also receives the proceeds of the initial sales charges paid upon the purchase of Class A shares and the contingent deferred sales charges paid by shareholders upon certain redemptions of Class A shares. UBS AM (US) has informed the Fund that for the period ended August 31, 2022, it earned $1,075 in initial sales charges on Class A shares.

Transfer agency and related services fees

UBS Financial Services Inc. provides certain services to the Fund pursuant to a delegation of authority from BNY Mellon Investment Servicing (US) Inc. ("BNY Mellon"), the Fund's transfer agent, and is compensated for these services by BNY Mellon, not the Fund. For the period ended August 31, 2022, UBS Financial Services Inc. received from BNY Mellon, not the Fund, $42,708 of the total transfer agency and related service fees paid by the Fund to BNY Mellon.

Securities lending

The Fund may lend securities up to 331/3% of its total assets to qualified broker-dealers or institutional investors. The loans are initially secured at all times by cash, US government securities and irrevocable letters of credit in an amount at least equal to 102% of the market value of the securities loaned with respect to domestic securities and 105% of the market value of the securities loaned with respect to foreign securities. In the event that the market value of the cash, US government securities, and irrevocable letters of credit securing the loan falls below 100% for domestic securities, and 103% for foreign securities, the borrower must provide additional cash, US government securities, and irrevocable letters of credit so that the total securing the loan is at least 102% of the market value for domestic securities and 105% of the market value for foreign securities.

The Fund will regain ownership of loaned securities to exercise certain beneficial rights; however, the Fund may bear the risk of delay in recovery of, or even loss of rights in, the securities loaned should the borrower fail financially. The Fund receives compensation for lending its securities from interest or dividends earned on the cash, US government securities and irrevocable letters of credit held as collateral, net of fee rebates paid to the borrower plus reasonable administrative and custody fees. Cash collateral received is invested in State Street Navigator Securities Lending Government Money Market Portfolio, which is included in the Fund's Portfolio of investments. State Street Bank and Trust Company serves as the Fund's lending agent.


50


UBS U.S. Allocation Fund

Notes to financial statements

At August 31, 2022, the Fund had securities on loan at value, cash collateral and non-cash collateral as follows:

Value of securities
on loan
 

Cash collateral

  Non-cash
collateral*
 

Total collateral

  Security types held
as non-cash
collateral
 
$

33,247

   

$

   

$

35,059

   

$

35,059

    U.S. Treasury Notes
and U.S. Treasury Bills
 

*  These securities are held for the benefit of the Fund at the Fund's custodian. The Fund cannot repledge or resell this collateral. As such, collateral is excluded from the Statement of assets and liabilities.

Bank line of credit

The Fund participates with other funds managed by UBS AM in a $185 million committed credit facility (the "Committed Credit Facility") with State Street Bank and Trust Company. The Committed Credit Facility is to be utilized for temporary financing until the settlement of sales or purchases of portfolio securities, the repurchase or redemption of shares of a participating Fund at the request of shareholders and other temporary or emergency purposes.

Interest on amounts borrowed is calculated based on prevailing rates in effect at the time of borrowing. The Advisor has agreed to pay commitment fees on the average daily balance of the Committed Credit Facility not utilized by the Fund. Commitment fees have been allocated among the funds in the Committed Credit Facility as follows: 50% of the allocation is based on the relative asset size of funds and the other 50% of the Allocation is based on utilization. For the period ended August 31, 2022, the Fund did not borrow under the Committed Credit Facility.

Additional information regarding compensation to affiliate of a board member

During his term of service on the Board through his retirement from the Board effective December 31, 2021, Professor Meyer Feldberg had also served as a senior advisor to Morgan Stanley, a financial services firm with which the Fund may conduct transactions, which resulted in him being an interested trustee of the Fund. The Fund has been informed that Professor Feldberg's role at Morgan Stanley did not involve matters directly affecting any UBS funds. Portfolio transactions are executed through Morgan Stanley based on that firm's ability to provide best execution of the transactions.

During the period ended August 31, 2022, the Fund paid brokerage commissions to Morgan Stanley in the amount of $3,476.

During the period ended August 31, 2022, the Fund purchased and sold certain securities (e.g., fixed income securities) in principal trades with Morgan Stanley, having an aggregate value of $214,630,055. Morgan Stanley received compensation in connection with these trades, which may have been in the form of a "mark-up" or "mark-down" of the price of the securities, a fee from the issuer, or some other form of compensation. Although the precise amount of this compensation is not generally known by the Fund's investment advisor, it is believed that under normal circumstances it represents a small portion of the total value of the transactions.

Purchases and sales of securities

For the period ended August 31, 2022, aggregate purchases and sales of portfolio securities, excluding short-term securities, were $218,701,125 and $232,874,781, respectively.


51


UBS U.S. Allocation Fund

Notes to financial statements

Shares of beneficial interest

There is an unlimited amount of $0.001 par value shares of beneficial interest authorized. Transactions in shares of beneficial interest were as follows:

For the year ended August 31, 2022:

   

Class A

 

Class P

 
   

Shares

 

Amount

 

Shares

 

Amount

 

Shares sold

   

11,984

   

$

619,067

     

49,025

   

$

2,502,010

   

Shares repurchased

   

(348,026

)

   

(17,786,304

)

   

(43,416

)

   

(2,340,402

)

 

Dividends reinvested

   

620,689

     

32,064,801

     

96,789

     

5,128,863

   

Net increase (decrease)

   

284,647

   

$

14,897,564

     

102,398

   

$

5,290,471

   

  

For the year ended August 31, 2021:

   

Class A

 

Class P

 
   

Shares

 

Amount

 

Shares

 

Amount

 

Shares sold

   

13,469

   

$

770,248

     

44,024

   

$

2,483,343

   

Shares repurchased

   

(331,190

)

   

(18,541,114

)

   

(57,027

)

   

(3,255,347

)

 

Dividends reinvested

   

252,686

     

13,571,750

     

39,559

     

2,170,974

   

Net increase (decrease)

   

(65,035

)

 

$

(4,199,116

)

   

26,556

   

$

1,398,970

   

  

Federal tax status

The Fund intends to distribute substantially all of its income and to comply with the other requirements of the Internal Revenue Code applicable to regulated investment companies. Accordingly, no provision for federal income taxes is required. In addition, by distributing during each calendar year substantially all of its net investment income, net realized capital gains and certain other amounts, if any, the Fund intends not to be subject to a federal excise tax.

The tax character of distributions paid during the fiscal years ended August 31, 2022 and August 31, 2021 were as follows:

Distributions paid from:

 

2022

 

2021

 

Ordinary Income

 

$

16,715,916

   

$

6,343,701

   

Long term realized capital gains

   

24,548,966

     

11,178,513

   

Aggregate cost for federal income tax purposes, including derivatives, was $242,208,449; and net unrealized appreciation (depreciation), including derivatives consisted of:

Gross unrealized appreciation

 

$

13,114,878

   

Gross unrealized depreciation

   

(16,651,836

)

 

Net unrealized appreciation (depreciation)

   

(3,536,958

)

 

The differences between book-basis and tax-basis unrealized appreciation/depreciation is attributable primarily to the tax deferral of losses on wash sales and tax treatment of certain derivative instruments.

At August 31, 2022, the components of accumulated earnings (deficit) on a tax basis were as follows:

Undistributed ordinary income

 

$

1,930,149

   

Undistributed long-term capital gain

   

17,303,423

   

Accumulated realized capital and other losses

   

   

Net unrealized appreciation of investments

   

(3,523,681

)

 

Total accumulated earnings (deficit)

   

15,709,891

   


52


UBS U.S. Allocation Fund

Notes to financial statements

There were no reclassifications arising from permanent "book/tax" differences for the period ended August 31, 2022.

Net capital losses recognized by the Fund may be carried forward indefinitely, and retain their character as short-term and/or long-term losses.

At August 31, 2022, the Fund had no net capital loss carryforward.

ASC 740-10 "Income Taxes—Overall" sets forth a minimum threshold for financial statement recognition of the benefit of a tax position taken or expected to be taken. The Fund has analyzed as of August 31, 2022 that there are no significant uncertain tax positions taken or expected to be taken that would require recognition in financial statements. The Fund recognizes interest and penalties, if any, related to uncertain tax positions as income tax expense in the Statement of operations. During the year ended August 31, 2022, the Fund did not incur any interest or penalties.

Under the applicable foreign tax laws, gains on certain securities held in certain foreign countries may be subject to taxes that will be paid by the Fund.

Each of the tax years in the four year period ended August 31, 2022, remains subject to examination by the Internal Revenue Service and state taxing authorities.


53


UBS U.S. Allocation Fund

Report of independent registered public accounting firm

To the Shareholders and Board of Trustees of
UBS U.S. Allocation Fund

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities of UBS U.S. Allocation Fund (the "Fund") (the sole fund constituting UBS Investment Trust (the "Trust")), including the portfolio of investments, as of August 31, 2022, and the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund (the sole fund constituting UBS Investment Trust) at August 31, 2022, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended and its financial highlights for each of the five years in the period then ended, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These financial statements are the responsibility of the Trust's management. Our responsibility is to express an opinion on the Fund's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Trust in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Trust is not required to have, nor were we engaged to perform, an audit of the Trust's internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Trust's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of August 31, 2022, by correspondence with the custodian, brokers and others; when replies were not received from brokers, we performed other auditing procedures. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

We have served as the auditor of one or more UBS investment companies since 1978.

New York, New York
October 28, 2022


54


UBS U.S. Allocation Fund

Tax information (unaudited)

We are required by Subchapter M of the Internal Revenue Code of 1986, as amended, to advise you as to the federal tax status of distributions received by shareholders during the fiscal year. Accordingly, the amount of ordinary dividends paid that qualify for the dividends received deduction for corporate shareholders and long-term capital gains are $1,343,593 and $24,548,966, respectively.

For the taxable period ended August 31, 2022, the Fund designates $1,423,769 as the maximum amount that may be considered qualified dividend income for individual shareholders.

Dividends received by tax-exempt recipients (e.g., IRAs and Keoghs) need not be reported as taxable income. Some retirement trusts (e.g., corporate, Keogh and 403(b)(7) plans) may need this information for their annual information reporting.

Shareholders should not use the above information to prepare their tax returns. Since the Fund's fiscal year is not the calendar year, another notification will be sent with respect to calendar year 2022. Such notification, which will reflect the amount to be used by calendar year taxpayers on their federal income tax returns, will be made in conjunction with Form 1099 DIV and will be mailed in February 2023. Shareholders are advised to consult their own tax advisers with respect to the tax consequences of their investment in each of the Fund.


55


UBS U.S. Allocation Fund

General information (unaudited)

Monthly and quarterly portfolio holdings disclosure

The Fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission ("SEC") for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund's Form N-PORT reports are available on the SEC's Web site at http://www.sec.gov. Additionally, you may obtain copies of Form N-PORT for the first and third quarters of each fiscal year from the Fund upon request by calling 1-800-647 1568.

Proxy voting policies, procedures and record

You may obtain a description of the Fund's (1) proxy voting policies, (2) proxy voting procedures and (3) information regarding how the Fund voted any proxies related to portfolio securities during the most recent 12-month period ended June 30 for which an SEC filing has been made, without charge, upon request by contacting the Fund directly at 1-800-647 1568, online on the Fund's Web site: www.ubs.com/ubsam-proxy, or on the EDGAR Database on the SEC's Web site (http://www.sec.gov).

Liquidity Risk Management Program

Pursuant to Rule 22e-4 under the 1940 Act, UBS Investment Trust (the "Trust") has adopted a liquidity risk management program (the "program") with respect to its series, UBS U.S. Allocation Fund (the "Fund").

UBS Asset Management (Americas) Inc. ("UBS AM") has been designated by the Trust's Board to administer the program, and UBS AM has delegated the responsibility to carry out certain functions described in the program to an internal group which is comprised of representatives of various investment and non-investment areas of the firm. Liquidity risk is defined as the risk that the Fund could not meet redemption requests without significant dilution of remaining shareholders' interests. The program is intended to provide a framework for the assessment, management and periodic review of the Fund's liquidity risks, taking into consideration, as applicable, the Fund's investment strategy and liquidity of portfolio investments during both normal and reasonably foreseeable stressed conditions; short-term and long-term cash flow projections during both normal and reasonably foreseeable stressed conditions; and holdings of cash and cash equivalents, as well as borrowing arrangements and other funding sources. The provisions of the program shall be administered for the Fund in a manner that is appropriately tailored to reflect the Fund's particular liquidity risks. UBS AM's process of determining the degree of liquidity of a Fund's investments is supported by a third-party liquidity assessment vendor. In May 2022, UBS AM provided the Board with a report addressing the operation of the program and assessing its adequacy and effectiveness of implementation (the "report"). The report covered the period from May 2, 2021 through May 1, 2022.

UBS AM's report concluded that the program was reasonably designed to assess and manage the Fund's liquidity risk, including during periods of market volatility and net redemptions. UBS AM reported that the program operated adequately and has been implemented effectively to assess and manage the Fund's liquidity risk.

There can be no assurance that the program will achieve its objectives in the future. Please refer to the Fund's prospectus for more information regarding the Fund's exposure to liquidity risk and other risks to which an investment in the Fund may be subject.


56


UBS U.S. Allocation Fund

Board approval of investment advisory and administration agreement (unaudited)

Background—At a meeting of the board of UBS Investment Trust (the "Trust") on July 19-20, 2022, the members of the board, including the trustees who are not "interested persons," as defined in the Investment Company Act of 1940, as amended, of the Trust ("Independent Trustees"), considered and approved the continuance of the investment advisory and administration contract (the "Investment Advisory and Administration Contract") of the Trust with respect to its series, UBS U.S. Allocation Fund (the "Fund"), with UBS Asset Management (Americas) Inc. ("UBS AM"). In preparing for the meeting, the Independent Trustees had requested and received extensive information from UBS AM to assist them, including information about UBS AM, as well as the advisory, administrative and distribution arrangements for the Fund. The board reviewed and discussed with management the materials initially provided by UBS AM prior to the scheduled board meeting. The Independent Trustees also met in executive session to review the disclosure that had been made to them. At these sessions the Independent Trustees were joined by their independent legal counsel. The Independent Trustees also received a memorandum from their independent legal counsel discussing the duties of board members in considering the approval of advisory, administration and distribution agreements.

In its consideration of the approval of the Investment Advisory and Administration Contract, the board reviewed the following factors:

Nature, extent and quality of the services under the Investment Advisory and Administration Contract—The board received and considered information regarding the nature, extent and quality of advisory services provided to the Fund by UBS AM under the Investment Advisory and Administration Contract during the past year. The board also considered the nature, extent and quality of administrative, distribution and shareholder services performed by UBS AM and its affiliates for the Fund and the resources devoted to, and the record of compliance with, the Fund's compliance policies and procedures. The board noted that it received information at regular meetings throughout the year regarding the services rendered by UBS AM concerning the management of the Fund's affairs and UBS AM's role in coordinating and overseeing providers of other services to the Fund. The board's evaluation of the services provided by UBS AM took into account the board's knowledge and familiarity gained as board members of funds in the UBS New York fund complex, including the scope and quality of UBS AM's investment advisory and other capabilities and the quality of its administrative and other services. The board observed that the scope of services provided by UBS AM had expanded over time as a result of regulatory and other developments, including maintaining and monitoring its own and the Fund's expanded compliance programs.

The board had available to it the qualifications, backgrounds and responsibilities of the senior personnel at UBS AM responsible for the Fund and had previously received information regarding the persons primarily responsible for the day-to-day management of the Fund. The board recognized that several senior personnel at UBS AM report to the board regularly and that at each regular meeting the board receives a detailed report from UBS AM on the Fund's performance. The board also considered, based on its knowledge of UBS AM and its affiliates, the financial resources available to UBS AM and its parent organization, UBS Group AG. In that regard, the board received extensive financial information regarding UBS AM and noted that it was a wholly owned, indirect subsidiary of one of the largest financial services firms in the world. It also was noted that UBS AM had approximately $290.6 billion in assets under management as of March 31, 2022 and was part of the UBS Asset Management Division, which had approximately $1.2 trillion in assets under management worldwide as of March 31, 2022. The board also was cognizant of, and considered, the regulatory and litigation actions and investigations occurring in the past few years involving UBS Group AG, UBS AM and certain of their affiliates.

The board concluded that, overall, it was satisfied with the nature, extent and quality of services provided (and expected to be provided) to the Fund under the Investment Advisory and Administration Contract.

Advisory fees and expense ratios—The board reviewed and considered the contractual management fee (the "Contractual Management Fee") payable by the Fund to UBS AM in light of the nature, extent and quality of the advisory and administrative services provided by UBS AM. The board also reviewed and considered the written


57


UBS U.S. Allocation Fund

Board approval of investment advisory and administration agreement (unaudited)

agreement between UBS AM and the Fund, which is separate from the Investment Advisory and Administration Contract, whereby UBS AM has agreed to permanently reduce its management fee based on the Fund's average daily net assets, which is discussed in more detail in the "Economies of scale" section, and considered the actual fee rate (after taking this agreement into account) (the "Actual Management Fee"). Additionally, the board received and considered information comparing the Fund's Contractual Management Fee, Actual Management Fee and total expenses with those of funds in a group of funds selected and provided by Broadridge, an independent provider of investment company data (the "Expense Group").

The comparative Broadridge information showed that the Fund's Contractual Management Fee, Actual Management Fee and total expenses were below the respective medians in the Fund's Expense Group for the comparison periods utilized in the Broadridge report. (Below median fees or expenses represent fees or expenses that are lower relative to the median, and above median fees or expenses represent fees or expenses that are higher relative to the median of the funds in the Expense Group.)

In light of the foregoing, the board determined that the management fee continued to be appropriate under the circumstances and in light of the nature, extent and quality of services provided to the Fund under the Investment Advisory and Administration Contract

Fund performance—The board received and considered (a) annualized total return information of the Fund compared to other funds (the "Performance Universe") selected by Broadridge over the one-, three-, five-, ten-year and since inception periods ended April 30, 2022 and (b) annualized performance information for each year in the ten-year period ended April 30, 2022. Although the board received information for the ten-year and since inception periods, in its analysis, it generally placed greater emphasis on the one-, three- and five-year periods. The board was provided with a description of the methodology Broadridge used to determine the similarity of the Fund with the funds included in its Performance Universe. The board also noted that it had received information throughout the year at periodic intervals with respect to the Fund's performance, including with respect to its benchmark index.

The comparative Broadridge information showed that the Fund's performance was above the median for all comparative periods. (Below median performance represents performance that is worse relative to the median, and above median performance represents performance that is better relative to the median.) Based on its review, the board concluded that the Fund's investment performance was acceptable.

Advisor profitability—The board received and considered a profitability analysis of UBS AM and its affiliates in providing services to the Fund and was provided information on UBS AM's expense allocation methodology. The board also received profitability information with respect to the UBS New York fund complex as a whole. The board observed that the profitability and expense analyses are substantially similar to those used by UBS AM for many internal purposes, and are subject to regular review with respect to how certain revenue and expenses should be allocated. UBS AM's profitability was considered not excessive in light of the nature, extent and quality of the services provided to the Fund.

Economies of scale—The board received and considered information from management regarding whether UBS AM realized economies of scale as the Fund's assets grew, whether the Fund has appropriately benefited from any material economies of scale, and whether there is potential for realization of any further material economies of scale for the Fund. The board considered whether economies of scale in the provision of services to the Fund were being passed along to the shareholders. The board noted that the Fund's Contractual Management Fee contained a single breakpoint and that the Fund's assets were above the breakpoint as of April 30, 2022.

While the Fund's Contractual Management Fee contained a single breakpoint, the board recognized that the Fund had entered into a separate agreement with UBS AM, whereby UBS AM agreed to permanently reduce its Contractual Management Fee at higher asset levels by utilizing several additional breakpoints based on the Fund's


58


UBS U.S. Allocation Fund

Board approval of investment advisory and administration agreement (unaudited)

average daily net assets, thereby achieving the same effect as if the Contractual Management Fee contained multiple breakpoints.

Generally, in light of UBS AM's profitability data, the Actual Management Fee, Contractual Management Fee, the breakpoints currently in place for the Fund and the current assets of the Fund, the board believed that UBS AM's arrangement for sharing economies of scale with the Fund was acceptable.

Other benefits to UBS AM—The board considered other benefits received by UBS AM and its affiliates as a result of its relationship with the Fund, including the opportunity to offer additional products and services to Fund shareholders. In light of the costs of providing investment advisory, administrative and other services to the Fund and UBS AM's ongoing commitment to the Fund, the profits and other ancillary benefits that UBS AM and its affiliates received were considered reasonable.

In light of all of the foregoing, the board, including a majority of the Independent Trustees, approved the Investment Advisory and Administration Contract. No single factor reviewed by the board was identified by the board as the principal factor in determining whether to approve the Investment Advisory and Administration Contract. The Independent Trustees were advised by separate independent legal counsel throughout the process. The board discussed the proposed continuance of the Investment Advisory and Administration Contract in private sessions with its independent legal counsel at which no representatives of UBS AM were present.


59


UBS U.S. Allocation Fund

Supplemental information (unaudited)

Board of Trustees & Officers

The Trust is governed by a Board of Trustees which oversees the Fund's operations. Each trustee serves an indefinite term of office. Officers are appointed by the trustees and serve at the pleasure of the Board. The table below shows, for each trustee and officer, his or her name, address and age, the position held with the Trust, the length of time served as a trustee or officer of the Trust, the trustee's or officer's principal occupations during the last five years, the number of portfolios in the UBS fund complex overseen by the trustee or for which a person served as an officer, and other directorships held by the trustee.

The Fund's Statement of Additional Information contains additional information about the trustees and is available, without charge, upon request by calling 1-800-647 1568.

Independent Trustees:

Name,
address,
and age
  Position(s)
held with
Trust
  Term of office1
and length of
time served
  Principal
occupation(s)
during past
5 years
  Number of
portfolios in fund
complex overseen
by Trustee
  Other
directorships
held by
Trustee
 
Alan S. Bernikow;
81
K2 Integrity
845 Third Avenue
New York, NY
 

Trustee and Chairman of the Board of Trustees

 

Since 2005 (Trustee); Since 2022 (Chairman of the Board of Trustees)

 

Mr. Bernikow is retired. Previously, he was deputy chief executive officer at Deloitte & Touche (international accounting and consulting firm). From 2003 to 2017, Mr. Bernikow was also a director of Destination XL Group, Inc. (menswear) (and served as a member of its nominating and corporate governance committee).

 

Mr. Bernikow is a trustee of 4 investment companies (consisting of 44 portfolios) for which UBS AM serves as investment advisor or manager.

 

Mr. Bernikow is also a director of Revlon, Inc. (cosmetics) (and serves as the chair of its audit committee and as the chair of the compensation committee), the lead director of Mack-Cali Realty Corporation (real estate investment trust) (and serves as the chair of its audit committee).

 
Richard R. Burt;
75
McLarty Associates
900 17th Street 8th Floor
Washington, D.C. 20006
 

Trustee

 

Since 2001

 

Mr. Burt is a managing partner of McLarty Associates (a consulting firm) (since 2007). He was chairman of IEP Advisors (international investments and consulting firm) until 2009.

 

Mr. Burt is a trustee of 4 investment companies (consisting of 44 portfolios) for which UBS AM serves as investment advisor or manager.

 

Mr. Burt is also a director of The Central Europe, Russia and Turkey Fund, Inc., The European Equity Fund, Inc. and The New Germany Fund, Inc. (and serves as a member of each such fund's audit, nominating and governance committee).

 
Bernard H. Garil;
82
6754 Casa Grande Way Delray Beach, FL 33446
 

Trustee

 

Since 2005

 

Mr. Garil is retired (since 2001). He was a managing director at PIMCO Advisory Services (from 1999 to 2001) where he served as president of closed-end funds and vice-president of the variable insurance product funds advised by OpCap Advisors (until 2001).

 

Mr. Garil is a trustee of 4 investment companies (consisting of 44 portfolios) for which UBS AM serves as investment advisor or manager.

 

Mr. Garil is a trustee for the Brooklyn College Foundation, Inc. (charitable foundation).

 


60


UBS U.S. Allocation Fund

Supplemental information (unaudited)

Independent Trustees (concluded):

Name,
address,
and age
  Position(s)
held with
Trust
  Term of office1
and length of
time served
  Principal
occupation(s)
during past
5 years
  Number of
portfolios in fund
complex overseen
by Trustee
  Other
directorships
held by
Trustee
 
Heather R. Higgins;
63
c/o Keith A. Weller
Fund Secretary
UBS Asset Management
(Americas) Inc.
One North Wacker Drive
Chicago, IL 60606
 

Trustee

 

Since 2005

  Mrs. Higgins is the president and director of The Randolph Foundation (charitable foundation) (since 1991). Mrs.. Higgins also serves (or has served) on the boards of several non-profit charitable groups, including the Independent Women's Forum (chairman) and the Philanthropy Roundtable (vice chairman). She also serves on the board of the Hoover Institution (from 2001 to 2007
and since 2009).
 

Mrs.. Higgins is a trustee of 7 investment companies (consisting of 47 portfolios) for which UBS AM or one of its affiliates serves as investment advisor or manager.

 

None

 


61


UBS U.S. Allocation Fund

Supplemental information (unaudited)

Officers:

Name,
address
and age
  Position(s)
held with
Trust
  Term of office1
and length of
time served
  Principal occupation(s) during past 5 years;
number of portfolios in fund complex
for which person serves as officer
 
Rose Ann Bubloski***;
54
 

Vice President and Assistant Treasurer

 

Since 2011

 

Ms. Bubloski is a director (since 2012) (prior to which she was an associate director (from 2008 to 2012)) and a senior manager of fund accounting—US (previously named product control and investment support) of UBS AM and/or UBS AM (US) ("UBS AM—Americas region"). Ms. Bubloski is vice president and assistant treasurer of 7 investment companies (consisting of 56 portfolios) for which UBS AM serves as investment advisor or manager.

 
Franklin P. Dickson***;
44
 

Vice President

 

Since 2017

 

Mr. Dickson is an associate director (since 2015) and tax compliance manager (since 2017) (prior to which he was a product controller (from 2015 to 2017) of fund accounting—US (previously named product control and investment support) of UBS AM—Americas region. Mr. Dickson is a vice president of 7 investment companies (consisting of 56 portfolios) for which UBS AM serves as investment advisor or manager.

 
Mark F. Kemper*;
64
 

Vice President and Assistant Secretary

 

Since 1999 and 2019, respectively

 

Mr. Kemper is a managing director (since 2006) and general counsel (2004 through 2019 and September 2021 to present) (prior to which he was senior legal counsel (2019 — 2020 and April 2021 to September 2021), Interim Head of Asia Pacific Legal (2020 through 2021) and Interim head of Compliance and Operational Risk Control (2019) of UBS AM—Americas region. He has been assistant secretary of UBS AM—Americas region since January 2022 (prior to which he was secretary (from 2004 until January 2022) and assistant secretary of UBS Asset Management Trust Company (since 1993). Mr. Kemper is vice president and assistant secretary of 7 investment companies (consisting of 56 portfolios) for which UBS AM serves as investment advisor or manager. Mr. Kemper is employed by UBS Business Solutions US LLC (since 2017).

 
Joanne M. Kilkeary***;
54
 

Vice President, Treasurer and Principal Accounting Officer

 

Since 1999 (Vice President); since 2017 (Treasurer and Principal Accounting Officer)

 

Ms. Kilkeary is an executive director (since 2013) (prior to which she was a director (from 2008 to 2013)) and head of regulatory, tax, audit and board governance for product control and investment support (from 2017 until 2020) (prior to which she was a senior manager of registered fund product control of UBS AM—Americas region (from 2004 to 2017)). Ms. Kilkeary is a vice president and assistant treasurer of 7 investment companies (consisting of 56 portfolios) for which UBS AM serves as investment advisor or manager.

 
Igor Lasun**;
43
 

President

 

Since 2018

 

Mr. Lasun is a managing director (since 2021) (prior to which he was an executive director (from 2018 until 2021)) and head of product development and management for UBS AM—Americas region (since 2018) (prior to which he was a senior fixed income product specialist from 2007 to 2018, and had joined the firm in 2005). In this role, he oversees development and management for both wholesale and institutional businesses. Mr. Lasun serves as president of 7 investment companies (consisting of 56 portfolios) for which UBS AM serves as investment advisor or manager.

 
Leesa Merrill*,
43
 

Chief Compliance Officer

 

Since May 2022

 

Ms. Merrill is a director (since 2014) and served as head of compliance risk (from 2020 to 2022) (prior to which she was a senior compliance officer (from 2004 until 2020) for UBS AM—Americas region. Ms. Merrill serves as chief compliance officer of 6 investment companies (consisting of 56 portfolios) for which UBS AM or one of its affiliates serves as investment advisor or manager.

 
Eric Sanders*;
57
 

Vice President and Assistant Secretary

 

Since 2005

 

Mr. Sanders is a director and associate general counsel with UBS Business Solutions US LLC (since 2017) and also with UBS AM—Americas region (since 2005). Mr. Sanders is a vice president and assistant secretary of 7 investment companies (consisting of 56 portfolios) for which UBS AM serves as investment advisor or manager.

 


62


UBS U.S. Allocation Fund

Supplemental information (unaudited)

Officers (concluded):

Name,
address
and age
  Position(s)
held with
Trust
  Term of office1
and length of
time served
  Principal occupation(s) during past 5 years;
number of portfolios in fund complex
for which person serves as officer
 
Philip Stacey*;
37
 

Vice President and Assistant Secretary

 

Since 2018

 

Mr. Stacey is an executive director (since 2019) (prior to which he was a director from 2015 to 2019) and associate general counsel with UBS Business Solutions US LLC (since 2017) and also with UBS AM—Americas region since 2015. Mr. Stacey is a vice president and assistant secretary of 7 investment companies (consisting of 56 portfolios) for which UBS AM serves as investment advisor or manager.

 
Keith A. Weller*;
61
 

Vice President and Secretary

 

Since 2000 and 2019, respectively

 

Mr. Weller is an executive director (since 2017), deputy general counsel (since 2019) and Head of Registered Funds Legal (since 2022) (prior to which he was senior associate general counsel) with UBS Business Solutions US LLC (since 2017) and also with UBS AM—Americas region (since 2005) and has been an attorney with affiliated entities since 1995. Mr. Weller is a vice president and secretary of 7 investment companies (consisting of 56 portfolios) for which UBS AM serves as investment advisor or manager, and is also involved with other funds for which UBS AM or an affiliate serves as investment advisor or administrator.

 

1  Each trustee holds office for an indefinite term. Officers are appointed by the trustees and serve at the pleasure of the Board.

*  This person's business address is One North Wacker Drive, Chicago, Illinois 60606.

**  This person's business address is 787 Seventh Avenue, New York, New York 10019.

***  This person's business address is 1000 Harbor Boulevard, Weehawken, New Jersey 07086.


63


Trustees

Alan S. Bernikow
Chairman

Richard R. Burt

Bernard H. Garil

Heather R. Higgins

Investment Manager and
Administrator

UBS Asset Management (Americas) Inc.
787 Seventh Avenue
New York, New York 10019

Principal Underwriter

UBS Asset Management (US) Inc.
787 Seventh Avenue
New York, New York 10019

This report is not to be used in connection with the offering of shares of the Portfolio unless accompanied or preceded by an effective prospectus.

©UBS 2022. All rights reserved.
UBS Asset Management (Americas) Inc.


PRESORTED
STANDARD
U.S. POSTAGE
PAID
COMPUTERSHARE

UBS Asset Management (Americas) Inc.

787 Seventh Avenue

New York, NY 10019

S049


  

(b)Copy of each notice transmitted to shareholders in reliance on Rule 30e-3 under the Investment Company Act of 1940, as amended (the "1940 Act"), that contains disclosures specified by paragraph (c)(3) of that rule: Not applicable to the registrant.

  

Item 2. Code of Ethics.

 

The registrant has adopted a code of ethics that applies to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions pursuant to Section 406 of the Sarbanes-Oxley Act of 2002. (The registrant has designated the code of ethics adopted pursuant to Sarbanes-Oxley as a “Code of Conduct” to lessen the risk of confusion with its separate code of ethics adopted pursuant to Rule 17j-1 under the 1940 Act.).

 

Item 3. Audit Committee Financial Expert.

 

The registrant’s Board has determined that the following person serving on the registrant’s Audit Committee is an “audit committee financial expert” as defined in item 3 of Form N-CSR: Alan S. Bernikow. Mr. Bernikow is independent as defined in item 3 of Form N-CSR.

 

Item 4. Principal Accountant Fees and Services. 

 

(a)Audit Fees:

 

For the fiscal years ended August 31, 2022 and August 31, 2021, the aggregate Ernst & Young LLP (E&Y) audit fees for professional services rendered to the registrant were approximately $73,107 and $73,107, respectively.

 

Fees included in the audit fees category are those associated with the annual audits of financial statements and services that are normally provided in connection with statutory and regulatory filings.

 

(b)Audit-Related Fees:

 

In each of the fiscal years ended August 31, 2022 and August 31, 2021, the aggregate audit-related fees billed by EY for services rendered to the registrant that are reasonably related to the performance of the audits of the financial statements, but not reported as audit fees, were approximately $2,910 and $2,910, respectively.

 

Fees included in the audit-related fees category are those associated with the reading and providing of comments on the 2022 and 2021 semiannual financial statements.

 

 

 

 

There were no audit-related fees required to be approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X during the fiscal years indicated above.

 

(c)Tax Fees:

 

In each of the fiscal years ended August 31, 2022 and August 31, 2021, the aggregate tax fees billed by EY for professional services rendered to the registrant were approximately $12,975 and $12,964, respectively.

 

Fees included in the tax fees category comprise all services performed by professional staff in the independent accountant’s tax division except those services related to the audits. This category comprises fees for review of tax compliance, tax return preparation and excise tax calculations.

 

There were no tax fees required to be approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X during the fiscal years indicated above.

 

(d)All Other Fees:

 

In each of the fiscal years ended August 31, 2022 and August 31, 2021, there were no fees billed by EY for products and services, other than the services reported in Item 4(a)-(c) above, rendered to the registrant.

 

Fees included in the all other fees category would consist of services related to internal control reviews, strategy and other consulting, financial information systems design and implementation, consulting on other information systems, and other tax services unrelated to the registrant.

 

There were no “all other fees” required to be approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X during the fiscal years indicated above.

 

(e)(1) Audit Committee Pre-Approval Policies and Procedures:

 

The registrant’s Audit Committee (“audit committee”) has adopted an “Audit Committee Charter (Amended and Restated as of September 14, 2016)” (the “charter”). The charter contains the audit committee’s pre-approval policies and procedures. Reproduced below is an excerpt from the charter regarding pre-approval policies and procedures:

 

The [audit] Committee shall:

 

… 

 

2.Pre-approve (a) all audit and permissible non-audit services1 to be provided to the Fund and (b) all permissible non-audit services to be provided by the Fund’s independent auditors to UBS AM and any Covered Service Providers, if the engagement relates directly to the operations and financial reporting of the Fund. In carrying out this responsibility, the Committee shall seek periodically from UBS AM and from the independent auditors a list of such audit and permissible non-audit services that can be expected to be rendered to the Fund, UBS AM or any Covered Service Providers by the Fund’s independent auditors, and an estimate of the fees sought to be paid in connection with such services. The Committee has delegated its responsibility to pre-approve any such audit and permissible non-audit services not exceeding $100,000 (excluding reasonable out-of-pocket expenses) on an annual basis to the Chairperson. All such pre-approvals will be reported to the full Committee on a quarterly basis at the Committee’s next regularly scheduled meeting after the pre-approval. The Committee may not delegate to management its responsibility to pre-approve services to be performed by the independent auditor. Requests or applications to provide services that require specific pre-approval by the Committee or the Chairperson will be submitted by both the Fund’s independent auditors and the Fund’s Treasurer or other designated Fund officer and must include a joint statement as to whether, in their view, the request or application is consistent with SEC rules on auditor independence. From year to year, the Committee shall report to the Board whether this system of pre-approval has been effective and efficient or whether this Charter should be amended to allow for pre-approval pursuant to such policies and procedures as the Committee shall approve, including the delegation of some or all of the Committee’s pre-approval responsibilities to other persons (other than UBS AM or the Fund’s officers).

 

 

 

1 The Committee will not approve non-audit services that the Committee believes may taint the independence of the auditors. Currently, permissible non-audit services include any professional services (including tax services) that are not prohibited services as described below, provided to the Fund by the independent auditors, other than those provided to the Fund in connection with an audit or a review of the financial statements of the Fund. Permissible non-audit services may not include: (i) bookkeeping or other services related to the accounting records or financial statements of the Fund; (ii) financial information systems design and implementation; (iii) appraisal or valuation services, fairness opinions or contribution-in-kind reports; (iv) actuarial services; (v) internal audit outsourcing services; (vi) management functions or human resources; (vii) broker or dealer, investment adviser or investment banking services; (viii) legal services and expert services unrelated to the audit; and (ix) any other service the Public Company Accounting Oversight Board determines, by regulation, is impermissible.

 

Pre-approval by the Committee of any permissible non-audit services is not required so long as: (i) the aggregate amount of all such permissible non-audit services provided to the Fund, UBS AM and any service providers controlling, controlled by or under common control with UBS AM that provide ongoing services to the Fund (“Covered Service Providers”) constitutes not more than 5% of the total amount of revenues paid to the independent auditors (during the fiscal year in which the permissible non-audit services are provided) by (a) the Fund, (b) its investment adviser and (c) any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the Fund during the fiscal year in which the services are provided that would have to be approved by the Committee; (ii) the permissible non-audit services were not recognized by the Fund at the time of the engagement to be non-audit services; and (iii) such services are promptly brought to the attention of the Committee and approved by the Committee (or its delegate(s)) prior to the completion of the audit.

 

 

 

  

(e) (2)   Services approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X: 

 

Audit-Related Fees:

 

There were no amounts that were approved by the audit committee pursuant to the de minimis exception for the fiscal years ended August 31, 2022 and August 31, 2021 on behalf of the registrant.

 

There were no amounts that were required to be approved by the audit committee pursuant to the de minimis exception for the fiscal years ended August 31, 2022 and August 31, 2021 on behalf of the registrant’s service providers that relate directly to the operations and financial reporting of the registrant.

 

Tax Fees:

 

There were no amounts that were approved by the audit committee pursuant to the de minimis exception for the fiscal years ended August 31, 2022 and August 31, 2021 on behalf of the registrant.

 

There were no amounts that were required to be approved by the audit committee pursuant to the de minimis exception for the fiscal years ended August 31, 2022 and August 31, 2021 on behalf of the registrant’s service providers that relate directly to the operations and financial reporting of the registrant.

 

All Other Fees:

 

There were no amounts that were approved by the audit committee pursuant to the de minimis exception for the fiscal years ended August 31, 2022 and August 31, 2021 on behalf of the registrant.

 

There were no amounts that were required to be approved by the audit committee pursuant to the de minimis exception for the fiscal years ended August 31, 2022 and August 31, 2021 on behalf of the registrant’s service providers that relate directly to the operations and financial reporting of the registrant.

 

(f)For the fiscal year ended August 31, 2022, if greater than 50%, specify the percentage of hours spent on the audit of the registrant’s financial statements for the most recent fiscal year that were attributed to work performed by persons who are not full-time, permanent employees of E&Y. According to E&Y, such amount was below 50%; therefore, disclosure item not applicable for this filing.

 

(g)For the fiscal years ended August 31, 2022 and August 31, 2021, the aggregate fees billed by EY of $588,825 and $200,614, respectively, for non-audit services rendered on behalf of the registrant (“covered”), its investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser) and any entity controlling, controlled by, or under common control with the adviser (“non-covered”) that provides ongoing services to the registrant for each of the last two fiscal years of the registrant is shown in the table below:

 

 

 

 

   2022   2021 
Covered Services  $15,885   $15,874 
Non-Covered Services  $572,940   $184,740 

 

(h)The registrant’s audit committee was not required to consider whether the provision of non-audit services that were rendered to the registrant’s investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant’s independence.

 

(i)Not applicable to the registrant.

 

(j)Not applicable to the registrant.

 

Item 5. Audit Committee of Listed Registrants.

 

Not applicable to the registrant. 

 

Item 6. Investments.

 

(a)Included as part of the report to shareholders filed under Item 1 of this form.

 

(b)Not applicable.

 

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

 

Not applicable to the registrant.

 

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

 

Not applicable to the registrant.

 

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

 

Not applicable to the registrant. 

 

Item 10. Submission of Matters to a Vote of Security Holders.

 

The registrant’s Board has established a Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee will consider nominees recommended by shareholders if a vacancy occurs among those board members who are not “interested persons” as defined in Section 2(a)(19) of the Investment Company Act of 1940, as amended. In order to recommend a nominee, a shareholder should send a letter to the chairperson of the Nominating and Corporate Governance Committee, Richard R. Burt, care of the Secretary of the registrant at UBS Asset Management, UBS Building, One North Wacker Drive, Chicago, IL 60606, Attn: Keith A. Weller, Secretary, and indicate on the envelope “Nominating and Corporate Governance Committee.” The shareholder’s letter should state the nominee’s name and should include the nominee’s resume or curriculum vitae, and must be accompanied by a written consent of the individual to stand for election if nominated for the Board and to serve if elected by shareholders.

 

 

 

 

Item 11. Controls and Procedures.

 

(a)The registrant’s principal executive officer and principal financial officer have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended) are effective based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this document.

 

(b)The registrant’s principal executive officer and principal financial officer are aware of no changes in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

  

Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

 

Not applicable to the registrant

 

Item 13. Exhibits.

 

(a)(1) Code of Ethics as required pursuant to Section 406 of the Sarbanes-Oxley Act of 2002 (and designated by registrant as a “Code of Conduct”) is filed herewith as Exhibit EX-99.CODE ETH.

 

(a)(2) Certifications of principal executive officer and principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto as Exhibit EX-99.CERT.

 

(a)(3) Written solicitation to purchase securities under Rule 23c-1 under the Investment Company Act of 1940 sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons – not applicable to the registrant.

 

  (a) (4) Change in the registrant’s independent public accountant – Not applicable to the registrant

  

(b)Certifications of principal executive officer and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto as Exhibit EX-99.906CERT.

 

(c)Disclosure pursuant to Section 13(r) of the Securities Exchange Act of 1934, as amended, is attached hereto as Exhibit EX-99.IRANNOTICE.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

UBS Investment Trust

 

By: /s/ Igor Lasun  
  Igor Lasun  
  President  

 

Date:     November 7, 2022 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By: /s/ Igor Lasun  
  Igor Lasun  
  President  

  

Date:    November 7, 2022

 

By: /s/ Joanne M. Kilkeary  
  Joanne M. Kilkeary  
  Vice President, Treasurer and Principal Accounting Officer  

  

Date:     November 7, 2022